https://drug.russellpublishing.co.uk/news/466/domain-therapeutics-enters-collaboration-xoma/2021-04-30T09:06:45+01:00https://drug.russellpublishing.co.uk/news/469/amgen-merck-announce-collaboration-evaluate-investigational-combination-treatment-advanced-melanoma/2018-06-29T14:24:38+01:00https://drug.russellpublishing.co.uk/news/472/pfizer-merck-collaborate-innovative-anti-cancer-combination-studies/2018-06-29T14:23:47+01:00https://drug.russellpublishing.co.uk/news/546/merck-samsung-bioepis-enter-collaboration-agreement-develop-commercialize-insulin-glargine-candidate-diabetes/2018-06-29T14:22:33+01:00https://drug.russellpublishing.co.uk/news/556/ebisc-first-european-bank-induced-pluripotent-stem-cells/2017-01-10T15:18:32+00:00https://drug.russellpublishing.co.uk/news/559/gsk-announces-start-phase-lll-study-mepolizumab-patients-eosinophilic-granulomatosis-polyangiitis/2017-01-10T15:11:34+00:00https://drug.russellpublishing.co.uk/news/562/daiichi-sankyo-umn-pharma-enter-collaborative-research-agreement-norovirus-vaccine/2017-01-10T15:09:46+00:00https://drug.russellpublishing.co.uk/news/569/novartis-expands-cancer-immunotherapy-research-program-acquisition-costim/2017-01-10T15:08:33+00:00https://drug.russellpublishing.co.uk/news/614/promega-interviewed-slas-2014/2017-01-06T09:26:51+00:00https://drug.russellpublishing.co.uk/news/661/roche-provides-update-phase-iii-study-onartuzumab-people-specific-type-lung-cancer/2017-01-10T15:05:25+00:00https://drug.russellpublishing.co.uk/news/663/new-phase-iii-data-show-tiotropium-respimat-effective-across-asthma-severities/2017-01-10T14:57:01+00:00https://drug.russellpublishing.co.uk/news/674/eisai-biogen-idec-enter-collaboration-develop-commercialize-alzheimers-disease-treatments/2017-01-10T14:55:58+00:00https://drug.russellpublishing.co.uk/news/677/merck-announces-results-phase-2b-study-mk-8237-investigational-house-dust-mite-sublingual-allergen-immunotherapy-tablet/2018-06-29T14:21:49+01:00https://drug.russellpublishing.co.uk/news/680/roches-lebrikizumab-phase-iib-data-show-reduction-asthma-attack-rates-improvement-lung-function-adult-patients-severe-uncontrolled-asthma/2017-01-10T14:43:50+00:00https://drug.russellpublishing.co.uk/news/690/bristol-myers-squibb-presents-promising-phase-iib-data-novel-investigational-attachment-inhibitor-hiv-1-infected-treatment-experienced-patients/2017-01-19T10:23:54+00:00https://drug.russellpublishing.co.uk/news/693/novartis-announces-positive-phase-iii-study-jakavi-patients-rare-blood-cancer-polycythemia-vera/2017-01-10T14:42:52+00:00https://drug.russellpublishing.co.uk/news/720/sanofi-ucb-partner-breakthrough-innovation-immune-mediated-diseases/2017-01-10T14:40:53+00:00https://drug.russellpublishing.co.uk/news/722/bayer-and-onyx-report-phase-3-study-results-of-nexavar-sorafenib-as-adjuvant-treatment-for-patients-with-liver-cancer/2017-01-10T14:40:06+00:00https://drug.russellpublishing.co.uk/news/738/gsk-announces-positive-results-phase-iii-studies-mepolizumab-severe-eosinophilic-asthma/2017-01-10T14:39:36+00:00https://drug.russellpublishing.co.uk/news/770/five-prime-therapeutics-bristol-myers-squibb-sign-collaboration-agreement-discover-novel-immuno-oncology-therapies-two-immune-checkpoint-pathways/2017-01-10T14:37:44+00:00https://drug.russellpublishing.co.uk/news/772/amgen-announces-positive-top-line-results-phase-3-tesla-trial-evolocumab-patients-homozygous-familial-hypercholesterolemia/2017-01-10T14:36:41+00:00https://drug.russellpublishing.co.uk/news/774/astellas-pharma-daiichi-sankyo-form-compound-library-sharing-partnership/2017-01-10T14:38:47+00:00https://drug.russellpublishing.co.uk/news/776/sanofi-pasteur-allies-sk-chemical-co-south-korea-pneumococcal-conjugate-vaccine/2017-01-10T14:33:30+00:00https://drug.russellpublishing.co.uk/news/779/new-data-phase-3-attain-study-janssens-daily-simeprevir-compared-telaprevir-treatment-experienced-adult-patients-genotype-1-chronic-hepatitis-c/2017-01-10T14:32:32+00:00https://drug.russellpublishing.co.uk/news/781/abbvie-initiates-new-clinical-trial-evaluate-humira-adalimumab-treatment-fingernail-psoriasis/2017-01-10T14:23:56+00:00https://drug.russellpublishing.co.uk/news/786/investigational-mage-a3-antigen-specific-cancer-immunotherapeutic-meet-first-co-primary-endpoints-magrit-phase-iii-non-small-cell-lung-cancer-clinical-trial/2017-01-10T14:13:34+00:00https://drug.russellpublishing.co.uk/news/815/abbvie-present-detailed-results-phase-iii-studies-patients-chronic-hepatitis-c-2014-international-liver-congress/2017-01-10T14:12:48+00:00https://drug.russellpublishing.co.uk/news/863/pfizer-achieves-primary-endpoint-phase-3b-top-line-results-genotropin-young-children-born-small-gestational-age/2017-01-10T14:11:09+00:00https://drug.russellpublishing.co.uk/news/879/start-developing-new-medicine/2017-01-10T14:05:22+00:00https://drug.russellpublishing.co.uk/news/907/european-pharmaceutical-review-interviews-waters-pittcon-2014/2017-01-06T09:32:43+00:00https://drug.russellpublishing.co.uk/news/911/drug-target-review-interviews-tecan-pittcon-2014/2017-01-06T09:32:08+00:00https://drug.russellpublishing.co.uk/news/917/astrazeneca-mrc-enter-strategic-collaboration-create-new-centre-early-drug-discovery-cambridge-uk/2017-01-10T14:01:56+00:00https://drug.russellpublishing.co.uk/news/922/lundbeck-enter-partnership-world-renowned-research-institute/2017-01-10T14:00:30+00:00https://drug.russellpublishing.co.uk/news/928/daiichi-sankyo-uc-san-francisco-announce-collaboration-drug-discovery-research-neurodegenerative-diseases/2017-01-10T13:59:07+00:00https://drug.russellpublishing.co.uk/news/936/roche-acquires-iquum-strengthen-offerings-molecular-diagnostics/2017-01-10T13:58:16+00:00https://drug.russellpublishing.co.uk/news/938/ema-australian-regulator-strengthen-collaboration-area-orphan-medicines/2017-01-10T13:56:34+00:00https://drug.russellpublishing.co.uk/news/941/oncoethix-presents-phase-interim-results-novel-anticancer-compound-otx015-aacr-2014/2017-01-10T13:47:00+00:00https://drug.russellpublishing.co.uk/news/944/bristol-myers-squibb-presents-phase-iii-data-demonstrating-investigational-oral-daclatasvir-asunaprevir-therapy-achieved-svr12-rates-90/2017-01-10T13:42:04+00:00https://drug.russellpublishing.co.uk/news/955/pfizer-announces-positive-top-line-results-two-phase-3-trials-tofacitinib-adults-moderate-severe-chronic-plaque-psoriasis/2017-01-10T12:31:07+00:00https://drug.russellpublishing.co.uk/news/960/bristol-myers-squibb-samsung-biologics-expand-manufacturing-agreement/2017-01-10T12:28:42+00:00https://drug.russellpublishing.co.uk/news/972/hydra-biosciences-boehringer-ingelheim-announce-worldwide-collaboration-develop-small-molecule-inhibitors-treatment-central-nervous-system-diseases-disorders/2017-01-10T12:27:27+00:00https://drug.russellpublishing.co.uk/news/974/quintiles-biogen-idec-announce-comprehensive-%e2%80%a8clinical-development-partnership/2017-01-10T12:25:31+00:00https://drug.russellpublishing.co.uk/news/993/gsk-mmv-announce-start-phase-iii-programme-tafenoquine-plasmodium-vivax-malaria/2017-01-10T12:24:27+00:00https://drug.russellpublishing.co.uk/news/997/teva-and-oncogenex-announce-top-line-survival-results-of-phase-iii-synergy-trial-evaluating-custirsen-in-combination-with-first-line-docetaxel-and-prednisone/2017-01-10T12:22:32+00:00https://drug.russellpublishing.co.uk/news/1003/teva-reports-positive-results-from-pivotal-phase-iii-study-to-evaluate-hydrocodone-bitartrate-extended-release-tablets-cep-33237/2017-01-10T12:21:42+00:00https://drug.russellpublishing.co.uk/news/1005/johnson-johnson-announces-new-collaboration-stop-tb-partnerships-global-drug-facility-enhance-access-anti-tb-compound/2017-01-10T12:20:32+00:00https://drug.russellpublishing.co.uk/news/1008/fibrotech-acquired-shire-us75m-plus-milestones/2017-01-10T12:18:45+00:00https://drug.russellpublishing.co.uk/news/1013/merck-endocyte-announce-independent-dsmb-recommends-vintafolide-proceed-phase-3-trial-stopped-futility-following-interim-analysis/2018-06-29T14:20:54+01:00https://drug.russellpublishing.co.uk/news/1015/end-hepatitis-c/2018-01-08T11:19:42+00:00https://drug.russellpublishing.co.uk/news/1018/lundbeck-receives-grant-michael-j-fox-foundation-biological-markers-identification-parkinsons-disease/2017-01-10T12:16:29+00:00https://drug.russellpublishing.co.uk/news/1093/amgen-astrazeneca-announce-positive-results-phase-iii-study-brodalumab-amg-827-patients-moderate-severe-plaque-psoriasis/2017-01-10T12:15:53+00:00https://drug.russellpublishing.co.uk/news/1095/boehringer-ingelheim-will-make-detailed-clinical-trial-data-available-scientific-community/2017-01-10T12:12:30+00:00https://drug.russellpublishing.co.uk/news/1120/janssen-announces-expanded-collaboration-international-partnership-microbicides-development-commercialization-dapivirine-prevention-sexual-transmission-hiv/2017-01-19T10:23:26+00:00https://drug.russellpublishing.co.uk/news/1123/gsk-announces-phase-iii-study-darapladib-meet-primary-endpoint-patients-following-acute-coronary-syndrome/2017-01-10T12:08:56+00:00https://drug.russellpublishing.co.uk/news/1152/abbott-expands-latin-american-presence-branded-generics-portfolio-acquisition-cfr-pharmaceuticals/2017-01-10T12:07:07+00:00https://drug.russellpublishing.co.uk/news/1158/american-college-physicians-cecity-pfizer-collaborate-increase-adult-immunization-rates/2017-01-10T12:02:29+00:00https://drug.russellpublishing.co.uk/news/1160/pharma-rd-europe-summits-series-registration-closing/2017-01-10T12:01:33+00:00https://drug.russellpublishing.co.uk/news/1166/ipf-phase-iii-results-published-nejm-show-nintedanib-slows-disease-progression/2017-01-10T11:59:51+00:00https://drug.russellpublishing.co.uk/news/1169/eureka-conferences-inc-announces-drug-discovery-therapy-world-congress-2014/2017-01-10T11:57:07+00:00https://drug.russellpublishing.co.uk/news/1173/perkinelmer-launches-next-generation-high-content-screening-system/2017-05-09T13:39:00+01:00https://drug.russellpublishing.co.uk/news/1205/sanford-burnham-daiichi-sankyo-form-alliance-study-novel-drug-targets-cardiovascular-metabolic-diseases/2017-01-10T11:49:07+00:00https://drug.russellpublishing.co.uk/news/1214/pfizer-announces-detailed-results-phase-3-opt-retreatment-study-tofacitinib-adults-moderate-severe-chronic-plaque-psoriasis/2017-01-10T11:47:09+00:00https://drug.russellpublishing.co.uk/news/1217/dainippon-sumitomo-pharma-daiichi-sankyo-cooperate-lurasidone-atypical-antipsychotic-agent-four-south-american-countries/2017-01-10T11:45:19+00:00https://drug.russellpublishing.co.uk/news/1288/john-herrmann-cso-eli-lilly-keynote-novel-cancer-therapeutics-summit-july-7-8-2014-boston/2017-01-10T11:43:40+00:00https://drug.russellpublishing.co.uk/news/1295/george-weinstock-keynote-next-generation-seq-meeting-june-19-20-2014-san-diego-ca/2017-01-10T11:42:02+00:00https://drug.russellpublishing.co.uk/news/1300/bionetworks-reviewing-various-collaborations-pharma-biotech-academia-venture-capitalists/2017-01-10T11:40:09+00:00https://drug.russellpublishing.co.uk/news/1317/leading-experts-pharma-biotech-companies-meet-london-september-biosimilars-biobetters-conference/2017-01-10T11:38:29+00:00https://drug.russellpublishing.co.uk/news/1338/gsk-announces-phase-iii-altto-results-anti-her2-therapy-combination-adjuvant-breast-cancer-treatment-setting/2017-01-10T11:36:50+00:00https://drug.russellpublishing.co.uk/news/1340/roche-acquires-genia-technologies-strengthen-next-generation-sequencing-pipeline/2017-01-10T11:35:52+00:00https://drug.russellpublishing.co.uk/news/1343/one-two-year-survival-rates-94-88-announced-phase-1b-trial-investigational-pd-1-checkpoint-inhibitor-nivolumab-yervoy-ipilimumab-advanced-melanoma/2017-01-10T11:34:27+00:00https://drug.russellpublishing.co.uk/news/1346/teva-acquire-labrys-biologics-inc-novel-migraine-prophylaxis-treatment-adds-significant-new-dimension-tevas-growing-pain-care-franchise/2017-01-10T11:33:11+00:00https://drug.russellpublishing.co.uk/news/1353/pivotal-phase-iii-data-show-polycythemia-vera-patients-novartis-drug-jakavi-achieved-significant-improvement-disease-control/2017-01-10T11:32:16+00:00https://drug.russellpublishing.co.uk/news/1356/gsk-announces-start-phase-iii-cardiovascular-outcomes-study-losmapimod-patients-acute-coronary-syndrome/2017-01-06T15:44:51+00:00https://drug.russellpublishing.co.uk/news/1358/first-patient-enrolled-new-phase-3-trial-program-investigating-daily-dosing-regimen-isentress-raltegravir/2018-06-29T14:20:04+01:00https://drug.russellpublishing.co.uk/news/1369/merck-acquire-idenix/2018-06-29T14:17:49+01:00https://drug.russellpublishing.co.uk/news/1372/institut-pasteur-myriad-rbm-publish-initial-results-landmark-study-immune-response/2017-01-06T15:40:47+00:00https://drug.russellpublishing.co.uk/news/1376/avert-trial-demonstrates-high-rates-das-defined-remission-orencia-abatacept-combination-methotrexate-adult-patients-early-rheumatoid-arthritis/2017-01-06T15:38:03+00:00https://drug.russellpublishing.co.uk/news/1378/sanofi-regeneron-announce-new-detailed-data-positive-sarilumab-phase-3-rheumatoid-arthritis-trial-eular/2017-01-06T15:36:20+00:00https://drug.russellpublishing.co.uk/news/1380/viiv-healthcare-announces-new-collaboration-janssen-investigate-single-tablet-regimen-maintenance-treatment-hiv-1/2019-09-10T08:44:47+01:00https://drug.russellpublishing.co.uk/news/1383/astrazeneca-licenses-synairgens-sng001-novel-immuno-modulatory-therapy-viral-induced-exacerbation-asthma/2017-01-16T11:16:36+00:00https://drug.russellpublishing.co.uk/news/1385/oxford-globals-inaugural-drug-discovery-usa-congress-hot-topics-announced/2017-01-06T15:34:45+00:00https://drug.russellpublishing.co.uk/news/1387/biogen-idec-abbvie-announce-positive-top-line-results-phase-3-study-investigating-daclizumab-high-yield-process-multiple-sclerosis/2017-01-06T15:34:08+00:00https://drug.russellpublishing.co.uk/news/1389/new-phase-3-study-shows-efficacy-safety-victoza-treatment-type-2-diabetes-adults-moderate-renal-impairment/2017-01-06T15:32:57+00:00https://drug.russellpublishing.co.uk/news/1392/jardiance-empagliflozin-add-therapy-significantly-reduced-blood-glucose-body-weight-two-newly-presented-phase-iii-trials/2017-01-06T15:32:02+00:00https://drug.russellpublishing.co.uk/news/1394/pfizer-cellectis-enter-global-strategic-cancer-immunotherapy-collaboration/2017-01-06T15:31:20+00:00https://drug.russellpublishing.co.uk/news/1396/janssen-announces-license-agreement-vertex-develop-novel-treatment-influenza/2017-01-06T15:30:13+00:00https://drug.russellpublishing.co.uk/news/1398/sanofi-reports-positive-phase-3-results-toujeo/2017-01-06T15:28:40+00:00https://drug.russellpublishing.co.uk/news/1404/merck-begins-tender-offer-acquire-idenix/2018-06-29T14:16:20+01:00https://drug.russellpublishing.co.uk/news/1406/phase-3a-liraglutide-3-mg-trial-demonstrated-significant-weight-loss-improved-cardiovascular-risk-factors-adults-obesity-type-2-diabetes-compared-placebo/2016-12-14T23:20:27+00:00https://drug.russellpublishing.co.uk/news/1409/abbott-acquire-veropharm/2017-01-06T15:19:48+00:00https://drug.russellpublishing.co.uk/news/1411/myriad-announces-diabetes-collaboration-sanofi/2017-01-06T15:18:42+00:00https://drug.russellpublishing.co.uk/news/1415/phase-3-first-line-melanoma-study-nivolumab-investigational-pd-1-checkpoint-inhibitor-demonstrates-superior-overall-survival-compared-dacarbazine-study-stopped-early/2017-01-06T15:17:47+00:00https://drug.russellpublishing.co.uk/news/1418/gsk-announces-start-phase-iii-study-eltrombopag-patients-myelodysplastic-syndromes/2017-01-06T15:15:35+00:00https://drug.russellpublishing.co.uk/news/1421/abbvie-announces-initiation-pivotal-phase-iii-study-veliparib-abt-888-patients-advanced-breast-cancer/2017-01-06T15:14:11+00:00https://drug.russellpublishing.co.uk/news/1423/mundipharma-edo-gmbh-shows-strong-activity-early-development-oncology/2017-01-06T15:13:22+00:00https://drug.russellpublishing.co.uk/news/1426/taiho-oncology-inc-announces-results-tas-102-global-phase-iii-recourse-trial-refractory-metastatic-colorectal-cancer/2017-01-06T15:12:21+00:00https://drug.russellpublishing.co.uk/news/1429/roche-announces-definitive-agreement-acquire-seragon-pharmaceuticals/2017-01-06T15:26:46+00:00https://drug.russellpublishing.co.uk/news/1431/actavis-completes-acquisition-furiex-pharmaceuticals/2017-01-06T15:10:44+00:00https://drug.russellpublishing.co.uk/news/1435/mrc-technology-astrazeneca-renew-collaboration-identify-novel-targets-discovery-research/2017-01-16T15:50:20+00:00https://drug.russellpublishing.co.uk/news/1439/drug-discovery-conversations-brian-pollok-entrepreneur-residence-university-virginia/2017-01-06T15:08:53+00:00https://drug.russellpublishing.co.uk/news/1444/davita-labs-myriad-rbm-announce-biomarker-research-collaboration/2017-01-06T15:03:46+00:00https://drug.russellpublishing.co.uk/news/1450/fraunhofer-ime-integrates-european-screeningport-enhance-expertise-capabilities-drug-discovery/2017-01-06T15:00:01+00:00https://drug.russellpublishing.co.uk/news/1453/domainex-reports-success-lead-compound-pre-clinical-model-copd-secures-1-4m-biomedical-catalyst-award/2017-01-16T11:18:27+00:00https://drug.russellpublishing.co.uk/news/1456/boehringer-ingelheims-volasertib-showed-phase-ii-study-improvement-overall-survival-older-aml-patients/2017-01-06T14:56:21+00:00https://drug.russellpublishing.co.uk/news/1475/mundipharma-edo-gmbh-shows-strong-preclinical-activity-lead-compound-edo-s101-multiple-myeloma/2017-01-06T14:51:14+00:00https://drug.russellpublishing.co.uk/news/1481/gsk-theravance-announce-initiation-phase-iii-programme-fixed-dose-triple-combination-treatment-ffumecvi-patients-copd/2017-01-16T11:18:04+00:00https://drug.russellpublishing.co.uk/news/1484/pfizer-acquire-innopharma-inc/2017-01-06T14:49:01+00:00https://drug.russellpublishing.co.uk/news/1486/roche-announces-phase-ii-clinical-results-crenezumab-alzheimers-disease/2017-01-06T14:46:06+00:00https://drug.russellpublishing.co.uk/news/1489/amgen-announces-positive-phase-3-results-amg-416-treatment-secondary-hyperparathyroidism-patients-chronic-kidney-disease-receiving-hemodialysis/2017-01-06T14:44:24+00:00https://drug.russellpublishing.co.uk/news/1500/teva-completes-acquisition-labrys/2017-01-06T14:43:17+00:00https://drug.russellpublishing.co.uk/news/1506/medimmune-advaxis-partner-immuno-oncology-combination-clinical-trial/2017-01-06T14:40:58+00:00https://drug.russellpublishing.co.uk/news/1510/gilead-announces-new-agreement-medicines-patent-pool-sccess-medicines-developing-world-countries/2017-01-19T10:22:27+00:00https://drug.russellpublishing.co.uk/news/1513/european-chmp-adopts-positive-opinion-gileads-zydelig-idelalisib-treatment-chronic-lymphocytic-leukemia-follicular-lymphoma/2017-01-06T14:35:39+00:00https://drug.russellpublishing.co.uk/news/1515/astrazeneca-roche-announce-partnership-develop-companion-diagnostic-test-azd9291/2017-01-06T14:33:10+00:00https://drug.russellpublishing.co.uk/news/1528/zealand-boehringer-ingelheim-sign-second-collaboration-agreement-advance-novel-peptide-medicines/2017-01-06T14:28:39+00:00https://drug.russellpublishing.co.uk/news/1530/roches-roactemra-receives-chmp-positive-opinion-europe-use-patients-early-rheumatoid-arthritis-ra-previously-treated-methotrexate-mtx/2017-01-06T14:26:49+00:00https://drug.russellpublishing.co.uk/news/1532/allied-minds-bristol-myers-squibb-form-new-enterprise-advance-discoveries-biopharmaceutical-innovations-leading-u-s-academic-research/2017-01-06T14:15:00+00:00https://drug.russellpublishing.co.uk/news/1534/roche-acquire-santaris-pharma-expand-discovery-development-rna-targeting-medicines/2017-01-06T14:13:49+00:00https://drug.russellpublishing.co.uk/news/1539/yabao-pharmaceuticals-changzhou-le-sun-pharmaceuticals-ltd-enter-innovative-partnership-develop-early-stage-oncology-compound/2017-01-06T14:12:53+00:00https://drug.russellpublishing.co.uk/news/1542/daiichi-sankyo-charleston-laboratories-announce-collaboration/2017-01-06T14:10:28+00:00https://drug.russellpublishing.co.uk/news/1544/faah-pharma-inc-announces-investment-tvm-life-science-ventures-vii-develop-new-treatment-neuropathic-pain/2017-01-04T22:25:08+00:00https://drug.russellpublishing.co.uk/news/1547/sanofi-mannkind-announce-global-licensing-agreement-afrezza-insulin-human-rapid-acting-inhaled-insulin/2017-01-06T14:08:35+00:00https://drug.russellpublishing.co.uk/news/1557/astrazeneca-advances-tralokinumab-phase-iii-severe-asthma/2017-01-06T14:05:53+00:00https://drug.russellpublishing.co.uk/news/1563/initiation-phase-3-trial-chs-0214-investigational-etanercept-biosimilar-japan-rapsody/2017-01-06T14:04:23+00:00https://drug.russellpublishing.co.uk/news/1594/pfizer-merck-collaborate-study-evaluating-novel-anti-cancer-combination-regimen/2018-06-29T14:11:55+01:00https://drug.russellpublishing.co.uk/news/1596/astrazeneca-announces-partnership-illumina-develop-next-generation-gene-sequencing-panel-companion-diagnostic-tests/2017-01-06T14:01:28+00:00https://drug.russellpublishing.co.uk/news/1638/dpt-laboratories-acquires-meda-pharmaceuticals-lakewood-new-jersey-location/2017-01-06T14:00:18+00:00https://drug.russellpublishing.co.uk/news/1642/ario-pharma-acquires-pharmestes-trpa1-research-assets/2017-01-16T11:23:52+00:00https://drug.russellpublishing.co.uk/news/1647/waters-unveils-global-mass-spectrometry-headquarters-uks-north-west/2017-01-06T13:56:40+00:00https://drug.russellpublishing.co.uk/news/1651/oxford-globals-drug-discovery-usa-congress-2014-new-hot-topics-released-regsitration-closing-soon/2017-01-06T13:55:35+00:00https://drug.russellpublishing.co.uk/news/1666/scientific-founder-intercept-pharmaceuticals-joins-tiziana-life-sciences/2017-01-06T13:40:35+00:00https://drug.russellpublishing.co.uk/news/1670/genetic-testing-can-identify-men-six-fold-increased-risk-prostate-cancer/2017-01-06T12:31:14+00:00https://drug.russellpublishing.co.uk/news/1673/curie-cancer-inventiva-announce-partnership-epigenetics-treatment-cancer/2017-01-06T12:29:21+00:00https://drug.russellpublishing.co.uk/news/1679/boehringer-ingelheim-curevac-announce-collaboration-develop-next-generation-lung-cancer-immunotherapy/2017-01-06T12:28:26+00:00https://drug.russellpublishing.co.uk/news/1681/sanofi-myokardia-announce-groundbreaking-collaboration-develop-targeted-therapies-patients-genetic-heart-disease/2017-08-03T14:43:56+01:00https://drug.russellpublishing.co.uk/news/1686/abcam-licenses-novel-ceefourin-inhibitors-multidrug-resistance-protein-4-australias-childrens-cancer-institute/2017-01-06T12:25:53+00:00https://drug.russellpublishing.co.uk/news/1690/horizon-discovery-group-plc-interim-results-six-months-ended-30-june-2014/2017-01-06T12:21:14+00:00https://drug.russellpublishing.co.uk/news/1693/dna-gene-deserts-linked-breast-cancer/2017-01-06T12:17:40+00:00https://drug.russellpublishing.co.uk/news/1695/nlife-therapeutics-receives-usd-350000-michael-j-fox-foundation-parkinsons-research/2017-01-06T12:16:30+00:00https://drug.russellpublishing.co.uk/news/1699/probiodrug-announces-intention-launch-initial-public-offering-listing-euronext-amsterdam/2017-01-06T12:15:04+00:00https://drug.russellpublishing.co.uk/news/1702/horizon-discovery-group-plc-signs-master-services-agreement-approximately-1-2-million/2017-01-06T12:13:47+00:00https://drug.russellpublishing.co.uk/news/1704/txcell-financial-results-first-half-2014/2017-01-06T12:11:33+00:00https://drug.russellpublishing.co.uk/news/1711/sgs-announces-completion-new-life-science-services-laboratory-carson-california/2017-01-06T12:10:03+00:00https://drug.russellpublishing.co.uk/news/1714/guidelines-raise-standards-contamination-control/2017-01-06T12:06:20+00:00https://drug.russellpublishing.co.uk/news/1731/pfizer-completes-acquisition-innopharma/2017-01-06T11:47:27+00:00https://drug.russellpublishing.co.uk/news/1738/eatris-enters-framework-agreement-roche-access-europe-wide-network-translational-researchers/2017-01-06T11:46:13+00:00https://drug.russellpublishing.co.uk/news/1741/sigmoid-enters-licence-agreement-pendopharm-commercialisation-rights-cycol-canada/2017-01-06T11:43:17+00:00https://drug.russellpublishing.co.uk/news/1744/kymab-strengthens-expands-capabilities-board-appointments-executive-promotions/2017-01-06T11:40:26+00:00https://drug.russellpublishing.co.uk/news/1747/tumour-profiling-caris-molecular-intelligence-offers-hope-patients-rare-cancers-identifying-new-personalised-treatment-options/2017-01-06T11:38:54+00:00https://drug.russellpublishing.co.uk/news/1750/horizon-discovery-group-plc-acquires-sage-labs-inc-48m-29m/2017-01-06T11:37:21+00:00https://drug.russellpublishing.co.uk/news/1753/daiichi-sankyo-acquire-ambit-biosciences/2017-01-06T11:35:42+00:00https://drug.russellpublishing.co.uk/news/1755/roche-purchases-shares-tender-offer-intermune-inc/2017-01-06T11:34:02+00:00https://drug.russellpublishing.co.uk/news/1763/avacta-life-sciences-takes-55bn-antibody-market-launch-affimers/2017-05-24T08:37:06+01:00https://drug.russellpublishing.co.uk/news/1772/cardio3-biosciences-announces-new-business-development-strategy-broaden-product-pipeline/2017-01-06T11:25:34+00:00https://drug.russellpublishing.co.uk/news/1776/thermo-scientific-tga-ir-module-enhances-materials-characterization-users-thermo-scientific-ft-ir-spectrometers/2017-01-06T11:09:28+00:00https://drug.russellpublishing.co.uk/news/1792/allied-bristol-life-sciences-appoints-satish-jindal-lead-discovery-drug-candidates-leading-academic-institutions/2016-12-09T15:36:51+00:00https://drug.russellpublishing.co.uk/news/1795/event-preview-drug-discovery-week-europe/2017-01-06T11:08:44+00:00https://drug.russellpublishing.co.uk/news/1799/obn-celebrates-stars-uk-life-sciences/2016-12-09T15:36:50+00:00https://drug.russellpublishing.co.uk/news/1828/merck-serono-collaborate-institute-cancer-research-london-wellcome-trust-co-develop-anti-cancer-drugs/2017-01-06T11:02:58+00:00https://drug.russellpublishing.co.uk/news/1830/bristol-myers-squibb-announces-collaboration-evaluate-opdivo-nivolumab-combination-targeted-therapies-novartis-treat-non-small-cell-lung-cancer/2017-01-06T11:01:37+00:00https://drug.russellpublishing.co.uk/news/1833/new-study-shows-uk-public-largely-unaware-stem-cells-potential-uses-still-realised/2019-10-23T10:55:07+01:00https://drug.russellpublishing.co.uk/news/1837/novartis-announces-clinical-collaboration-evaluate-bristol-myers-squibbs-novel-immunotherapy-combination-treatments-nsclc/2017-01-06T10:04:50+00:00https://drug.russellpublishing.co.uk/news/1868/advanced-cell-diagnostics-awarded-1-4-million-nci-grant-develop-ultrasensitive-diagnostic-test-b-cell-lymphoma/2017-01-06T10:56:58+00:00https://drug.russellpublishing.co.uk/news/1871/horizon-discovery-group-plc-acquires-sage-labs-inc-48m-29m-2/2017-01-06T10:55:05+00:00https://drug.russellpublishing.co.uk/news/1873/abpi-obn-announce-memorandum-understanding/2017-01-06T10:49:41+00:00https://drug.russellpublishing.co.uk/news/1876/rigontec-gmbh-raises-e9-45m-first-closing-series-financing-round-advance-rna-based-immunotherapeutics-cancer-viral-diseases/2017-01-06T10:46:17+00:00https://drug.russellpublishing.co.uk/news/1879/new-oncology-gustave-roussy-announce-collaboration-genetic-testing/2017-01-06T10:43:52+00:00https://drug.russellpublishing.co.uk/news/1882/imaxio-signs-option-license-agreement-german-cancer-research-center-dkfz/2017-01-06T10:40:49+00:00https://drug.russellpublishing.co.uk/news/1892/auspherix-domainex-announce-collaboration-develop-new-drugs-treat-antibiotic-resistant-bacterial-infections/2017-01-06T10:39:42+00:00https://drug.russellpublishing.co.uk/news/1894/seahorse-bioscience-university-alabama-partner-advance-validation-bioenergetic-health-index-personalized-medicine/2017-01-06T10:38:21+00:00https://drug.russellpublishing.co.uk/news/1921/calixar-aston-university-together-collaborative-research-tackle-multidrug-resistance-targets/2017-01-06T10:35:08+00:00https://drug.russellpublishing.co.uk/news/1930/mucosis-presents-data-intranasal-rsv-vaccine-syngem-vaccines-2014-conference/2017-01-06T10:30:10+00:00https://drug.russellpublishing.co.uk/news/1933/rosetta-genomics-institute-molecular-translational-medicine-partner/2017-01-06T10:28:30+00:00https://drug.russellpublishing.co.uk/news/1936/global-network-collaboration-major-translational-health-research-centres-announced/2017-01-06T10:22:42+00:00https://drug.russellpublishing.co.uk/news/1978/cancer-drug-discovery-system-broken-global-summit-hears/2017-01-06T10:07:51+00:00https://drug.russellpublishing.co.uk/news/1984/txcell-achieves-positive-results-col-treg-model-autoimmune-uveitis/2017-01-06T10:02:02+00:00https://drug.russellpublishing.co.uk/news/1988/probiodrug-sponsors-5th-biannual-nubin-symposium/2016-12-09T15:34:29+00:00https://drug.russellpublishing.co.uk/news/1998/cardio3-biosciences-acquires-corquest-medical-inc/2017-01-06T09:19:58+00:00https://drug.russellpublishing.co.uk/news/2002/carlina-technologies-signs-partnership-agreement-genbiotech-develop-sustained-release-protein-formulation-cartilage-repair/2017-01-06T09:26:51+00:00https://drug.russellpublishing.co.uk/news/2005/felicitex-therapeutics-selvita-initiate-strategic-collaboration-target-cancer-quiescence/2017-01-06T09:54:25+00:00https://drug.russellpublishing.co.uk/news/2011/daiichi-sankyo-selects-research-partners-taneds-collaborative-drug-discovery-project/2017-01-06T09:53:11+00:00https://drug.russellpublishing.co.uk/news/2015/enterome-enters-microbiome-based-development-collaboration-abbvie-crohns-disease/2017-01-06T09:51:46+00:00https://drug.russellpublishing.co.uk/news/2017/new-oncology-collaborate-national-cancer-centre-singapore-genetic-testing/2017-01-06T09:47:57+00:00https://drug.russellpublishing.co.uk/news/2022/amgen-highlight-new-data-investigational-cholesterol-lowering-medication-evolocumab/2017-01-06T09:44:54+00:00https://drug.russellpublishing.co.uk/news/2024/bristol-myers-squibb-sponsored-partnering-curetm-programme-announces-new-winning-projects-designed-investigate-novel-ways-cure-viral-diseases/2017-01-06T09:41:46+00:00https://drug.russellpublishing.co.uk/news/2028/nosopharm-hires-four-new-international-experts-scientific-advisory-board/2017-01-19T11:15:54+00:00https://drug.russellpublishing.co.uk/news/2033/bergenbio-receives-orphan-drug-designation-fda-bgb324-treatment-acute-myeloid-leukaemia/2017-01-06T09:32:57+00:00https://drug.russellpublishing.co.uk/news/2036/scientists-discover-bacterias-clever-defence-mechanism/2017-01-06T09:13:33+00:00https://drug.russellpublishing.co.uk/news/2043/professor-paul-workman-pledges-three-pronged-cancer-attack/2017-01-06T09:13:04+00:00https://drug.russellpublishing.co.uk/news/2050/mrc-and-yabao-pharma-in-parkinsons-partnership/2017-01-10T16:03:13+00:00https://drug.russellpublishing.co.uk/news/2054/bristol-myers-squibb-five-prime-therapeutics-evaluate-combination-opdivo-nivolumab-fpa008-six-tumor-types/2017-01-06T09:30:20+00:00https://drug.russellpublishing.co.uk/news/2057/understanding-bacterial-toxins-target-human-cells-will-help-develop-new-drugs/2016-12-09T15:34:24+00:00https://drug.russellpublishing.co.uk/news/2059/lavision-biotec-reports-award-winning-scientist-peter-friedl-work-imaging-cancer-growth/2017-01-10T16:02:09+00:00https://drug.russellpublishing.co.uk/news/2079/abivax-successfully-completes-first-man-study-abx464-highly-differentiated-small-molecule-targeting-hiv/2017-01-10T16:01:09+00:00https://drug.russellpublishing.co.uk/news/2082/international-college-neuropsychopharmacology-cinp-calls-governments-reverse-disturbing-trend-lack-new-drugs-10-global-population-affected-brain-d/2016-12-09T15:34:23+00:00https://drug.russellpublishing.co.uk/news/2084/worlds-first-artificial-enzymes-created-using-synthetic-biology/2017-01-10T16:45:05+00:00https://drug.russellpublishing.co.uk/news/2088/mrc-technology-shandong-international-biotechnology-park-china-cooperate-new-drug-alzheimers/2017-01-10T16:44:31+00:00https://drug.russellpublishing.co.uk/news/2091/bioversys-enamine-announce-extension-drug-discovery-collaboration-address-multidrug-resistant-bacterial-infections/2017-01-19T11:32:28+00:00https://drug.russellpublishing.co.uk/news/2095/evotec-sanofi-discuss-major-multi-component-strategic-collaboration/2017-01-06T08:54:30+00:00https://drug.russellpublishing.co.uk/news/2098/alize-pharma-acquires-new-peptide-to-tackle-bone-diseases/2016-12-09T15:34:22+00:00https://drug.russellpublishing.co.uk/news/2101/reviral-receives-us1mn-funding/2017-01-10T16:41:55+00:00https://drug.russellpublishing.co.uk/news/2106/scifluor-life-sciences-awarded-u-s-patent-integrin-%ce%b1v%ce%b23-inhibitors-designed-topical-treatment-retinal-disease/2017-01-10T16:41:13+00:00https://drug.russellpublishing.co.uk/news/2109/codexis-uses-codeevolver-protein-engineering-platform-technology-develop-enzyme-therapeutic-candidate-potential-treatment-phenylketonuria-pku-via-oral-administration/2017-01-10T16:40:14+00:00https://drug.russellpublishing.co.uk/news/2113/alize-pharma-announces-positive-results-azp-531-unacylated-ghrelin-analog-two-phase-clinical-trials-healthy-volunteers-obese-subjects/2017-01-10T16:15:26+00:00https://drug.russellpublishing.co.uk/news/2119/zobio-domainex-join-forces-deliver-crucial-drug-target-information-support-forma-therapeutics-drug-discovery-programs/2017-01-10T16:13:40+00:00https://drug.russellpublishing.co.uk/news/2123/anticoagulant-effect-eliquis-apixaban-reversed-two-separate-4-factor-prothrombin-complex-concentrates-healthy-subjects/2017-01-10T16:11:45+00:00https://drug.russellpublishing.co.uk/news/2126/molecular-methods-rapidly-gain-ground-infectious-disease-diagnostics/2017-01-10T16:10:10+00:00https://drug.russellpublishing.co.uk/news/2129/new-targeted-drugs-treat-drug-resistant-skin-cancer/2017-01-10T16:08:30+00:00https://drug.russellpublishing.co.uk/news/2138/kymab-wellcome-trust-initiate-ebola-project/2017-01-10T16:05:35+00:00https://drug.russellpublishing.co.uk/news/2140/curie-cancer-gamamabs-pharma-renew-research-partnership-develop-antibody-gynecological-cancers/2017-01-10T16:05:02+00:00https://drug.russellpublishing.co.uk/news/2144/midatech-pharma-awarded-eu-grant-funding-support-training-research-glycan-based-multivalent-immunotherapeutics/2017-01-10T17:01:11+00:00https://drug.russellpublishing.co.uk/news/2146/key-us-patents-granted-gpcr-focused-drug-discovery-platform-arising-pioneering-research-translational-expertise-mrc-mrc-technology/2017-01-10T16:58:46+00:00https://drug.russellpublishing.co.uk/news/2163/pfizer-acquires-redvax-gmbh/2017-01-10T16:56:41+00:00https://drug.russellpublishing.co.uk/news/2165/trial-finds-cancer-drug-can-block-key-signal-cancer-growth-drug-resistance/2017-01-10T16:55:07+00:00https://drug.russellpublishing.co.uk/news/2167/txcell-receives-eu-orphan-drug-designation-col-treg-treatment-non-infectious-uveitis/2017-01-10T16:53:55+00:00https://drug.russellpublishing.co.uk/news/2189/uk-patients-moderately-severely-active-ulcerative-colitis-gain-access-range-biologic-therapies-nhs/2017-01-10T16:53:29+00:00https://drug.russellpublishing.co.uk/news/2193/aaa-fully-acquires-atreus-pharmaceuticals/2017-01-10T16:52:40+00:00https://drug.russellpublishing.co.uk/news/2196/scifluor-life-sciences-awarded-u-s-patent-kcnq23-activator-designed-treatment-epilepsy-related-neurological-disorders/2017-01-10T16:51:44+00:00https://drug.russellpublishing.co.uk/news/2199/oxford-global-conferences-received-excellent-feedback-2014-drug-discovery-usa-congress/2017-01-10T16:51:22+00:00https://drug.russellpublishing.co.uk/news/2201/protagen-ag-appoints-bernhard-kirschbaum-new-board-member/2017-01-10T16:50:32+00:00https://drug.russellpublishing.co.uk/news/2211/fda-approves-roches-cobas-taqscreen-mpx-test-v2-0-use-detection-identification-hiv-hcv-hbv/2017-01-06T08:42:56+00:00https://drug.russellpublishing.co.uk/news/2214/kymab-partners-cancer-immunotherapy-expert-anti-cancer-therapeutics/2017-01-10T16:48:36+00:00https://drug.russellpublishing.co.uk/news/2216/roche-enters-broad-strategic-collaboration-foundation-medicine-field-molecular-information-oncology/2017-01-10T16:47:37+00:00https://drug.russellpublishing.co.uk/news/2218/oryzon-appoints-greg-weaver-global-chief-financial-officer/2017-01-10T16:47:11+00:00https://drug.russellpublishing.co.uk/news/2221/medimmune-enters-licensing-agreement-omnis-pharmaceuticals-oncolytic-viruses-immuno-oncology/2017-01-10T16:46:40+00:00https://drug.russellpublishing.co.uk/news/2225/roche-meiji-fedora-join-forces-tackle-increasing-bacterial-resistance-antibiotics/2017-01-11T10:34:06+00:00https://drug.russellpublishing.co.uk/news/2227/biodesix-raises-additional-series-e-financing/2017-01-11T10:26:30+00:00https://drug.russellpublishing.co.uk/news/2230/isarna-therapeutics-unveils-new-selective-tgf-beta-antagonist-program-targeting-multiple-indications-ophthalmology/2017-01-11T10:25:42+00:00https://drug.russellpublishing.co.uk/news/2255/catalent-sanofi-collaborate-smartag-antibody-drug-conjugate-technology-sanofis-proprietary-antibodies/2017-01-11T10:24:57+00:00https://drug.russellpublishing.co.uk/news/2258/treeway-announces-license-collaboration-agreement-uniqure-develop-gene-therapy-amyotrophic-lateral-sclerosis/2017-01-11T10:23:51+00:00https://drug.russellpublishing.co.uk/news/2263/new-oncology-university-hospital-oslo-announce-genomic-profiling-collaboration/2017-01-06T14:24:16+00:00https://drug.russellpublishing.co.uk/news/2265/syncona-llp-ucl-business-plc-announce-formation-autolus-limited-cancer-immunotherapy-company/2017-01-11T10:06:30+00:00https://drug.russellpublishing.co.uk/news/2278/genticel-continue-per-protocol-phase-2-clinical-study-procervix-2nd-review-dsmb/2017-01-11T10:02:57+00:00https://drug.russellpublishing.co.uk/news/2285/txcell-receives-eur-1-7-million-bpifrance-ovasaver-clinical-development-refractory-crohns-disease/2017-01-11T09:43:43+00:00https://drug.russellpublishing.co.uk/news/2288/genticel-business-update-fourth-quarter-2014/2017-01-11T09:33:53+00:00https://drug.russellpublishing.co.uk/news/2290/tau-based-vaccines-transform-early-alzheimers-disease-treatment-says-globaldata-analyst/2017-01-11T09:28:47+00:00https://drug.russellpublishing.co.uk/news/2294/txcell-receives-eur-1-million-milestone-payment-regarding-ovasaver-collaboration-agreement-trizell/2017-01-11T09:21:00+00:00https://drug.russellpublishing.co.uk/news/2296/minister-announces-14m-investment-stratified-medicine/2017-01-11T09:11:32+00:00https://drug.russellpublishing.co.uk/news/2298/txcell-announces-financial-calendar-2015/2017-01-11T09:04:24+00:00https://drug.russellpublishing.co.uk/news/2303/cardis-project-target-early-stage-cardio-vascular-disease/2017-01-05T16:28:49+00:00https://drug.russellpublishing.co.uk/news/2306/treatment-first-hiv-positive-patient-abivaxs-phase-iia-clinical-trial-abx464/2017-01-05T16:28:33+00:00https://drug.russellpublishing.co.uk/news/2340/first-patient-enrolled-new-drugs-4-bad-bugs-nd4bb-programme/2017-01-19T11:32:19+00:00https://drug.russellpublishing.co.uk/news/2364/motif-bio-announces-intention-float-aim/2017-01-05T16:28:04+00:00https://drug.russellpublishing.co.uk/news/2374/oncologic-imaging-innovation-enabling-earlier-detection-cancers/2017-01-05T16:27:48+00:00https://drug.russellpublishing.co.uk/news/2378/mrc-technology-appoints-general-counsel-company-secretary/2017-01-11T11:20:04+00:00https://drug.russellpublishing.co.uk/news/2381/major-study-links-two-new-genetic-variants-breast-cancer/2017-01-06T14:18:22+00:00https://drug.russellpublishing.co.uk/news/2385/rigontec-gmbh-appoints-dr-christian-schetter-ceo/2017-01-11T11:19:38+00:00https://drug.russellpublishing.co.uk/news/2387/txcell-reports-revenues-2014-updates-upcoming-milestones/2017-01-06T14:30:39+00:00https://drug.russellpublishing.co.uk/news/2390/two-major-studies-strengthen-case-prostate-cancer-drug-chemotherapy/2017-01-11T11:18:48+00:00https://drug.russellpublishing.co.uk/news/2398/genticel-presents-pipeline-development-eurogin-congress-held-seville-spain-4-7-february-2015/2017-01-11T11:14:03+00:00https://drug.russellpublishing.co.uk/news/2400/nobel-laureates-stem-cell-company-cell-therapy-limited-sets-new-crowdfunding-record-raising-691000-crowdcube/2017-01-11T11:11:08+00:00https://drug.russellpublishing.co.uk/news/2403/sensiq-technologies-inventiva-set-european-center-excellence-surface-plasmon-resonance-spr-technologies/2017-01-11T10:54:37+00:00https://drug.russellpublishing.co.uk/news/2414/key-bioelectronic-medical-patent-cancer-treatment-issued-u-s-patent-trademark-office/2017-01-06T11:02:16+00:00https://drug.russellpublishing.co.uk/news/2421/two-major-scientific-articles-validate-effimunes-drug-candidate/2017-01-11T10:46:48+00:00https://drug.russellpublishing.co.uk/news/2451/leading-dementia-charity-launches-three-drug-discovery-institutes/2017-01-06T11:20:12+00:00https://drug.russellpublishing.co.uk/news/2457/patrice-denefle-is-the-new-head-of-the-roche-institute-for-research-and-translational-medicine-created-by-roche-france/2017-01-06T11:22:02+00:00https://drug.russellpublishing.co.uk/news/2459/cancer-risk-linked-to-dna-wormholes/2017-01-11T11:47:37+00:00https://drug.russellpublishing.co.uk/news/2465/eyevensys-announced-appointment-of-dr-violaine-desort-henin-as-clinical-director/2017-01-06T11:20:15+00:00https://drug.russellpublishing.co.uk/news/2468/data-show-the-worlds-first-ema-approved-biosimilar-monoclonal-antibody-remsima-could-reduce-cost-of-treating-crohns-disease-by-up-to-e336-million-over-five-years/2017-01-11T11:40:43+00:00https://drug.russellpublishing.co.uk/news/2471/prexton-therapeutics-raises-e8-7-million-10-million-in-a-series-a-round/2017-01-11T11:39:57+00:00https://drug.russellpublishing.co.uk/news/2486/mundipharma-launches-remsima%e2%96%bc-infliximab-a-new-generation-value-based-monoclonal-antibody-in-six-european-markets/2017-01-06T10:57:10+00:00https://drug.russellpublishing.co.uk/news/2489/registration-is-open-for-the-16th-annual-drug-discovery-summit-in-berlin-8th-9th-june-2015/2017-01-11T11:33:18+00:00https://drug.russellpublishing.co.uk/news/2492/registration-is-open-for-the-3rd-annual-discovery-chemistry-drug-design-in-berlin-8th-9th-june-2015/2017-01-11T11:32:43+00:00https://drug.russellpublishing.co.uk/news/2498/nice-issues-guidance-on-biologic-treatments-for-ulcerative-colitis/2017-01-06T12:17:10+00:00https://drug.russellpublishing.co.uk/news/2500/launch-of-the-anti-cancer-agent-braf-inhibitor-zelboraf/2017-01-06T12:26:57+00:00https://drug.russellpublishing.co.uk/news/2508/txcell-to-present-at-roth-capital-partners-investor-conference-in-us/2017-01-11T11:29:28+00:00https://drug.russellpublishing.co.uk/news/2510/study-of-next-generation-investigational-hiv-1-maturation-inhibitor-shows-positive-results-in-preventing-viral-replication-via-different-mechanism-of-action-than-current-therapies/2017-01-19T10:21:36+00:00https://drug.russellpublishing.co.uk/news/2513/new-breast-cancer-test-links-immune-hotspots-to-better-survival/2017-01-11T11:26:39+00:00https://drug.russellpublishing.co.uk/news/2519/northern-health-science-alliance-welcomes-funding-to-boost-life-and-health-sciences-in-the-north-of-england/2017-01-11T12:01:46+00:00https://drug.russellpublishing.co.uk/news/2521/mrc-technology-launches-respiratory-call-for-targets/2017-01-16T11:23:02+00:00https://drug.russellpublishing.co.uk/news/2523/data-on-glutaminyl-cyclases-qcs-in-its-relation-to-alzheimers-disease-ad-published-in-acta-neuropathologica/2017-01-11T11:24:55+00:00https://drug.russellpublishing.co.uk/news/2552/bristol-myers-squibb-signs-exclusive-agreement-with-bavarian-nordic-for-prostvac-a-prostate-specific-antigen-targeting-cancer-immunotherapy/2017-01-11T11:34:32+00:00https://drug.russellpublishing.co.uk/news/2554/oryx-therapeutic-vaccine-micoryx-successfully-completes-phase-iiia-trial-to-treat-msh-h-colorectal-cancer/2017-01-11T12:02:17+00:00https://drug.russellpublishing.co.uk/news/2558/domain-therapeutics-launches-specific-purpose-vehicle-kaldi-pharma-to-harness-the-potential-of-its-adenosine-programs/2017-01-11T12:01:00+00:00https://drug.russellpublishing.co.uk/news/2565/manipulating-cells-shapes-could-treat-breast-cancer/2017-01-11T12:00:27+00:00https://drug.russellpublishing.co.uk/news/2569/stem-cell-test-could-identify-most-aggressive-breast-cancers/2017-01-11T11:59:48+00:00https://drug.russellpublishing.co.uk/news/2571/cheminteract-consortium-wins-funding-to-develop-chemical-toxicity-assessment-tool/2017-01-11T11:59:12+00:00https://drug.russellpublishing.co.uk/news/2581/combination-cell-gene-therapy-for-lung-cancer-to-be-tested-in-uk-patients/2017-01-11T11:55:36+00:00https://drug.russellpublishing.co.uk/news/2583/baxters-bioscience-business-acquires-biopharmaceutical-company-suppremol/2017-01-11T11:55:08+00:00https://drug.russellpublishing.co.uk/news/2593/university-spin-out-gets-crowdfunding-investment-to-develop-a-cure-for-parkinsons-disease/2017-01-11T11:54:07+00:00https://drug.russellpublishing.co.uk/news/2595/oryx-successfully-completes-phase-iiia-trial-with-therapeutic-vaccine-vicoryx-to-treat-hpv-associated-cancers/2017-01-11T11:53:52+00:00https://drug.russellpublishing.co.uk/news/2602/phico-therapeutics-receives-translation-award-to-advance-its-saspject-pt4-aimed-at-escherichia-coli-and-klebsiella-pneumoniae-towards-clinical-trials/2016-12-09T15:34:01+00:00https://drug.russellpublishing.co.uk/news/2604/probiodrug-announces-enrolment-of-first-patient-in-phase-2-study-of-novel-treatment-for-alzheimers-disease/2017-01-11T11:53:25+00:00https://drug.russellpublishing.co.uk/news/2623/tataa-biocenter-introduces-partnership-with-qlucore-to-use-qlucore-omics-explorer-in-its-next-generation-sequencing-courses-and-client-services/2016-12-09T15:34:01+00:00https://drug.russellpublishing.co.uk/news/2674/first-treatment-approved-under-eams-developed-using-antibody-humanization-expertise-at-uks-mrc-technology/2017-01-16T15:49:25+00:00https://drug.russellpublishing.co.uk/news/2740/parp-inhibitors-could-work-in-larger-group-of-patients/2017-01-05T16:08:09+00:00https://drug.russellpublishing.co.uk/news/2747/key-txcell-patent-to-be-granted-in-the-us-for-its-lead-product-ovasaver/2016-12-14T23:17:23+00:00https://drug.russellpublishing.co.uk/news/2760/mission-therapeutics-appoints-paul-wallace-as-chief-business-officer/2016-12-22T23:40:36+00:00https://drug.russellpublishing.co.uk/news/2775/targeted-therapies-offer-novel-treatment-modalities-for-breast-cancer/2017-01-05T16:07:53+00:00https://drug.russellpublishing.co.uk/news/2789/alize-pharma-iii-raises-e1-8-million-1-94-million-in-first-financing-round/2017-01-05T16:07:38+00:00https://drug.russellpublishing.co.uk/news/2802/prothena-reports-robust-reduction-of-free-serum-alpha-synuclein-of-up-to-96-after-single-dose-of-prx002-a-novel-protein-immunotherapy-for-parkinsons-disease/2017-01-05T16:07:25+00:00https://drug.russellpublishing.co.uk/news/2814/probiodrug-to-present-data-on-its-anti-pglu-3-abeta-monoclonal-antibody-at-the-12th-international-conference-on-alzheimers-and-parkinsons-diseases/2017-01-05T16:07:11+00:00https://drug.russellpublishing.co.uk/news/2829/a-vaccine-against-placental-malaria-made-with-expres2ion-biotechnologies-protein-expression-technology-expres2-is-ready-to-start-human-tests-in-germany-and-benin/2017-01-05T16:06:59+00:00https://drug.russellpublishing.co.uk/news/2835/detecting-prostate-tumour-cells-in-blood-can-give-an-early-warning-of-treatment-failure/2017-01-05T16:06:34+00:00https://drug.russellpublishing.co.uk/news/2850/confluence-pharmaceuticals-signs-co-development-and-marketing-agreement-with-aop-orphan-for-fragile-x-syndrome-drug/2017-01-05T16:06:46+00:00https://drug.russellpublishing.co.uk/news/2877/rigontec-gmbh-raises-e4-8m-in-a-second-closing-of-its-series-a-financing/2017-01-05T15:57:21+00:00https://drug.russellpublishing.co.uk/news/2900/bristol-myers-squibb-acquires-exclusive-license-from-novo-nordisk-for-a-discovery-research-programme-focused-on-autoimmune-diseases/2017-01-05T15:57:10+00:00https://drug.russellpublishing.co.uk/news/2910/semma-therapeutics-announces-44-million-in-funding-to-develop-cell-therapy-for-treating-type-1-diabetes/2017-01-05T15:55:05+00:00https://drug.russellpublishing.co.uk/news/2918/cancer-research-uk-partners-with-the-engineering-and-physical-sciences-research-council-epsrc-to-inspire-innovation/2017-01-05T15:54:47+00:00https://drug.russellpublishing.co.uk/news/2922/astrazeneca-to-collaborate-with-the-hsci-in-search-for-new-diabetes-treatments/2017-01-05T15:54:35+00:00https://drug.russellpublishing.co.uk/news/2927/medical-breakthroughs-on-the-horizon-with-32m-boost-from-the-biomedical-catalyst/2017-01-05T15:54:21+00:00https://drug.russellpublishing.co.uk/news/2999/taconic-biosciences-and-cellaria-biosciences-agree-to-scientific-collaboration-to-facilitate-xenograft-use-in-oncology-research/2017-01-05T15:54:09+00:00https://drug.russellpublishing.co.uk/news/3013/new-role-uncovered-for-oldest-tumour-suppressor-gene-the-retinoblastoma-gene/2017-01-05T16:40:22+00:00https://drug.russellpublishing.co.uk/news/3030/ebola-1-million-grant-to-develop-in-the-field-test/2017-01-05T15:53:37+00:00https://drug.russellpublishing.co.uk/news/3042/cellectis-announces-pricing-of-its-initial-public-offering-of-american-depositary-shares/2017-01-05T15:53:15+00:00https://drug.russellpublishing.co.uk/news/3047/new-abatacept-trial-to-investigate-if-targeted-immunotherapy-can-prevent-rheumatoid-arthritis/2017-01-05T15:53:02+00:00https://drug.russellpublishing.co.uk/news/3058/mrc-and-ucb-collaborate-to-offer-access-to-ucbs-novel-antibody-discovery-platform/2017-01-05T15:52:48+00:00https://drug.russellpublishing.co.uk/news/3062/nanoparticles-could-provide-a-new-treatment-option-for-patients-with-amd/2017-01-05T15:52:37+00:00https://drug.russellpublishing.co.uk/news/3074/crt-and-bioinvent-expand-collaboration-with-university-of-southampton-to-develop-new-immunotherapy-treatments-for-cancer/2017-01-05T15:52:13+00:00https://drug.russellpublishing.co.uk/news/3092/merck-serono-and-intrexon-announce-agreement-for-the-development-and-commercialisation-of-car-t-cancer-therapy/2018-06-29T14:26:39+01:00https://drug.russellpublishing.co.uk/news/3095/pfizer-appoints-dr-charles-reay-mackay-as-chief-scientific-officer-inflammation-and-immunology-research-unit/2017-01-05T15:50:01+00:00https://drug.russellpublishing.co.uk/news/3100/novartis-accelerates-cancer-immunotherapy-efforts-with-aduro-biotech-alliance/2017-01-05T15:49:42+00:00https://drug.russellpublishing.co.uk/news/3103/astrazeneca-joins-genomics-england-to-accelerate-the-development-of-new-treatments-arising-from-the-100000-genomes-project/2017-01-05T15:49:30+00:00https://drug.russellpublishing.co.uk/news/3107/invectys-raises-1-7-million-euros-more-to-finance-the-clinical-development-of-its-therapeutic-cancer-vaccine/2017-01-05T15:49:17+00:00https://drug.russellpublishing.co.uk/news/3111/selvita-initiates-ind-enabling-studies-for-its-first-in-class-pimflt3-inhibitor/2017-01-05T15:49:04+00:00https://drug.russellpublishing.co.uk/news/3171/consortium-signs-deal-with-basilea-to-develop-resistance-busting-cancer-drugs/2017-01-05T15:48:53+00:00https://drug.russellpublishing.co.uk/news/3211/fda-encourages-manufacturers-to-develop-abuse-deterrent-drugs/2017-01-05T15:48:17+00:00https://drug.russellpublishing.co.uk/news/3215/merck-serono-and-medicines-for-malaria-venture-sign-agreement-to-develop-potential-antimalarial-therapy/2017-01-11T12:21:05+00:00https://drug.russellpublishing.co.uk/news/3217/peptidream-announces-license-of-peptide-discovery-platform-system-pdps-technology-to-novartis/2017-01-11T12:20:34+00:00https://drug.russellpublishing.co.uk/news/3226/bristol-myers-squibb-and-uniqure-enter-into-exclusive-strategic-collaboration-to-develop-gene-therapies-for-cardiovascular-diseases/2017-01-11T12:20:09+00:00https://drug.russellpublishing.co.uk/news/3236/phoremost-ltd-founded-to-identify-new-druggable-targets-for-therapeutics/2017-01-05T15:44:36+00:00https://drug.russellpublishing.co.uk/news/3246/pfizer-announces-kathrin-jansen-as-new-senior-vice-president-vaccine-research-development/2017-01-11T12:19:31+00:00https://drug.russellpublishing.co.uk/news/3251/edaravone-could-help-stop-the-progression-of-alzheimers-disease/2017-01-05T15:43:54+00:00https://drug.russellpublishing.co.uk/news/3254/nabriva-therapeutics-announces-financing-to-advance-clinical-development-of-new-class-of-antibiotics/2017-01-11T12:17:54+00:00https://drug.russellpublishing.co.uk/news/3260/arvinas-announces-multi-year-collaboration-with-merck-to-study-protein-degradation-technology/2018-06-29T14:10:33+01:00https://drug.russellpublishing.co.uk/news/3263/cardio3-biosciences-receives-notice-of-allowance-for-first-u-s-patent-broadly-covering-tcr-deficient-t-cells-engineered-to-express-a-chimeric-antigen-receptor/2017-01-05T15:35:14+00:00https://drug.russellpublishing.co.uk/news/3273/implementation-of-qbd-in-lyophilisation-gsk-takeda-boehringer-ingelheim-and-baxter-sciences-explain-how-at-lyophilisation-europe-2015/2017-01-11T12:14:13+00:00https://drug.russellpublishing.co.uk/news/3311/inovio-selected-by-darpa-to-lead-a-team-to-expedite-development-of-novel-products-to-prevent-and-treat-ebola/2017-01-05T15:34:53+00:00https://drug.russellpublishing.co.uk/news/3388/cellectis-opens-labs-and-offices-in-new-york/2017-01-05T15:34:39+00:00https://drug.russellpublishing.co.uk/news/3419/pfizer-launches-new-competitive-grants-programme-to-advance-cardiovascular-disease-research/2017-01-11T12:05:40+00:00https://drug.russellpublishing.co.uk/news/3430/new-study-reveals-anisina-kills-melanoma-cells-regardless-of-their-mutation-status/2017-01-05T15:34:10+00:00https://drug.russellpublishing.co.uk/news/3499/genomics-plc-and-eisai-to-collaborate-in-analyses-of-large-scale-genotypephenotype-data-to-inform-drug-discovery/2017-01-05T15:33:56+00:00https://drug.russellpublishing.co.uk/news/3509/broad-institute-and-bayer-healthcare-expand-collaboration-to-help-create-new-cardiovascular-therapies/2017-01-05T15:33:42+00:00https://drug.russellpublishing.co.uk/news/3516/medivir-and-crt-collaborate-to-develop-new-class-of-cancer-drugs/2017-01-05T15:33:27+00:00https://drug.russellpublishing.co.uk/news/3520/astrazeneca-and-patientslikeme-announce-global-research-collaboration/2017-01-05T15:33:12+00:00https://drug.russellpublishing.co.uk/news/3527/new-research-highlights-the-potential-of-bi-1206-to-help-overcome-antibody-drug-resistance-in-cancer-therapy/2017-01-05T15:30:16+00:00https://drug.russellpublishing.co.uk/news/3531/alnylam-and-collaborators-publish-pre-clinical-results-on-aln-at3-for-the-treatment-of-haemophilia/2016-12-14T22:42:00+00:00https://drug.russellpublishing.co.uk/news/3534/hydra-biosciences-and-boehringer-ingelheim-collaborate-to-research-treatments-for-renal-diseases-and-disorders/2017-01-05T15:29:53+00:00https://drug.russellpublishing.co.uk/news/3540/lexicon-and-bristol-myers-squibb-select-development-candidate-for-neuropathic-pain/2017-01-05T15:29:38+00:00https://drug.russellpublishing.co.uk/news/3545/new-pre-clinical-data-on-g1t28-to-be-presented-at-aacr-annual-meeting/2017-01-05T15:28:09+00:00https://drug.russellpublishing.co.uk/news/3548/celprogen-introduces-a-novel-pharmacological-inhibitor-cep1430-for-the-treatment-of-pancreatic-cancer/2017-01-05T15:26:40+00:00https://drug.russellpublishing.co.uk/news/3558/ferring-and-the-institut-pasteur-collaborate-in-novel-idb-drug-development-project/2017-01-19T10:37:35+00:00https://drug.russellpublishing.co.uk/news/3563/innate-pharma-and-sanofi-collaborate-to-develop-new-antibody-drug-conjugates/2017-01-05T15:25:55+00:00https://drug.russellpublishing.co.uk/news/3571/cira-and-takeda-to-collaborate-on-ips-cell-research/2017-01-05T15:25:21+00:00https://drug.russellpublishing.co.uk/news/3575/anaptysbio-advances-first-in-class-anti-il-36-receptor-antibody-anb019/2017-01-05T15:22:22+00:00https://drug.russellpublishing.co.uk/news/3578/iavi-lead-team-defines-new-method-that-holds-promise-for-hiv-vaccine-development/2017-01-05T15:16:50+00:00https://drug.russellpublishing.co.uk/news/3593/novogen-and-the-feinstein-institute-collaborate-to-develop-effective-treatments-for-brain-cancers/2017-01-05T15:16:39+00:00https://drug.russellpublishing.co.uk/news/3605/consortium-awarded-e8-4-million-for-development-of-thermo-stable-and-cold-chain-independent-virosome-based-vaccines/2021-03-22T15:41:03+00:00https://drug.russellpublishing.co.uk/news/3608/peloton-therapeutics-presents-promising-data-on-pt2385-the-first-inhibitor-of-hif-2a-for-renal-cell-carcinoma/2017-01-05T15:16:05+00:00https://drug.russellpublishing.co.uk/news/3609/oxford-globals-interview-with-araz-raoof-of-janssen-pharmaceuticals-and-juan-miguel-jimenez-of-vertex-pharmaceuticals-in-the-lead-up-to-the-16th-annual-drug-discovery-summit/2017-01-11T12:30:32+00:00https://drug.russellpublishing.co.uk/news/3613/blueprint-medicines-presents-preclinical-data-demonstrating-significant-anti-tumour-activity-of-blu-285-in-treatment-resistant-gist/2017-01-11T12:29:29+00:00https://drug.russellpublishing.co.uk/news/3618/delmar-presents-positive-preclinical-data-on-val-083-for-treatment-of-non-small-cell-lung-cancer/2017-01-05T15:15:28+00:00https://drug.russellpublishing.co.uk/news/3625/positive-preclinical-data-on-irak4-inhibitor-compounds-presented-at-aacr-2015/2017-01-05T15:15:15+00:00https://drug.russellpublishing.co.uk/news/3630/new-collaboration-to-research-rna-binding-proteins-to-create-new-therapeutic-target-candidates/2017-01-05T15:15:02+00:00https://drug.russellpublishing.co.uk/news/3636/results-announced-from-a-preclinical-study-of-av-380-for-the-treatment-of-cancer-associated-cachexia/2017-01-05T15:14:05+00:00https://drug.russellpublishing.co.uk/news/3640/mrc-technology-appoints-andrew-mercieca-as-finance-director/2017-01-05T15:13:52+00:00https://drug.russellpublishing.co.uk/news/3644/cardio3-biosciences-announces-infusion-of-first-patient-in-nkg2d-phase-i-trial/2017-01-05T15:10:59+00:00https://drug.russellpublishing.co.uk/news/3648/transgene-presents-preclinical-data-for-tg4010-and-tg3003-at-aacr-2015/2017-01-05T15:10:43+00:00https://drug.russellpublishing.co.uk/news/3659/trial-shows-benefit-of-brca-targeting-drug-olaparib-in-prostate-cancer/2017-01-05T15:10:00+00:00https://drug.russellpublishing.co.uk/news/3664/maxcyte-and-johns-hopkins-university-announce-strategic-collaboration-to-advance-car-t-cell-therapies/2017-01-11T12:24:17+00:00https://drug.russellpublishing.co.uk/news/3669/epizyme-presents-preclinical-research-on-carm1-and-prmt6/2017-01-05T15:09:37+00:00https://drug.russellpublishing.co.uk/news/3674/astellas-and-potenza-enter-rd-collaboration-for-immuno-oncology-therapeutics/2017-01-11T13:38:45+00:00https://drug.russellpublishing.co.uk/news/3679/ariad-announces-results-of-preclinical-studies-on-brigatinib-at-aacr-2015/2017-01-11T13:39:16+00:00https://drug.russellpublishing.co.uk/news/3685/blend-presents-preclinical-data-for-btp-114-that-demonstrates-superiority-to-cisplatin-in-tumour-growth-inhibition/2016-12-14T23:15:46+00:00https://drug.russellpublishing.co.uk/news/3690/immunexcite-presents-new-preclinical-data-on-its-mabxcite-platform/2017-01-05T15:08:50+00:00https://drug.russellpublishing.co.uk/news/3758/new-research-describes-blueprint-for-truly-personalised-cancer-immunotherapies/2017-01-05T15:08:20+00:00https://drug.russellpublishing.co.uk/news/3836/dimension-therapeutics-to-develop-gene-therapy-treatments-for-patients-with-ornithine-transcarbamylase-deficiency-and-glycogen-storage-disease-type-ia/2017-01-05T15:05:50+00:00https://drug.russellpublishing.co.uk/news/3839/preclinical-and-mechanistic-data-supports-use-of-cytori-cell-therapy-in-wounds-combining-thermal-burn-and-radiation-exposure/2017-01-05T15:05:37+00:00https://drug.russellpublishing.co.uk/news/3842/international-consortium-cancer-id-to-develop-novel-biomarker-technologies-in-cancer/2017-01-11T13:40:32+00:00https://drug.russellpublishing.co.uk/news/3847/mrc-technology-collaborates-with-nyu-school-of-medicine-to-develop-biologics-for-inflammatory-osteolysis/2017-01-05T15:03:41+00:00https://drug.russellpublishing.co.uk/news/3850/preclinical-data-demonstrates-blu-554-induces-significant-tumour-regression-in-models-of-hepatocellular-carcinoma/2017-01-05T15:03:13+00:00https://drug.russellpublishing.co.uk/news/3856/astrazeneca-and-celgene-collaborate-to-develop-medi4736-for-patients-with-serious-blood-cancers/2017-01-05T15:02:48+00:00https://drug.russellpublishing.co.uk/news/3860/argen-x-announces-publication-on-therapeutic-potential-of-argx-115-in-cancer-immunotherapy/2017-01-05T15:02:31+00:00https://drug.russellpublishing.co.uk/news/3874/preclinical-data-from-novel-syn-005-programme-for-the-treatment-of-pertussis-presented-at-eccmid-2015/2017-01-05T14:59:49+00:00https://drug.russellpublishing.co.uk/news/3879/nanoviricides-discuss-the-effectiveness-of-its-anti-herpes-drug-candidates-in-a-lethal-animal-model-of-dermal-herpes-infection/2017-01-05T14:59:34+00:00https://drug.russellpublishing.co.uk/news/3883/stealth-biotherapeutics-expands-ocuvias-clinical-development-into-rare-mitochondrial-optic-neuropathies/2017-01-05T14:59:20+00:00https://drug.russellpublishing.co.uk/news/3887/4dmt-and-roche-sign-collaboration-agreement-for-gene-therapy-vector-discovery-and-product-development/2017-01-05T14:59:07+00:00https://drug.russellpublishing.co.uk/news/3893/new-signalling-pathway-discovered-in-her2-positive-breast-cancer/2017-01-05T14:58:56+00:00https://drug.russellpublishing.co.uk/news/3899/new-therapeutic-target-for-colorectal-cancer-has-been-identified/2017-01-05T14:58:40+00:00https://drug.russellpublishing.co.uk/news/3906/discovery-of-an-unexpected-function-of-the-protein-ddsk2/2017-01-05T14:58:24+00:00https://drug.russellpublishing.co.uk/news/3924/new-study-explores-memory-rescuing-potential-of-inhibiting-hdacs/2017-01-05T14:58:11+00:00https://drug.russellpublishing.co.uk/news/3928/genetic-mutation-could-protect-against-development-of-type-2-diabetes/2017-01-05T14:57:55+00:00https://drug.russellpublishing.co.uk/news/3932/biotech-companies-present-novel-approaches-to-fight-infections-at-eccmids-pipeline-corner/2017-01-19T11:31:12+00:00https://drug.russellpublishing.co.uk/news/3953/nih-to-fund-10-5-million-multi-site-interdisciplinary-research-effort-to-investigate-the-role-of-non-inherited-genetic-mutations-in-schizophrenia/2017-01-05T14:57:24+00:00https://drug.russellpublishing.co.uk/news/3959/new-method-of-investigating-human-lung-tissue-enables-improved-drug-target-validation-for-copd-treatment/2017-01-16T11:17:27+00:00https://drug.russellpublishing.co.uk/news/3965/itim-receptors-important-to-development-of-acute-myeloid-leukaemia/2017-01-05T14:55:38+00:00https://drug.russellpublishing.co.uk/news/3977/reneuron-gets-approval-to-start-a-phase-iii-clinical-trial-in-the-us-in-retinitis-pigmentosa/2017-01-05T14:55:25+00:00https://drug.russellpublishing.co.uk/news/3982/the-michael-j-fox-foundation-and-prothena-partner-to-accelerate-discovery-of-novel-biomarkers-for-parkinsons-disease/2017-01-05T14:55:12+00:00https://drug.russellpublishing.co.uk/news/3986/shire-and-foundation-fighting-blindness-announce-new-adrp-research-agreement/2017-01-05T14:54:56+00:00https://drug.russellpublishing.co.uk/news/3990/kallistem-announces-a-world-first-human-spermatogenesis-in-vitro/2017-01-05T14:54:41+00:00https://drug.russellpublishing.co.uk/news/3994/drug-discovery-company-selvita-establishes-uk-subsidiary-in-cambridge/2017-01-05T14:54:30+00:00https://drug.russellpublishing.co.uk/news/3998/discovery-could-help-reverse-glucocorticoid-resistance-in-young-leukaemia-patients/2017-01-11T13:47:15+00:00https://drug.russellpublishing.co.uk/news/4001/breast-cancer-vaccines-may-work-better-with-silicon-microparticles/2017-01-05T14:54:18+00:00https://drug.russellpublishing.co.uk/news/4007/me-344-shows-enhanced-anti-tumour-activity-in-combination-with-tyrosine-kinase-inhibitor-in-preclinical-studies/2017-01-05T14:53:49+00:00https://drug.russellpublishing.co.uk/news/4013/mabvax-therapeutics-humab-5b1-antibody-successfully-clears-important-early-toxicology-testing/2017-01-05T14:53:34+00:00https://drug.russellpublishing.co.uk/news/4018/rock-inhibitors-could-stop-the-spread-of-melanoma-cells/2017-01-05T14:53:04+00:00https://drug.russellpublishing.co.uk/news/4023/gilead-acquires-epitherapeutics-for-65-million/2017-01-11T13:46:05+00:00https://drug.russellpublishing.co.uk/news/4026/positive-preclinical-data-for-dicerna-pharmaceuticals-dsirna-ex-conjugates-presented-at-tides-2015/2017-01-05T14:52:24+00:00https://drug.russellpublishing.co.uk/news/4030/pfizer-announces-key-appointments-in-biotherapeutics-rd-and-rinat/2017-01-11T13:44:30+00:00https://drug.russellpublishing.co.uk/news/4036/plexxikon-and-merck-team-up-to-evaluate-plx3397-in-combination-with-keytruda/2018-06-29T14:09:07+01:00https://drug.russellpublishing.co.uk/news/4041/new-anti-cancer-stem-cell-compound-in-development/2017-01-05T14:09:07+00:00https://drug.russellpublishing.co.uk/news/4045/anticonvulsant-epilepsy-drug-holds-promise-as-alzheimers-disease-treatment/2017-01-05T14:08:54+00:00https://drug.russellpublishing.co.uk/news/4049/scientists-able-to-see-all-the-proteins-that-help-repair-damaged-dna/2017-01-05T14:08:40+00:00https://drug.russellpublishing.co.uk/news/4054/scientists-determine-the-molecular-structure-of-amyloid-beta-42-in-alzheimers-disease/2017-01-19T09:51:54+00:00https://drug.russellpublishing.co.uk/news/4058/potential-new-painkiller-boronicaine-provides-longer-lasting-effects/2017-01-05T14:08:04+00:00https://drug.russellpublishing.co.uk/news/4063/morphosys-acquires-peptide-therapeutic-company-lanthio-pharma/2017-01-05T14:08:15+00:00https://drug.russellpublishing.co.uk/news/4069/domainex-granted-us-and-eu-patents-for-its-lead-programme-targeting-ikk-epsilon-and-tbk1/2017-01-16T11:22:30+00:00https://drug.russellpublishing.co.uk/news/4076/positive-preclinical-results-support-the-development-of-isth0036-for-the-treatment-of-glaucoma/2017-01-05T14:07:06+00:00https://drug.russellpublishing.co.uk/news/4080/phoremost-awarded-1-4m-to-develop-lead-oncology-programme-targeting-mutant-kras-cancers/2017-01-05T14:06:54+00:00https://drug.russellpublishing.co.uk/news/4085/studies-confirm-trxe-009-kills-resistant-paediatric-brain-cancer-cells/2017-01-05T14:06:07+00:00https://drug.russellpublishing.co.uk/news/4091/gsk-partners-with-unc-chapel-hill-to-accelerate-search-for-hiv-cure/2017-01-05T14:06:21+00:00https://drug.russellpublishing.co.uk/news/4095/hemispherx-biopharma-receives-ema-orphan-medicine-designation-for-ampligen-to-treat-ebola/2017-01-05T14:06:34+00:00https://drug.russellpublishing.co.uk/news/4102/fda-grants-qidp-and-fast-track-designations-to-cd101-iv-for-the-treatment-of-candidemia/2017-01-19T10:15:35+00:00https://drug.russellpublishing.co.uk/news/4108/biontech-and-lilly-enter-into-cancer-immunotherapy-research-collaboration/2017-01-05T14:05:40+00:00https://drug.russellpublishing.co.uk/news/4112/haplogen-and-cyclenium-pharma-announce-research-and-development-collaboration/2017-01-05T14:04:33+00:00https://drug.russellpublishing.co.uk/news/4116/new-map-of-ttll7-protein-helps-researchers-understand-cellular-transport/2017-01-19T09:51:37+00:00https://drug.russellpublishing.co.uk/news/4122/significant-progress-made-towards-individualised-cancer-immunotherapy/2017-01-11T13:53:42+00:00https://drug.russellpublishing.co.uk/news/4128/invectys-initiates-phase-i-clinical-trial-evaluating-invac-1-therapeutic-vaccine-for-cancer-patients/2017-01-05T14:03:34+00:00https://drug.russellpublishing.co.uk/news/4132/soligenix-enters-agreement-with-emergent-biosolutions-to-develop-ricin-vaccine-rivax/2017-01-05T14:03:20+00:00https://drug.russellpublishing.co.uk/news/4136/genethon-and-selecta-biosciences-to-research-repeat-dosing-for-gene-therapies/2017-01-05T14:03:06+00:00https://drug.russellpublishing.co.uk/news/4141/sanofi-exercises-option-on-second-therapeutic-programme-with-selecta-biosciences-to-develop-a-treatment-for-coeliac-disease/2017-01-11T14:13:12+00:00https://drug.russellpublishing.co.uk/news/4145/immunomic-therapeutics-awarded-1-2m-to-develop-peanut-allergy-treatment/2017-01-05T14:02:51+00:00https://drug.russellpublishing.co.uk/news/4151/antibiotic-research-uk-welcomes-the-oneill-commissions-recommendation-to-create-2b-global-fund-to-tackle-antibiotic-resistance/2017-01-19T11:31:04+00:00https://drug.russellpublishing.co.uk/news/4162/acucela-announces-publication-of-preclinical-data-for-emixustat/2017-01-05T14:02:23+00:00https://drug.russellpublishing.co.uk/news/4168/anisina-confirmed-as-effective-anti-cancer-agent-in-preclinical-studies/2017-01-05T14:02:10+00:00https://drug.russellpublishing.co.uk/news/4172/lilly-and-sanford-burnham-to-collaborate-to-discover-immunological-therapies/2017-01-05T14:01:56+00:00https://drug.russellpublishing.co.uk/news/4177/contraceptive-and-cholesterol-lowering-drug-combination-bap-used-to-treat-cancer/2017-01-05T14:01:40+00:00https://drug.russellpublishing.co.uk/news/4194/ablynx-and-genzyme-to-collaborate-on-multiple-sclerosis-research-project/2017-01-05T14:01:25+00:00https://drug.russellpublishing.co.uk/news/4203/anavex-releases-preclinical-anti-seizure-data-for-anavex-2-73/2017-01-05T14:01:11+00:00https://drug.russellpublishing.co.uk/news/4207/broad-institute-receives-10-million-from-the-gerstner-family-foundation-to-research-cancer-drug-resistance/2017-01-05T14:00:31+00:00https://drug.russellpublishing.co.uk/news/4211/scientists-discover-why-streptococcus-pneumoniae-infections-can-cause-fatal-heart-complications/2017-01-05T14:00:17+00:00https://drug.russellpublishing.co.uk/news/4215/genmab-and-biontech-sign-co-development-agreement-in-immuno-oncology/2017-01-05T14:00:04+00:00https://drug.russellpublishing.co.uk/news/4220/mucosis-to-present-data-on-intranasal-rsv-vaccine-syngem-at-mvads-2015/2017-01-05T13:59:52+00:00https://drug.russellpublishing.co.uk/news/4245/ipsen-signs-agreement-to-acquire-octreopharm-sciences/2017-01-05T13:59:40+00:00https://drug.russellpublishing.co.uk/news/4250/zealand-starts-clinical-development-of-a-multiple-dose-version-of-zp4207/2017-01-11T14:09:59+00:00https://drug.russellpublishing.co.uk/news/4254/scientists-unveil-rosetta-stone-of-prostate-cancer/2017-01-05T13:58:24+00:00https://drug.russellpublishing.co.uk/news/4259/first-cancer-promoting-oncogenes-discovered-in-choroid-plexus-carcinoma/2017-01-05T13:59:15+00:00https://drug.russellpublishing.co.uk/news/4265/re-engineered-spectinomycin-shows-potential-for-treatment-of-drug-resistant-bacteria/2017-01-05T13:58:36+00:00https://drug.russellpublishing.co.uk/news/4270/orphan-drug-designation-granted-in-the-eu-for-isth0036-to-treat-advanced-stage-glaucoma/2017-01-05T13:59:01+00:00https://drug.russellpublishing.co.uk/news/4275/alnylam-files-clinical-trial-application-for-aln-aat-for-the-treatment-of-alpha-1-liver-disease/2017-01-05T13:58:47+00:00https://drug.russellpublishing.co.uk/news/4281/eureka-therapeutics-and-boehringer-ingelheim-enter-into-antibody-research-agreement/2017-01-05T13:58:13+00:00https://drug.russellpublishing.co.uk/news/4288/janssen-and-achillion-enter-into-worldwide-collaboration-to-combat-hepatitis-c/2017-01-05T13:56:45+00:00https://drug.russellpublishing.co.uk/news/4292/anti-stroke-drug-vinpocetine-could-be-effective-as-a-treatment-for-middle-ear-infections/2017-01-19T11:30:55+00:00https://drug.russellpublishing.co.uk/news/4300/eisai-to-promote-clinical-trial-data-disclosure-for-the-advancement-of-science-and-medicine/2017-01-11T14:28:18+00:00https://drug.russellpublishing.co.uk/news/4304/tsri-chemists-devise-inexpensive-method-for-synthesising-amines/2017-01-05T13:55:14+00:00https://drug.russellpublishing.co.uk/news/4309/an-interview-with-ben-busby-national-center-for-biotechnology-information-ncbi/2017-01-11T14:22:35+00:00https://drug.russellpublishing.co.uk/news/4312/achilles-heel-of-ebola-virus-identified-in-new-study/2017-01-05T13:54:55+00:00https://drug.russellpublishing.co.uk/news/4324/merozyne-therapeutics-launches-project-to-develop-a-treatment-for-patients-with-mdc1a/2017-01-05T13:54:43+00:00https://drug.russellpublishing.co.uk/news/4333/dormant-cancer-cells-can-wake-up-after-decades/2017-01-11T14:17:04+00:00https://drug.russellpublishing.co.uk/news/4348/blocking-lox-enzyme-could-prevent-breast-cancer-from-spreading/2017-01-05T13:54:30+00:00https://drug.russellpublishing.co.uk/news/4381/tsri-scientists-win-2-2-million-to-expand-study-of-ip6k1-to-help-develop-new-obesity-therapies/2017-01-05T13:53:54+00:00https://drug.russellpublishing.co.uk/news/4389/presence-of-igfbps-correlates-with-tumour-promoting-effects-of-mmp9-in-breast-cancer/2017-01-05T13:52:55+00:00https://drug.russellpublishing.co.uk/news/4394/padlock-therapeutics-accelerates-pipeline-development-through-agreement-with-gsk/2017-01-11T14:32:06+00:00https://drug.russellpublishing.co.uk/news/4398/degenerating-white-matter-may-be-early-marker-of-alzheimers-disease/2017-01-05T13:53:40+00:00https://drug.russellpublishing.co.uk/news/4411/first-subject-dosed-in-phase-1-clinical-trial-of-emb-001/2017-01-11T14:34:31+00:00https://drug.russellpublishing.co.uk/news/4418/az-and-lilly-team-up-to-evaluate-medi4736-and-ramucirumab-in-advanced-solid-tumours/2017-01-05T13:51:59+00:00https://drug.russellpublishing.co.uk/news/4432/analysis-of-human-aqueous-humour-reveals-386-new-proteins-as-biomarker-candidates/2017-01-05T13:51:46+00:00https://drug.russellpublishing.co.uk/news/4437/researchers-engineer-probiotics-to-detect-liver-tumours/2017-01-05T13:51:15+00:00https://drug.russellpublishing.co.uk/news/4442/genticel-announces-positive-preclinical-proof-of-concept-results-for-its-multivalent-hpv-therapeutic-vaccine-gtl002/2017-01-05T13:49:48+00:00https://drug.russellpublishing.co.uk/news/4448/mgb-biopharma-succeeds-in-developing-an-iv-formulation-of-mgb-bp-3-for-the-treatment-of-hospital-acquired-infections/2017-01-05T13:49:26+00:00https://drug.russellpublishing.co.uk/news/4452/astellas-and-anokion-establish-kanyos-bio-to-develop-products-for-type-1-diabetes-and-coeliac-disease/2017-01-05T13:49:10+00:00https://drug.russellpublishing.co.uk/news/4455/ldc-and-qurient-sign-licence-agreement-to-advance-cdk7-inhibitors-for-the-treatment-of-cancer/2017-01-05T13:48:55+00:00https://drug.russellpublishing.co.uk/news/4459/anti-ebola-mva-vaccine-produced-on-probiogens-age1-cr-cell-line-platform-enters-clinical-trials/2017-01-05T13:48:39+00:00https://drug.russellpublishing.co.uk/news/4463/auspherix-raises-6-million-to-progress-novel-antibiotics-and-establishes-uk-operations/2017-01-05T13:47:43+00:00https://drug.russellpublishing.co.uk/news/4467/inovio-partners-with-geneone-life-science-for-mers-vaccine-clinical-development/2017-01-05T13:46:29+00:00https://drug.russellpublishing.co.uk/news/4472/merck-extends-immuno-oncology-collaboration-with-agenus/2018-06-29T14:28:00+01:00https://drug.russellpublishing.co.uk/news/4477/triple-treatment-keeps-lung-cancer-from-coming-back/2017-01-05T13:46:16+00:00https://drug.russellpublishing.co.uk/news/4482/amended-celgene-and-bluebird-bio-collaboration-to-focus-on-the-development-of-anti-bcma-products/2017-01-05T13:45:55+00:00https://drug.russellpublishing.co.uk/news/4490/vbi-vaccines-presents-data-supporting-the-use-of-its-evlp-platform-to-develop-a-novel-hcv-vaccine-candidate/2017-01-05T13:45:35+00:00https://drug.russellpublishing.co.uk/news/4499/ampliphis-bacteriophage-manufacturing-facility-receives-cgmp-certification/2017-01-19T10:37:29+00:00https://drug.russellpublishing.co.uk/news/4505/t-cell-exhaustion-study-has-possible-implications-for-cancer-and-antiviral-therapies/2017-01-05T13:44:45+00:00https://drug.russellpublishing.co.uk/news/4515/drug-abuse-triggers-regulations-to-push-the-development-of-abuse-free-opioid-formulations/2017-01-05T13:43:52+00:00https://drug.russellpublishing.co.uk/news/4524/organ-on-a-chip-and-3d-printing-in-the-life-sciences-conference-boston-july-8-9-2015-features-international-roster-of-speakers/2017-01-11T14:44:23+00:00https://drug.russellpublishing.co.uk/news/4526/lab-on-a-chip-microfluidics-point-of-care-diagnostics-and-global-health-the-road-to-diagnostics-congress/2017-01-11T14:42:33+00:00https://drug.russellpublishing.co.uk/news/4534/merck-illumina-and-genea-form-the-global-fertility-alliance/2018-06-29T14:05:43+01:00https://drug.russellpublishing.co.uk/news/4544/myxoma-virus-kills-cancer-cells-while-blocking-graft-versus-host-disease-in-bone-marrow-transplants/2017-01-05T12:29:12+00:00https://drug.russellpublishing.co.uk/news/4567/fibrocell-and-intrexon-announce-positive-preclinical-data-for-fcx-007-in-rdeb/2017-01-05T12:28:57+00:00https://drug.russellpublishing.co.uk/news/4571/fda-and-ema-grants-orphan-drug-designation-to-recap-for-the-treatment-of-hypophosphatasia/2017-01-05T12:28:44+00:00https://drug.russellpublishing.co.uk/news/4576/calcineurin-inhibitor-based-medications-may-protect-against-alzheimers-disease/2017-01-05T12:28:30+00:00https://drug.russellpublishing.co.uk/news/4581/fda-grants-orphan-status-for-atx-f8-117-for-the-treatment-of-haemophilia-a-patients-in-the-us/2016-12-14T22:32:36+00:00https://drug.russellpublishing.co.uk/news/4586/tillots-and-numab-to-collaborate-to-develop-inflammatory-bowel-disease-treatments/2017-01-05T12:28:12+00:00https://drug.russellpublishing.co.uk/news/4590/protein-from-vibrio-vulnificus-can-inhibit-tumour-cell-growth-by-cutting-the-protein-ras/2017-01-05T12:27:59+00:00https://drug.russellpublishing.co.uk/news/4593/lycera-and-celgene-collaborate-to-advance-novel-immune-modulators/2017-01-05T12:27:31+00:00https://drug.russellpublishing.co.uk/news/4596/researchers-discover-how-the-c-difficile-toxins-enter-the-interiors-of-cells/2017-01-05T12:27:45+00:00https://drug.russellpublishing.co.uk/news/4620/mrc-technology-and-peptinnovate-collaborate-on-therapeutics-for-bone-diseases/2017-01-05T12:27:18+00:00https://drug.russellpublishing.co.uk/news/4632/discovery-gives-hope-for-finding-a-treatment-for-amyotrophic-lateral-sclerosis/2017-01-05T12:27:05+00:00https://drug.russellpublishing.co.uk/news/4639/polar-distribution-of-micrornas-discovered-within-eukaryotic-cells/2017-01-05T12:26:43+00:00https://drug.russellpublishing.co.uk/news/4657/selecta-biosciences-initiates-phase-1-clinical-study-of-sel-212-in-gout/2016-12-14T23:03:20+00:00https://drug.russellpublishing.co.uk/news/4672/fda-awards-isarna-orphan-drug-designation-for-isth0036-to-improve-glaucoma-treatment-outcome/2017-01-05T12:25:49+00:00https://drug.russellpublishing.co.uk/news/4681/discovery-of-cellular-mechanism-of-action-of-tacpa-in-rheumatoid-arthritis/2017-01-05T12:25:36+00:00https://drug.russellpublishing.co.uk/news/4685/tlr4-has-opposing-roles-in-breast-cancer-development/2017-01-05T12:25:22+00:00https://drug.russellpublishing.co.uk/news/4689/unique-microbial-signature-identified-in-systemic-sclerosis/2017-01-05T12:25:09+00:00https://drug.russellpublishing.co.uk/news/4694/ldc-and-johnson-johnson-innovation-to-collaborate-to-discover-drug-candidates/2017-01-05T12:24:50+00:00https://drug.russellpublishing.co.uk/news/4698/escmid-launches-a-new-forensic-microbiology-breakthrough-study-group/2017-01-05T12:24:37+00:00https://drug.russellpublishing.co.uk/news/4702/biontech-launches-mammatyper-breast-cancer-diagnostic-test-in-europe/2017-01-05T12:24:25+00:00https://drug.russellpublishing.co.uk/news/4706/naturally-occurring-genetic-variation-gives-complete-resistance-in-prion-diseases/2017-01-05T12:24:14+00:00https://drug.russellpublishing.co.uk/news/4712/mutated-tcf12-gene-linked-to-aggressive-form-of-brain-cancer/2017-01-05T12:24:00+00:00https://drug.russellpublishing.co.uk/news/4717/experts-to-discuss-the-science-behind-stimulating-the-vagus-nerve/2017-01-05T12:23:44+00:00https://drug.russellpublishing.co.uk/news/4721/tessella-joins-pistoia-alliance-to-lower-barriers-in-innovation-in-life-sciences-rd-analytics/2017-01-11T14:47:24+00:00https://drug.russellpublishing.co.uk/news/4725/scientists-uncover-the-unique-role-of-bdnf-neurons-in-the-bodys-use-of-energy/2017-01-05T12:23:27+00:00https://drug.russellpublishing.co.uk/news/4729/new-compound-that-represses-the-ppary-protein-could-be-potential-treatment-for-osteoporosis/2017-01-05T12:22:51+00:00https://drug.russellpublishing.co.uk/news/4734/mini-breast-grown-in-petri-dishes-a-new-tool-for-cancer-research/2017-01-05T12:23:16+00:00https://drug.russellpublishing.co.uk/news/4743/alk1-protein-may-play-a-role-in-breast-cancer-metastasis/2017-01-05T12:22:29+00:00https://drug.russellpublishing.co.uk/news/4747/powerful-mri-scanner-reveals-brain-cell-density-remains-constant-throughout-life/2017-01-05T12:21:23+00:00https://drug.russellpublishing.co.uk/news/4753/lmp2a-protein-camouflages-epstein-barr-virus-in-human-cells/2017-01-05T12:20:58+00:00https://drug.russellpublishing.co.uk/news/4756/modulation-of-b-lymphocyte-function-may-regulate-t-lymphocyte-function/2017-01-05T12:20:46+00:00https://drug.russellpublishing.co.uk/news/4760/agalimmune-licenses-kode-biotechs-fsl-technology-for-development-of-cancer-immunotherapeutics/2017-01-05T12:20:32+00:00https://drug.russellpublishing.co.uk/news/4765/antibiotics-research-risks-another-lost-decade-while-rare-diseases-research-steams-ahead/2017-01-05T12:20:18+00:00https://drug.russellpublishing.co.uk/news/4769/scripps-florida-study-points-to-drug-target-for-huntingtons-disease/2017-01-05T12:20:04+00:00https://drug.russellpublishing.co.uk/news/4775/understanding-regulation-of-urocortin-3-could-lead-to-new-diabetes-treatments/2017-01-05T12:19:52+00:00https://drug.russellpublishing.co.uk/news/4779/rapamycin-reduces-body-fat-and-appetite-in-older-rats/2017-01-05T12:19:35+00:00https://drug.russellpublishing.co.uk/news/4783/chemists-find-scalable-way-to-synthesise-the-potential-brain-protecting-compound-jiadifenolide/2017-01-05T12:19:23+00:00https://drug.russellpublishing.co.uk/news/4787/new-target-may-increase-odds-of-successful-mosquito-based-malaria-vaccine/2017-01-05T12:19:09+00:00https://drug.russellpublishing.co.uk/news/4793/inhibition-of-15-pgdh-has-a-positive-effect-on-tissue-regeneration/2017-01-05T12:18:55+00:00https://drug.russellpublishing.co.uk/news/4798/astrazeneca-and-inserm-collaborate-to-investigate-new-therapeutic-approaches-to-diabetes-and-ckd/2017-01-05T12:18:41+00:00https://drug.russellpublishing.co.uk/news/4804/researchers-identify-stem-cell-population-important-in-the-growth-of-colon-cancer/2017-01-05T12:18:28+00:00https://drug.russellpublishing.co.uk/news/4810/gsk-invests-95m-to-launch-altius-with-goal-of-radically-changing-and-improving-medicines-development/2017-01-05T12:18:12+00:00https://drug.russellpublishing.co.uk/news/4822/anika-therapeutics-announces-strategic-collaboration-with-the-institute-for-applied-life-sciences-ials-at-the-university-of-massachusetts/2017-01-05T12:17:57+00:00https://drug.russellpublishing.co.uk/news/4826/immunogens-imgn529-demonstrates-synergistic-activity-with-rituximab-in-preclinical-models-of-non-hodgkin-lymphoma/2017-01-05T12:13:14+00:00https://drug.russellpublishing.co.uk/news/4836/ebola-virus-mutated-slower-than-first-thought/2017-01-05T12:16:36+00:00https://drug.russellpublishing.co.uk/news/4840/discovery-could-lead-to-targeted-melanoma-therapies/2017-01-05T12:16:20+00:00https://drug.russellpublishing.co.uk/news/4844/new-biomarkers-might-help-personalise-metastatic-colorectal-cancer-treatment/2017-01-05T12:16:08+00:00https://drug.russellpublishing.co.uk/news/4849/new-tool-identifies-potential-anti-diabetes-compound-azoramide/2016-12-17T00:16:46+00:00https://drug.russellpublishing.co.uk/news/4855/scifluor-life-sciences-patented-compound-sf0034-highlighted-in-the-journal-of-neuroscience/2017-01-05T12:15:45+00:00https://drug.russellpublishing.co.uk/news/4867/reneuron-and-benitec-extend-research-collaboration/2017-01-05T12:15:05+00:00https://drug.russellpublishing.co.uk/news/4871/brain-inflammation-targeted-in-first-dementia-consortium-drug-discovery-project/2017-01-05T12:14:51+00:00https://drug.russellpublishing.co.uk/news/4877/reactivating-happy-memories-can-cure-the-symptoms-of-depression/2017-01-05T12:13:56+00:00https://drug.russellpublishing.co.uk/news/4881/mers-cov-candidate-vaccine-gears-up-for-clinical-trials/2017-01-05T12:14:37+00:00https://drug.russellpublishing.co.uk/news/4888/psma-617-can-be-used-to-irradiate-prostate-cancer-cells-from-the-inside/2017-01-05T12:14:22+00:00https://drug.russellpublishing.co.uk/news/4900/hiv-vaccine-research-generates-key-antibodies-in-animal-models/2017-01-05T12:14:09+00:00https://drug.russellpublishing.co.uk/news/4914/blueprint-medicines-announces-first-preclinical-data-for-blu6864/2017-01-05T12:13:44+00:00https://drug.russellpublishing.co.uk/news/4918/researchers-develop-a-smart-insulin-patch/2017-01-05T12:13:31+00:00https://drug.russellpublishing.co.uk/news/4924/purdue-researchers-successfully-target-achilles-heel-of-mers-virus/2017-01-05T12:13:00+00:00https://drug.russellpublishing.co.uk/news/4933/ayoxxa-and-grunenthal-complete-research-collaboration/2017-01-05T12:11:33+00:00https://drug.russellpublishing.co.uk/news/4941/study-demonstrates-how-huntingtons-disease-proteins-spread-from-cell-to-cell/2017-01-05T12:11:19+00:00https://drug.russellpublishing.co.uk/news/4945/scientists-discover-blood-protein-that-may-indicate-risk-of-alzheimers/2017-01-05T12:11:05+00:00https://drug.russellpublishing.co.uk/news/4951/novogens-anisina-on-track-to-enter-the-clinic-in-2016/2017-01-05T12:10:43+00:00https://drug.russellpublishing.co.uk/news/4955/sandoz-to-speak-on-their-first-biosimilar-approved-by-the-fda-at-biosimilars-biobetters-usa-in-iselin/2017-01-11T14:50:34+00:00https://drug.russellpublishing.co.uk/news/4962/viratherapeutics-raises-e3-6-million-to-advance-its-lead-product-vsv-gp/2017-01-05T12:10:21+00:00https://drug.russellpublishing.co.uk/news/4968/bristol-myers-squibb-expands-rd-presence-in-the-us/2017-01-05T12:10:09+00:00https://drug.russellpublishing.co.uk/news/4972/researchers-grow-neurons-affected-by-parkinsons-disease/2017-01-05T12:09:55+00:00https://drug.russellpublishing.co.uk/news/4978/ucl-scientists-design-compound-that-shrinks-pancreatic-cancer-tumours-and-prevents-regrowth/2017-01-05T12:09:43+00:00https://drug.russellpublishing.co.uk/news/4985/researchers-uncover-epigenetic-switches-that-turn-stem-cells-into-endothelial-cells/2017-01-11T14:53:29+00:00https://drug.russellpublishing.co.uk/news/4989/invenra-and-oxford-biotherapeutics-enter-collaboration-to-discover-novel-therapeutic-antibodies-targeting-cancer/2017-01-05T12:07:56+00:00https://drug.russellpublishing.co.uk/news/4993/siemens-and-biontech-cooperate-on-production-of-personalised-cancer-vaccines/2017-01-05T12:07:41+00:00https://drug.russellpublishing.co.uk/news/4999/a-close-up-view-of-the-ebola-virus-life-cycle/2017-01-05T12:07:26+00:00https://drug.russellpublishing.co.uk/news/5005/preclinical-data-on-neuralstems-genetically-modified-hk532-igf-1-stem-cells-in-alzheimers-disease-presented-at-isscr/2017-01-05T12:06:59+00:00https://drug.russellpublishing.co.uk/news/5008/immunocore-and-lilly-announce-immunotherapy-based-clinical-trial-collaboration-in-melanoma/2017-01-05T12:06:45+00:00https://drug.russellpublishing.co.uk/news/5012/researchers-find-new-antibodies-that-protect-against-marburg-virus/2017-01-05T12:01:04+00:00https://drug.russellpublishing.co.uk/news/5016/bioiberica-to-trial-new-compound-that-may-prevent-memory-loss-in-patients-with-mild-alzheimers/2017-01-05T12:00:45+00:00https://drug.russellpublishing.co.uk/news/5019/faron-and-turku-pet-centre-team-up-to-develop-clevegen/2017-01-05T11:59:52+00:00https://drug.russellpublishing.co.uk/news/5023/regenerons-veloci-technologies-used-to-develop-human-antibodies-in-the-fight-against-mers/2017-01-05T11:59:30+00:00https://drug.russellpublishing.co.uk/news/5027/celgene-and-juno-therapeutics-announce-10-year-immunotherapy-collaboration/2017-01-05T11:59:18+00:00https://drug.russellpublishing.co.uk/news/5031/research-reveals-new-insights-into-a-key-antibiotic-target-in-the-fight-against-tb/2017-01-05T11:59:01+00:00https://drug.russellpublishing.co.uk/news/5039/removing-a-protein-slows-the-growth-of-tumour-blood-vessels/2017-01-05T11:58:49+00:00https://drug.russellpublishing.co.uk/news/5043/researchers-programme-solitary-yeast-cells-to-talk-to-one-another/2017-01-05T11:58:29+00:00https://drug.russellpublishing.co.uk/news/5048/first-european-nanomedicine-characterisation-laboratory-launches/2017-01-05T11:58:13+00:00https://drug.russellpublishing.co.uk/news/5052/scientists-use-cryo-em-to-image-one-of-the-central-proteins-of-life/2017-10-27T15:16:16+01:00https://drug.russellpublishing.co.uk/news/5055/research-points-to-microglia-as-potential-therapeutic-target-in-retinitis-pigmentosa/2017-01-05T11:57:44+00:00https://drug.russellpublishing.co.uk/news/5059/micrornas-found-to-play-important-role-in-memory-formation/2017-01-05T11:57:17+00:00https://drug.russellpublishing.co.uk/news/5067/biogen-and-agtc-team-up-to-develop-gene-therapies-for-ophthalmic-diseases/2017-01-05T11:57:06+00:00https://drug.russellpublishing.co.uk/news/5073/research-demonstrates-method-for-quantifying-the-effectiveness-of-different-stem-cells/2017-01-05T11:56:53+00:00https://drug.russellpublishing.co.uk/news/5078/discovery-could-lead-to-a-universal-flu-vaccine/2017-01-11T15:00:31+00:00https://drug.russellpublishing.co.uk/news/5087/cevecs-cap-go-derived-recombinant-placental-human-alkaline-phosphatase-plap-shows-promise/2017-01-11T15:08:19+00:00https://drug.russellpublishing.co.uk/news/5094/registration-now-open-for-oxford-globals-2nd-annual-stem-cell-congress-2015/2017-01-11T14:56:22+00:00https://drug.russellpublishing.co.uk/news/5098/schwann-cells-digest-myelin-from-injured-nerves/2017-01-05T11:55:04+00:00https://drug.russellpublishing.co.uk/news/5104/methotrexate-could-be-repurposed-to-treat-patients-with-blood-cancers/2017-01-05T11:54:52+00:00https://drug.russellpublishing.co.uk/news/5108/rambo-protein-could-protect-against-heart-failure/2017-01-05T11:54:39+00:00https://drug.russellpublishing.co.uk/news/5113/scientists-identify-a-new-way-to-kill-the-malaria-parasite/2017-01-05T11:54:24+00:00https://drug.russellpublishing.co.uk/news/5117/researchers-identify-two-biomarkers-linked-to-severe-atherosclerosis/2017-01-05T11:54:08+00:00https://drug.russellpublishing.co.uk/news/5120/cancer-drug-fy26-found-to-be-49-times-more-potent-than-cisplatin/2017-01-05T11:53:40+00:00https://drug.russellpublishing.co.uk/news/5122/registration-has-now-opened-for-oxford-globals-2nd-annual-drug-discovery-usa-congress-2015/2017-01-11T15:30:42+00:00https://drug.russellpublishing.co.uk/news/5129/douglas-scientific-and-tataa-biocenter-announce-tumor-cell-profiling-study-contest/2017-01-20T10:27:43+00:00https://drug.russellpublishing.co.uk/news/5133/registration-has-now-opened-for-oxford-globals-cell-gene-therapy-congress-2015/2017-01-11T15:29:57+00:00https://drug.russellpublishing.co.uk/news/5135/pfizers-centres-for-therapeutic-innovation-and-the-jeffrey-modell-foundation-team-up-to-advance-immunological-research/2017-01-05T11:53:05+00:00https://drug.russellpublishing.co.uk/news/5139/netrin-1-favours-the-production-of-ips-cells/2017-01-05T11:52:52+00:00https://drug.russellpublishing.co.uk/news/5146/phe-spins-out-its-drug-development-and-production-as-a-new-company-porton-biopharma-limited/2017-01-19T10:00:34+00:00https://drug.russellpublishing.co.uk/news/5155/didehydro-cortistatin-a-reduces-hiv-reactivation-rate/2017-01-19T10:21:09+00:00https://drug.russellpublishing.co.uk/news/5159/epizyme-and-celgene-extend-cancer-therapy-research-collaboration/2017-01-05T11:51:08+00:00https://drug.russellpublishing.co.uk/news/5162/evorx-and-astrazeneca-successfully-complete-research-collaboration/2017-01-05T11:50:57+00:00https://drug.russellpublishing.co.uk/news/5173/researchers-identify-cause-of-heart-damage-in-sepsis-patients/2017-01-05T11:50:43+00:00https://drug.russellpublishing.co.uk/news/5177/apceth-and-university-of-cologne-to-join-forces-on-combination-cellular-immunotherapies-for-cancer/2017-01-05T11:50:31+00:00https://drug.russellpublishing.co.uk/news/5187/regen-biopharma-reports-successful-dosing-of-hemaxellerate-in-fda-requested-glp-animal-study/2017-05-30T15:19:10+01:00https://drug.russellpublishing.co.uk/news/5205/effimune-launches-phase-i-clinical-trial-of-fr104/2017-01-05T11:49:54+00:00https://drug.russellpublishing.co.uk/news/5210/probiodrug-funds-brigham-and-womens-hospital-research-into-pglu-abeta-for-the-treatment-of-alzheimers-disease/2017-01-05T11:49:43+00:00https://drug.russellpublishing.co.uk/news/5214/final-agenda-released-for-the-next-generation-sequencing-usa-congress-co-located-single-cell-genomics-and-transcriptomics-usa-congress-27-28-october-2015-boston-usa/2017-01-11T15:33:30+00:00https://drug.russellpublishing.co.uk/news/5219/cell-mesh-discovery-advances-understanding-of-cancer-development/2017-01-05T11:49:26+00:00https://drug.russellpublishing.co.uk/news/5223/usc-stem-cell-researchers-identify-genes-that-affect-blood-stem-cell-development/2017-01-05T11:48:58+00:00https://drug.russellpublishing.co.uk/news/5233/cimaas-and-pharmacell-announce-collaboration/2017-01-05T11:48:14+00:00https://drug.russellpublishing.co.uk/news/5237/summit-therapeutics-publishes-preclinical-data-on-disease-modifying-potential-of-utrophin-modulation-in-dmd/2017-01-05T11:48:45+00:00https://drug.russellpublishing.co.uk/news/5244/genomics-soon-to-be-the-biggest-big-data-beast/2017-01-05T11:48:28+00:00https://drug.russellpublishing.co.uk/news/5252/researchers-identify-a-gene-linked-to-neurodegenerative-disorders-slc25a46/2017-01-05T11:47:49+00:00https://drug.russellpublishing.co.uk/news/5265/imperial-innovations-gets-gbp-50-million-eib-backing-to-strengthen-investment-in-biotech-spin-offs/2017-01-05T11:46:17+00:00https://drug.russellpublishing.co.uk/news/5279/preclinical-studies-suggest-anisina-may-improve-chemotherapy-effectiveness-in-childhood-cancer/2017-01-05T11:46:02+00:00https://drug.russellpublishing.co.uk/news/5298/the-francis-crick-institute-and-gsk-join-forces-to-forge-new-scientific-discoveries/2017-01-05T11:45:49+00:00https://drug.russellpublishing.co.uk/news/5302/stem-cells-might-heal-damaged-lungs/2016-12-17T00:12:46+00:00https://drug.russellpublishing.co.uk/news/5309/mrc-gsk-and-five-leading-uk-universities-collaborate-to-crack-difficult-disease-areas/2017-01-16T11:21:46+00:00https://drug.russellpublishing.co.uk/news/5313/gene-therapy-gives-long-term-protection-to-photoreceptor-cells-in-retinitis-pigmentosa-model/2017-01-05T11:45:08+00:00https://drug.russellpublishing.co.uk/news/5322/musc-and-bristol-myers-squibb-announce-research-collaboration-focused-on-fibrotic-diseases/2017-01-05T11:44:45+00:00https://drug.russellpublishing.co.uk/news/5327/galapagos-licenses-hub-organoid-technology-for-use-in-cystic-fibrosis-and-ibd-research/2016-12-16T23:39:55+00:00https://drug.russellpublishing.co.uk/news/5336/new-resource-makes-crisprcas9-technology-even-more-user-friendly/2016-12-17T00:08:41+00:00https://drug.russellpublishing.co.uk/news/5342/two-stat3-inhibitors-show-potential-in-fighting-brain-and-breast-cancers/2017-01-05T11:44:20+00:00https://drug.russellpublishing.co.uk/news/5351/achaogen-awarded-4-5-million-contract-to-advance-lpxc-inhibitors/2017-01-05T11:44:07+00:00https://drug.russellpublishing.co.uk/news/5355/novogens-anisina-receives-orphan-drug-designation-from-fda-for-neuroblastoma/2017-01-05T11:43:55+00:00https://drug.russellpublishing.co.uk/news/5363/anti-malaria-drugs-could-be-a-potential-treatment-for-parkinsons-disease/2017-01-05T11:39:47+00:00https://drug.russellpublishing.co.uk/news/5368/teva-to-share-a-case-study-on-how-biosimilarity-has-supported-their-biosimilar-projects-biosimilars-and-biobetters/2016-12-09T15:29:41+00:00https://drug.russellpublishing.co.uk/news/5377/in-conversation-thoughts-on-the-current-status-of-the-sequencing-industry-an-interview-with-jacqueline-boultwood-university-of-oxford/2017-01-11T15:35:03+00:00https://drug.russellpublishing.co.uk/news/5385/cellecta-receives-nih-grant-to-develop-crispr-knockout-library-of-guide-rna-sequences/2017-01-05T11:36:49+00:00https://drug.russellpublishing.co.uk/news/5391/cholesterol-metabolism-in-immune-cells-linked-to-hiv-progression/2017-01-19T10:20:25+00:00https://drug.russellpublishing.co.uk/news/5395/genetic-markers-linking-risk-for-type-2-diabetes-and-alzheimers-identified/2017-01-05T11:36:23+00:00https://drug.russellpublishing.co.uk/news/5400/novel-treatments-emerging-for-human-mitochondrial-diseases/2017-01-05T11:36:10+00:00https://drug.russellpublishing.co.uk/news/5406/treventis-trv-101-demonstrates-significant-reduction-in-both-amyloid-beta-and-tau-toxic-aggregates-in-animal-models-of-alzheimers-disease/2017-01-05T11:35:57+00:00https://drug.russellpublishing.co.uk/news/5410/scientists-see-iron-containing-microglia-in-alzheimers-brains/2017-01-05T11:35:44+00:00https://drug.russellpublishing.co.uk/news/5414/symic-biomedical-selects-sbcv-030-as-vascular-clinical-candidate/2017-01-05T11:35:30+00:00https://drug.russellpublishing.co.uk/news/5418/new-insights-into-biofilm-formation-could-lead-to-better-therapies/2017-01-05T11:35:17+00:00https://drug.russellpublishing.co.uk/news/5425/emergent-awarded-19-7-million-barda-contract-to-develop-ebola-monoclonal-antibodies/2017-01-05T11:35:05+00:00https://drug.russellpublishing.co.uk/news/5431/researchers-discover-new-peptide-toxins-in-cone-snail-venom/2017-01-05T11:34:47+00:00https://drug.russellpublishing.co.uk/news/5434/mrc-scientists-regrow-liver-from-liver-stem-cells/2017-01-05T11:34:30+00:00https://drug.russellpublishing.co.uk/news/5440/new-tripadvisor-site-to-address-use-of-substandard-chemical-probes/2017-01-11T15:38:12+00:00https://drug.russellpublishing.co.uk/news/5447/virus-like-particle-vaccine-protects-mice-from-many-influenza-strains/2017-01-05T11:34:02+00:00https://drug.russellpublishing.co.uk/news/5451/roche-diagnostics-strengthens-its-blood-screening-portfolio-with-an-assay-to-identify-htlv-virus-iii-infection/2017-01-05T11:33:44+00:00https://drug.russellpublishing.co.uk/news/5455/kalvista-raises-33-million-to-advance-development-of-kallikrein-inhibitors/2017-01-05T11:33:29+00:00https://drug.russellpublishing.co.uk/news/5459/ablynx-expands-its-immuno-oncology-collaboration-with-merck/2018-06-29T14:03:49+01:00https://drug.russellpublishing.co.uk/news/5469/mass-produced-stem-cells-on-the-horizon/2017-01-05T11:28:04+00:00https://drug.russellpublishing.co.uk/news/5479/cct245737-boosts-the-effectiveness-of-chemotherapy/2017-01-05T11:27:30+00:00https://drug.russellpublishing.co.uk/news/5485/biomed-x-and-merck-serono-extend-collaboration/2018-06-29T14:28:36+01:00https://drug.russellpublishing.co.uk/news/5489/lilly-to-extend-san-diego-biotechnology-centre/2017-01-05T11:27:03+00:00https://drug.russellpublishing.co.uk/news/5493/magi-web-app-helps-researchers-explore-cancer-genetics/2017-01-05T11:26:48+00:00https://drug.russellpublishing.co.uk/news/5497/reseachers-develop-first-test-to-predict-tumour-radiation-therapy-sensitivity/2017-01-05T11:26:36+00:00https://drug.russellpublishing.co.uk/news/5501/new-polio-like-virus-discovered-in-the-us/2017-01-05T11:26:22+00:00https://drug.russellpublishing.co.uk/news/5507/positive-topline-results-from-brincidofovir-smallpox-study/2017-01-05T11:26:10+00:00https://drug.russellpublishing.co.uk/news/5511/ucla-scientists-discover-therapy-that-can-suppress-the-ulcerative-colitis/2017-01-05T11:25:54+00:00https://drug.russellpublishing.co.uk/news/5516/evotec-gladstone-institutes-and-dolby-family-ventures-team-up-to-find-alzheimers-cure/2017-01-05T11:25:40+00:00https://drug.russellpublishing.co.uk/news/5520/six-major-projects-to-bring-molecular-pathology-tests-to-patients/2017-01-05T11:25:27+00:00https://drug.russellpublishing.co.uk/news/5527/cancer-can-be-caused-by-protein-imbalances-within-cells/2017-01-05T11:25:15+00:00https://drug.russellpublishing.co.uk/news/5533/protein-rgs2-helps-prepare-for-healthy-egg-sperm-union/2017-01-05T11:24:55+00:00https://drug.russellpublishing.co.uk/news/5538/biogen-sparks-up-strategic-alliance-with-the-parkinsons-institute-and-clinical-centre/2017-01-05T11:24:23+00:00https://drug.russellpublishing.co.uk/news/5543/regeneron-and-sanofi-launch-major-immuno-oncology-collaboration/2017-01-05T11:23:26+00:00https://drug.russellpublishing.co.uk/news/5545/scientists-discover-exercise-mimicking-molecule-compound-14/2017-01-05T11:22:40+00:00https://drug.russellpublishing.co.uk/news/5551/umg-and-mrc-technology-collaborate-to-develop-alzheimers-therapy/2017-01-05T11:22:14+00:00https://drug.russellpublishing.co.uk/news/5555/researchers-discover-new-type-of-mycovirus/2017-10-27T15:17:03+01:00https://drug.russellpublishing.co.uk/news/5560/basis-for-new-treatment-options-for-a-fatal-leukaemia-revealed/2017-01-05T11:21:46+00:00https://drug.russellpublishing.co.uk/news/5564/experimental-mers-vaccine-shows-promise-in-animal-studies/2017-01-05T11:21:33+00:00https://drug.russellpublishing.co.uk/news/5575/cystic-fibrosis-microbes-able-to-survive-on-little-to-no-oxygen/2016-12-16T23:37:37+00:00https://drug.russellpublishing.co.uk/news/5579/scientists-successfully-edit-human-t-cells-using-crispr/2017-01-05T11:20:58+00:00https://drug.russellpublishing.co.uk/news/5589/sygnature-discovery-delivers-clinical-candidate-cort125134-to-corcept/2017-01-05T11:20:46+00:00https://drug.russellpublishing.co.uk/news/5593/inovios-dna-based-monoclonal-antibody-dmab-protects-against-dengue/2017-01-05T11:20:32+00:00https://drug.russellpublishing.co.uk/news/5596/il-35-injections-show-promise-as-type-1-diabetes-treatment/2017-01-05T11:20:18+00:00https://drug.russellpublishing.co.uk/news/5599/researchers-design-first-artificial-ribosome/2017-01-05T11:19:54+00:00https://drug.russellpublishing.co.uk/news/5603/researchers-uncover-signals-govern-fate-tfh-cells/2017-01-05T11:19:40+00:00https://drug.russellpublishing.co.uk/news/5611/researchers-resurrect-ancient-virus-to-improve-gene-therapy/2017-01-05T11:19:27+00:00https://drug.russellpublishing.co.uk/news/5614/st-jude-scientists-identify-new-mechanism-of-p53-induced-cell-death/2017-01-19T09:50:27+00:00https://drug.russellpublishing.co.uk/news/5620/oxford-globals-qa-session-with-drug-discovery-usa-speaker-matthew-wagoner-a-discovery-safety-specialist-from-astrazeneca/2017-01-11T15:51:15+00:00https://drug.russellpublishing.co.uk/news/5626/az-and-isis-pharmaceuticals-to-discover-antisense-drugs/2017-01-05T11:17:54+00:00https://drug.russellpublishing.co.uk/news/5630/prokarium-gets-funding-from-synbicite-to-develop-chlamydia-vaccine/2017-01-05T11:17:41+00:00https://drug.russellpublishing.co.uk/news/5640/neuroblastoma-cells-drain-immune-systems-batteries/2017-01-05T11:17:27+00:00https://drug.russellpublishing.co.uk/news/5644/global-vaccine-development-fund-could-save-thousands-of-lives/2017-01-05T11:17:16+00:00https://drug.russellpublishing.co.uk/news/5649/nanoparticles-used-to-breach-lung-mucus-barrier/2016-12-17T00:03:56+00:00https://drug.russellpublishing.co.uk/news/5654/oncology-treatment-pipeline-offers-significant-opportunities/2017-01-05T11:16:59+00:00https://drug.russellpublishing.co.uk/news/5658/morphosys-and-g7-therapeutics-to-develop-antibodies-targeting-gpcrs/2017-01-05T11:16:47+00:00https://drug.russellpublishing.co.uk/news/5662/pharmaxis-and-synairgen-team-up-to-develop-loxl2-inhibitor/2017-01-05T11:16:33+00:00https://drug.russellpublishing.co.uk/news/5666/adxs-psa-awarded-grants-from-pcf-and-movember-foundation/2017-01-05T11:16:19+00:00https://drug.russellpublishing.co.uk/news/5672/astrazeneca-and-heptares-to-develop-novel-immuno-oncology-treatments/2017-01-05T11:16:05+00:00https://drug.russellpublishing.co.uk/news/5678/medimmune-and-mirati-in-lung-cancer-therapy-collaboration/2017-01-05T11:15:50+00:00https://drug.russellpublishing.co.uk/news/5682/scientists-discover-why-moles-stop-growing/2017-01-05T11:15:38+00:00https://drug.russellpublishing.co.uk/news/5689/scientists-make-strides-towards-therapeutics-for-relapse-prevention/2017-01-05T11:14:57+00:00https://drug.russellpublishing.co.uk/news/5693/scientists-mimic-realistic-tumour-conditions/2017-01-05T11:13:56+00:00https://drug.russellpublishing.co.uk/news/5701/key-paper-on-proteomics-in-the-field-of-allergy-published-in-the-world-allergy-journal/2017-01-05T11:13:36+00:00https://drug.russellpublishing.co.uk/news/5703/round-8-of-biomedical-catalyst-awards-announced/2016-12-22T23:39:26+00:00https://drug.russellpublishing.co.uk/news/5711/merus-prevails-in-inequitable-conduct-case-against-regeneron/2017-01-05T11:13:15+00:00https://drug.russellpublishing.co.uk/news/5716/research-identifies-trigger-responsible-for-regenerating-hair-and-skin-after-trauma/2017-01-05T11:13:03+00:00https://drug.russellpublishing.co.uk/news/5726/research-suggests-ion-channel-blocking-drugs-could-be-used-in-cancer-therapy/2017-01-05T11:12:11+00:00https://drug.russellpublishing.co.uk/news/5729/ampliphi-biosciences-announce-financial-results-q2-2015/2017-01-19T10:37:22+00:00https://drug.russellpublishing.co.uk/news/5735/cells-regenerate-liver-without-cancer-risk/2017-01-05T11:11:24+00:00https://drug.russellpublishing.co.uk/news/5741/epstein-barr-virus-vaccine-induces-potent-neutralising-antibodies/2017-01-05T11:11:09+00:00https://drug.russellpublishing.co.uk/news/5745/researchers-discover-adhesive-strategy-of-h-pylori/2017-01-05T11:10:55+00:00https://drug.russellpublishing.co.uk/news/5749/promising-new-target-for-cognitive-and-anxiety-disorders-identified/2017-01-05T11:10:41+00:00https://drug.russellpublishing.co.uk/news/5753/bionic-liver-organs-explain-toxicity-of-paracetamol/2017-01-05T11:10:28+00:00https://drug.russellpublishing.co.uk/news/5758/genetic-test-could-improve-myeloma-treatment/2017-01-05T11:10:04+00:00https://drug.russellpublishing.co.uk/news/5762/clr01-targets-hiv-and-prevents-semen-from-promoting-infection/2017-10-27T15:17:03+01:00https://drug.russellpublishing.co.uk/news/5768/european-antibody-congress-2015-comes-to-basel/2017-01-11T15:55:18+00:00https://drug.russellpublishing.co.uk/news/5771/cancer-research-uk-funding-preclinical-study-of-imprime-pgg/2017-01-05T11:08:26+00:00https://drug.russellpublishing.co.uk/news/5775/ampliphi-biosciences-receives-approval-for-listing-on-nyse-mkt/2017-01-05T11:08:13+00:00https://drug.russellpublishing.co.uk/news/5779/roche-to-acquire-kapa-biosystems/2017-01-05T11:08:02+00:00https://drug.russellpublishing.co.uk/news/5789/new-high-throughput-screening-method-could-speed-drug-discovery/2017-01-05T11:07:39+00:00https://drug.russellpublishing.co.uk/news/5797/mers-cov-vaccine-successfully-tested-in-monkeys-and-camels/2017-01-05T11:07:15+00:00https://drug.russellpublishing.co.uk/news/5801/new-insights-into-blocking-asthma-pathways/2017-01-05T11:07:01+00:00https://drug.russellpublishing.co.uk/news/5806/molecular-feedback-process-may-protect-against-alzheimers/2017-01-05T11:06:48+00:00https://drug.russellpublishing.co.uk/news/5812/janus-biotherapeutics-and-roche-collaborate-on-autoimmune-disease-therapies/2017-01-05T11:06:36+00:00https://drug.russellpublishing.co.uk/news/5816/scientists-replicate-newt-cell-regeneration-human-cells/2017-01-05T11:06:24+00:00https://drug.russellpublishing.co.uk/news/5833/efficacy-of-iclaprim-confirmed-in-independent-laboratory-study/2017-01-05T11:06:10+00:00https://drug.russellpublishing.co.uk/news/5862/new-drug-protects-against-the-effects-of-nuclear-radiation/2017-01-05T11:05:57+00:00https://drug.russellpublishing.co.uk/news/5867/ocata-receives-sbir-grant-to-develop-hmc-therapy-for-lupus-nephritis/2017-01-05T11:05:33+00:00https://drug.russellpublishing.co.uk/news/5876/morphosys-and-immatics-enter-immuno-oncology-alliance/2017-01-05T11:01:56+00:00https://drug.russellpublishing.co.uk/news/5880/major-advance-towards-long-lasting-universal-influenza-vaccine/2017-01-05T11:00:43+00:00https://drug.russellpublishing.co.uk/news/5883/oncodrone-to-progress-prostate-cancer-drug-with-e2-5m-grant/2017-01-05T10:59:50+00:00https://drug.russellpublishing.co.uk/news/5888/immatics-us-launched-to-develop-adoptive-cellular-therapies/2017-01-05T10:54:32+00:00https://drug.russellpublishing.co.uk/news/5892/human-rsv-study-launched-to-aid-vaccine-development/2017-01-05T10:54:18+00:00https://drug.russellpublishing.co.uk/news/5897/flu-remedies-help-combat-e-coli/2017-01-05T10:54:03+00:00https://drug.russellpublishing.co.uk/news/5902/nerve-growth-factor-triggers-functional-cell-growth-in-alzheimers-disease/2017-01-05T10:53:47+00:00https://drug.russellpublishing.co.uk/news/5906/scientists-discover-potential-drug-therapy-for-tinnitus/2017-01-05T10:53:35+00:00https://drug.russellpublishing.co.uk/news/5912/mission-therapeutics-appoints-dr-michael-koslowski-as-chief-medical-officer/2016-12-22T23:42:00+00:00https://drug.russellpublishing.co.uk/news/5916/bristol-myers-squibb-and-qimr-berghofer-medical-research-institute-announce-worldwide-collaboration-to-discover-novel-immuno-oncology-antibodies/2017-01-05T10:53:18+00:00https://drug.russellpublishing.co.uk/news/5923/positive-initial-clinical-data-from-phase-1-trial-with-aln-pcssc/2017-01-05T10:52:58+00:00https://drug.russellpublishing.co.uk/news/5927/novogen-announces-outcome-of-science-review/2017-01-05T10:52:38+00:00https://drug.russellpublishing.co.uk/news/5933/escmid-publishes-guidelines-aimed-at-preventing-build-up-of-biofilms/2017-01-19T11:30:50+00:00https://drug.russellpublishing.co.uk/news/5937/genetic-testing-reveals-new-drug-targets-in-oesophageal-cancer/2017-01-05T10:52:18+00:00https://drug.russellpublishing.co.uk/news/5943/horizon-and-redx-sign-cancer-research-collaboration/2017-01-05T10:52:06+00:00https://drug.russellpublishing.co.uk/news/5948/breakthrough-in-fighting-liver-disease/2017-01-05T10:51:51+00:00https://drug.russellpublishing.co.uk/news/5954/ampliphi-appoints-new-vp-of-chemisty-manufacturing-control/2017-01-19T10:37:15+00:00https://drug.russellpublishing.co.uk/news/5959/antisense-rnai-therapeutics-deals-value-approached-5-6-billion-in-2014/2017-01-05T10:51:06+00:00https://drug.russellpublishing.co.uk/news/5963/researchers-use-kg5-to-sensitise-tumours-to-radiation-and-chemotherapy/2017-01-05T10:50:11+00:00https://drug.russellpublishing.co.uk/news/5968/another-step-closer-to-cheap-synthetic-antivenoms/2017-01-05T10:49:59+00:00https://drug.russellpublishing.co.uk/news/5973/aspirin-could-boost-cancer-immunotherapy/2017-01-05T10:49:46+00:00https://drug.russellpublishing.co.uk/news/5978/final-agenda-is-now-available-for-our-2nd-annual-drug-discovery-usa-congress-in-boston/2017-01-11T15:59:10+00:00https://drug.russellpublishing.co.uk/news/5980/in-conversation-thoughts-on-the-current-status-of-the-sequencing-industry-an-interview-with-jacqueline-boultwood-university-of-oxford-2/2017-01-20T10:32:10+00:00https://drug.russellpublishing.co.uk/news/5983/wasp-venom-toxin-mp1-blasts-holes-in-cancer-cells/2017-01-19T09:49:44+00:00https://drug.russellpublishing.co.uk/news/5989/inhaled-dosage-form-of-bal30072-to-be-formulated-for-patients-with-cystic-fibrosis/2016-12-16T23:35:17+00:00https://drug.russellpublishing.co.uk/news/5993/immunocore-ranks-high-in-the-sunday-times-hiscox-tech-track-100/2017-01-05T10:49:09+00:00https://drug.russellpublishing.co.uk/news/5999/kymab-on-sunday-times-tech-track-ones-to-watch-list/2017-01-05T10:48:56+00:00https://drug.russellpublishing.co.uk/news/6003/reviral-announces-21m-fundraising-to-advance-rsv-drug/2017-01-05T10:48:44+00:00https://drug.russellpublishing.co.uk/news/6008/pierre-fabre-and-addex-sign-early-stage-agreement-in-cns-field/2017-01-05T10:48:32+00:00https://drug.russellpublishing.co.uk/news/6012/amra-and-pfizer-team-up-for-mr-imaging-project/2017-01-05T10:48:16+00:00https://drug.russellpublishing.co.uk/news/6016/researchers-win-ebf-funding-to-advance-wolfram-syndrome-project/2017-01-05T10:47:32+00:00https://drug.russellpublishing.co.uk/news/6021/testicular-cancer-found-to-be-strongly-heritable/2017-01-05T10:47:17+00:00https://drug.russellpublishing.co.uk/news/6032/txcell-announces-preclinical-efficacy-results-for-col-treg-in-autoimmune-uveitis/2017-01-05T10:47:03+00:00https://drug.russellpublishing.co.uk/news/6067/scientists-make-biodegradable-pharmaceuticals/2017-01-05T10:45:32+00:00https://drug.russellpublishing.co.uk/news/6087/pretreated-monocytes-may-confer-positive-effects-for-alzheimers-sufferers/2017-01-05T10:45:19+00:00https://drug.russellpublishing.co.uk/news/6148/blueprint-medicines-to-advance-blu-285-in-phase-1-trial-for-systemic-mastocytosis/2017-01-05T10:44:56+00:00https://drug.russellpublishing.co.uk/news/6154/mgb-biopharma-wins-scottish-business-award/2017-01-05T10:44:44+00:00https://drug.russellpublishing.co.uk/news/6180/sas1b-discovery-could-fundamentally-alter-cancer-treatment/2017-01-05T10:44:31+00:00https://drug.russellpublishing.co.uk/news/6183/gencia-and-takeda-to-develop-novel-mitochondrial-therapeutics/2017-01-05T10:43:58+00:00https://drug.russellpublishing.co.uk/news/6187/technology-for-large-scale-protein-manufacture-unveiled/2017-01-05T10:43:47+00:00https://drug.russellpublishing.co.uk/news/6193/scientists-discover-why-levodopa-can-lead-to-dyskinesia/2017-01-05T10:43:25+00:00https://drug.russellpublishing.co.uk/news/6198/researchers-develop-a-new-computational-method-to-study-cancer-drug-effects/2017-01-05T10:42:54+00:00https://drug.russellpublishing.co.uk/news/6203/new-technique-improves-the-selectivity-of-kinase-inhibitors/2016-12-09T15:27:19+00:00https://drug.russellpublishing.co.uk/news/6210/takeda-joins-malaria-and-tb-drug-discovery-consortium-wipo-research/2017-01-05T10:42:39+00:00https://drug.russellpublishing.co.uk/news/6214/researchers-discover-new-group-of-antibiotics/2017-01-05T10:42:27+00:00https://drug.russellpublishing.co.uk/news/6225/cancer-research-uk-and-medimmune-launch-biotherapeutics-research-centre/2017-01-05T10:41:56+00:00https://drug.russellpublishing.co.uk/news/6231/transatlantic-partnership-to-develop-treatments-for-pancreatic-cancer/2017-01-05T10:41:30+00:00https://drug.russellpublishing.co.uk/news/6250/desktop-genetics-raises-1-37m-to-accelerate-development-of-deskgen/2017-01-05T10:40:07+00:00https://drug.russellpublishing.co.uk/news/6253/auspherix-and-domainex-expand-antibiotics-partnership/2017-01-05T10:39:52+00:00https://drug.russellpublishing.co.uk/news/6257/chimerix-gets-contract-extension-for-smallpox-treatment/2017-01-05T10:39:39+00:00https://drug.russellpublishing.co.uk/news/6261/usp19-inhibition-protects-against-muscle-wasting/2017-01-05T10:39:25+00:00https://drug.russellpublishing.co.uk/news/6270/dementia-consortium-funds-project-focusing-on-als-and-ftld/2017-01-16T15:48:53+00:00https://drug.russellpublishing.co.uk/news/6274/cevec-and-genethon-to-develop-lentivirus-packaging-cell-lines/2017-01-05T10:38:59+00:00https://drug.russellpublishing.co.uk/news/6278/piramal-encourages-pharma-to-embrace-green-chemistry/2017-01-05T10:38:45+00:00https://drug.russellpublishing.co.uk/news/6284/amgen-and-xencor-enter-cancer-immunotherapy-and-inflammation-collaboration/2017-01-05T10:38:33+00:00https://drug.russellpublishing.co.uk/news/6288/scientists-create-immunity-to-e-histolytica-by-silencing-genes/2017-01-05T10:38:18+00:00https://drug.russellpublishing.co.uk/news/6305/researchers-identify-possible-ovarian-cancer-biomarkers/2017-01-05T10:38:05+00:00https://drug.russellpublishing.co.uk/news/6310/ermani-protein-prevents-hiv-virus-from-replicating/2017-01-19T10:20:16+00:00https://drug.russellpublishing.co.uk/news/6362/selvita-expands-its-operations-into-the-us/2017-01-05T10:37:39+00:00https://drug.russellpublishing.co.uk/news/6374/dr-jeanette-wood-joins-nuevolution-as-scientific-advisor/2017-01-05T10:37:25+00:00https://drug.russellpublishing.co.uk/news/6378/bergenbio-presents-positive-preclinical-data-on-bgb324/2017-01-05T10:37:12+00:00https://drug.russellpublishing.co.uk/news/6384/inovio-receives-24m-grant-to-advance-ebola-programme/2017-01-05T10:36:58+00:00https://drug.russellpublishing.co.uk/news/6458/boehringer-ingelheim-and-biomed-x-team-up-for-copd-project/2017-01-16T11:17:04+00:00https://drug.russellpublishing.co.uk/news/6488/h3-and-selvita-extend-precision-cancer-drug-collaboration/2017-01-05T10:35:24+00:00https://drug.russellpublishing.co.uk/news/6492/zedira-and-cardiff-university-to-research-transglutaminase-6-in-ataxia/2017-01-05T10:35:12+00:00https://drug.russellpublishing.co.uk/news/6529/genital-herpes-vaccine-demonstrates-prophylactic-and-therapeutic-efficacy/2017-01-05T10:34:59+00:00https://drug.russellpublishing.co.uk/news/6619/dexstr-presents-data-management-tool-inquiro-at-pharmaceutical-it-congress/2017-01-05T10:34:48+00:00https://drug.russellpublishing.co.uk/news/6627/c4xd-provides-update-on-diabetes-inflammation-compounds/2017-01-16T11:20:34+00:00https://drug.russellpublishing.co.uk/news/6668/nihs-and-ac-immune-to-develop-alzheimers-diagnostic/2017-01-05T10:34:23+00:00https://drug.russellpublishing.co.uk/news/6680/smart-robot-accelerates-cancer-treatment-research/2017-01-05T10:34:08+00:00https://drug.russellpublishing.co.uk/news/6699/mission-therapeutics-receives-funding-for-dub-cancer-programme/2016-12-22T23:42:41+00:00https://drug.russellpublishing.co.uk/news/6706/mrc-technology-university-of-lausanne-collaborate-on-malt1-inhibitors/2017-01-16T15:47:33+00:00https://drug.russellpublishing.co.uk/news/6774/regeneron-and-eti-team-up-to-discover-monoclonal-antibodies/2017-01-05T10:33:38+00:00https://drug.russellpublishing.co.uk/news/6806/new-collaboration-to-interpret-human-proteome-information/2017-01-05T10:33:26+00:00https://drug.russellpublishing.co.uk/news/6811/tsri-awarded-6-million-to-develop-hivaids-vaccine-ecd4-lg/2017-01-05T10:33:00+00:00https://drug.russellpublishing.co.uk/news/6816/study-highlights-the-potential-of-fak-inhibition-in-fighting-cancer/2017-01-05T10:32:45+00:00https://drug.russellpublishing.co.uk/news/6829/medimmune-and-3m-partner-to-develop-novel-tlr-agonist-cancer-therapies/2017-01-05T10:31:55+00:00https://drug.russellpublishing.co.uk/news/6838/bms-and-moffitt-form-immuno-oncology-partnership/2017-01-05T10:30:38+00:00https://drug.russellpublishing.co.uk/news/6850/protectimmun-and-icl-team-up-for-preclinical-asthma-research/2017-01-05T10:30:26+00:00https://drug.russellpublishing.co.uk/news/6859/h7n9-influenza-vaccine-failure-due-to-immune-camouflage/2017-01-05T10:30:13+00:00https://drug.russellpublishing.co.uk/news/6863/heptares-gets-grant-to-develop-cocaine-addiction-treatment/2017-01-05T10:30:00+00:00https://drug.russellpublishing.co.uk/news/6867/new-crispr-system-could-change-the-scientific-landscape/2017-01-05T10:29:47+00:00https://drug.russellpublishing.co.uk/news/6871/ldc-and-infinity-to-work-together-on-oncology-drug-discovery/2017-01-05T10:29:34+00:00https://drug.russellpublishing.co.uk/news/6875/pl-3994-reduces-cardiac-hypertrophy-in-heart-failure-study/2017-01-05T10:29:22+00:00https://drug.russellpublishing.co.uk/news/6879/apitope-raises-e12-million-in-series-b-funding/2016-12-14T22:34:40+00:00https://drug.russellpublishing.co.uk/news/6883/new-company-la-cell-to-focus-on-cell-penetrating-antibody-therapies/2017-01-05T10:29:03+00:00https://drug.russellpublishing.co.uk/news/6889/innovate-uk-awards-congenica-300000/2017-01-05T10:28:51+00:00https://drug.russellpublishing.co.uk/news/6893/carsgen-partners-with-shanghai-cancer-institute-to-advance-car-t-therapies/2017-01-05T10:28:23+00:00https://drug.russellpublishing.co.uk/news/6899/ubivac-and-janssen-to-develop-vaccine-to-intercept-oral-cancer/2017-01-05T10:25:33+00:00https://drug.russellpublishing.co.uk/news/6903/aspen-park-acquires-rights-to-castration-resistant-prostate-cancer-drug/2017-01-05T10:25:19+00:00https://drug.russellpublishing.co.uk/news/6911/fda-grants-orphan-drug-designation-to-blu-554/2017-01-05T10:25:06+00:00https://drug.russellpublishing.co.uk/news/6942/cancer-stopped-in-its-tracks-by-reprogrammed-fibroblasts/2017-01-05T10:24:47+00:00https://drug.russellpublishing.co.uk/news/6946/drug-discovery-initiative-taneds-opens-for-applications/2017-01-11T16:06:51+00:00https://drug.russellpublishing.co.uk/news/6951/receptor-identified-as-potential-target-for-treatment-of-autism/2017-01-05T10:22:37+00:00https://drug.russellpublishing.co.uk/news/6957/1000-genomes-project-team-create-largest-catalogue-of-genomic-differences/2017-01-05T10:22:22+00:00https://drug.russellpublishing.co.uk/news/6961/scientists-develop-drug-to-prevent-diabetic-enteropathy/2017-01-05T10:22:09+00:00https://drug.russellpublishing.co.uk/news/6969/genisphere-raises-4m-in-funding-to-extend-its-3dna-platform/2017-01-05T10:21:45+00:00https://drug.russellpublishing.co.uk/news/6972/researchers-disguise-anti-cancer-drugs-as-platelets/2017-01-05T10:20:56+00:00https://drug.russellpublishing.co.uk/news/6981/xoma-licenses-anti-tgfb-antibody-programme-to-novartis/2017-01-05T10:20:34+00:00https://drug.russellpublishing.co.uk/news/7005/biogen-to-work-with-genomics-to-refine-drug-target-selection/2017-01-05T10:20:20+00:00https://drug.russellpublishing.co.uk/news/7010/nobel-prize-recognises-discoveries-in-parasitic-diseases/2017-01-05T10:20:07+00:00https://drug.russellpublishing.co.uk/news/7015/cancer-drug-rgfp966-appears-to-sharpen-memory/2017-01-05T10:19:53+00:00https://drug.russellpublishing.co.uk/news/7019/targeting-cancers-nutrient-seeking-protein-could-restrict-growth/2017-01-05T10:19:40+00:00https://drug.russellpublishing.co.uk/news/7025/gene-therapy-shows-success-in-vision-loss-mitochondrial-disease/2017-01-05T10:19:24+00:00https://drug.russellpublishing.co.uk/news/7031/non-therapeutic-applications-to-add-revenue-to-the-global-human-albumin-market/2017-10-27T15:22:58+01:00https://drug.russellpublishing.co.uk/news/7035/adaptimmune-to-expand-its-rd-operation-in-oxfordshire/2017-01-05T10:18:38+00:00https://drug.russellpublishing.co.uk/news/7038/discovery-could-transform-rheumatoid-arthritis-patient-care/2017-01-05T10:18:26+00:00https://drug.russellpublishing.co.uk/news/7043/horizon-discovery-group-in-licenses-oncology-programme-from-servier/2017-01-05T09:38:30+00:00https://drug.russellpublishing.co.uk/news/7048/global-and-usa-biosimilar-market-latest-updates-from-hospira-sandoz-merck-teva-boehringer-ingelheim/2018-06-29T14:29:07+01:00https://drug.russellpublishing.co.uk/news/7057/cell-therapy-catapult-launches-the-cell-history-file/2017-01-05T09:38:12+00:00https://drug.russellpublishing.co.uk/news/7063/c4xd-provides-a-research-update-on-its-il-17-targeting-leads/2017-01-05T09:37:59+00:00https://drug.russellpublishing.co.uk/news/7102/cancer-research-uk-invests-15m-to-develop-new-cancer-treatments/2017-01-05T09:37:45+00:00https://drug.russellpublishing.co.uk/news/7144/nektar-submits-ind-for-nktr-214-to-treat-solid-tumours/2017-01-05T09:37:31+00:00https://drug.russellpublishing.co.uk/news/7187/two-hit-approach-shows-promise-in-breast-cancer-study/2017-01-05T09:37:19+00:00https://drug.russellpublishing.co.uk/news/7192/acceleran-presents-preclinical-data-for-muscle-therapeutics-ace-083-and-ace-2494/2017-01-05T09:37:01+00:00https://drug.russellpublishing.co.uk/news/7198/researchers-turn-stem-cells-into-mini-kidneys/2016-12-10T12:53:31+00:00https://drug.russellpublishing.co.uk/news/7203/gene-therapy-prevents-disease-effects-in-parkinsons-disease-model/2017-01-05T09:36:40+00:00https://drug.russellpublishing.co.uk/news/7211/nav1-5-identified-as-potential-therapeutic-target-for-breast-cancer/2017-01-05T09:36:26+00:00https://drug.russellpublishing.co.uk/news/7215/scientists-use-nano-diamonds-to-light-up-tumours/2017-01-05T09:36:12+00:00https://drug.russellpublishing.co.uk/news/7218/eyevensys-completes-e7-5m-series-a-financing-to-develop-eys606/2017-01-05T09:35:56+00:00https://drug.russellpublishing.co.uk/news/7222/lilly-announces-new-york-rd-site-expansion/2017-01-05T09:35:43+00:00https://drug.russellpublishing.co.uk/news/7226/3sbio-enters-licensing-deal-for-antibody-drug-conjugate-alt-p7/2017-01-05T09:35:29+00:00https://drug.russellpublishing.co.uk/news/7229/lilly-and-innovent-expand-anti-pd-1-bispecific-antibody-collaboration/2017-01-05T09:34:23+00:00https://drug.russellpublishing.co.uk/news/7232/astex-pharmaceuticals-joins-the-dementia-consortium/2017-01-05T09:34:08+00:00https://drug.russellpublishing.co.uk/news/7241/cancer-research-uk-launches-the-grand-challenge-to-help-beat-cancer/2017-01-05T09:33:50+00:00https://drug.russellpublishing.co.uk/news/7248/collaboration-to-investigate-acute-myeloid-leukaemia-therapeutic-approaches/2017-01-05T09:33:34+00:00https://drug.russellpublishing.co.uk/news/7256/asterias-collaborates-with-cell-therapy-catapult-to-scale-production-of-ast-vac2/2017-01-05T09:33:21+00:00https://drug.russellpublishing.co.uk/news/7260/tamoxifen-beats-mrsa-superbug-in-mice-models/2017-01-05T09:33:06+00:00https://drug.russellpublishing.co.uk/news/7263/exon-skipping-demonstrates-success-in-severe-form-of-muscular-dystrophy/2017-01-05T09:32:40+00:00https://drug.russellpublishing.co.uk/news/7268/lilly-and-imaginab-to-investigate-imaging-agent-in-immuno-oncology-therapies/2017-01-05T09:32:27+00:00https://drug.russellpublishing.co.uk/news/7271/malaria-vaccine-provides-hope-for-a-cure-for-cancer/2017-01-05T09:32:12+00:00https://drug.russellpublishing.co.uk/news/7275/researchers-develop-animal-free-renal-screening-platform/2017-01-05T09:31:58+00:00https://drug.russellpublishing.co.uk/news/7280/ucl-and-takeda-to-identify-targets-for-neurodegenerative-diseases/2017-01-05T09:31:42+00:00https://drug.russellpublishing.co.uk/news/7284/minoryx-to-validate-min-102-with-series-a-funding/2017-01-05T09:31:25+00:00https://drug.russellpublishing.co.uk/news/7289/gene-therapy-shows-promise-in-retinitis-pigmentosa/2017-01-05T09:31:11+00:00https://drug.russellpublishing.co.uk/news/7299/gpr3-identified-as-a-new-target-for-alzheimers-disease-treatment/2017-01-05T09:30:57+00:00https://drug.russellpublishing.co.uk/news/7304/oicr-novera-and-janssen-to-develop-haematological-cancer-therapies/2017-01-05T09:30:44+00:00https://drug.russellpublishing.co.uk/news/7309/ablynxs-nanobody-construct-achieves-proof-of-concept-in-tumour-model/2018-06-29T14:02:22+01:00https://drug.russellpublishing.co.uk/news/7313/breast-cancer-vaccine-oqr200-completes-proof-of-concept-study/2017-01-05T09:29:35+00:00https://drug.russellpublishing.co.uk/news/7317/researchers-describe-new-molecular-markers-for-high-risk-neuroblastoma/2017-01-05T09:29:23+00:00https://drug.russellpublishing.co.uk/news/7322/york-scientists-one-step-closer-to-finding-a-new-generation-of-antibiotics/2017-01-05T09:29:05+00:00https://drug.russellpublishing.co.uk/news/7328/inflammation-in-the-brain-linked-to-risk-of-schizophrenia/2017-01-05T09:28:52+00:00https://drug.russellpublishing.co.uk/news/7336/nuevolution-in-drug-discovery-collaboration-with-janssen/2017-01-05T09:28:16+00:00https://drug.russellpublishing.co.uk/news/7340/new-project-aims-to-establish-genome-sequencing-as-a-clinical-tool/2017-01-05T09:28:03+00:00https://drug.russellpublishing.co.uk/news/7344/data-on-pglu-3-abeta-antibody-presented-at-neuroscience-2015/2017-01-05T09:27:46+00:00https://drug.russellpublishing.co.uk/news/7349/investigational-new-drug-application-filed-for-mers-vaccine/2017-01-05T09:27:33+00:00https://drug.russellpublishing.co.uk/news/7353/positive-results-for-delmars-val-083-in-ovarian-cancer/2017-01-05T09:27:21+00:00https://drug.russellpublishing.co.uk/news/7365/scripps-scientists-make-leukaemia-cells-kill-each-other/2017-01-05T09:27:01+00:00https://drug.russellpublishing.co.uk/news/7370/hifalpha-gene-could-hold-key-to-treating-parkinsons-disease/2017-01-05T09:26:48+00:00https://drug.russellpublishing.co.uk/news/7375/domainex-and-icl-team-up-to-discover-myocardial-infarction-therapies/2017-01-05T09:26:29+00:00https://drug.russellpublishing.co.uk/news/7379/bbi-acquires-exclusive-global-licence-for-mers-and-sars-vaccines/2017-01-05T09:26:15+00:00https://drug.russellpublishing.co.uk/news/7387/team-successfully-performs-surgery-on-a-human-genome/2017-01-05T09:26:01+00:00https://drug.russellpublishing.co.uk/news/7392/investigational-aerosol-tb-vaccine-induces-potent-immune-response/2017-01-05T09:25:04+00:00https://drug.russellpublishing.co.uk/news/7397/launch-of-dementia-discovery-fund-to-deliver-new-dementia-treatments-by-2025/2017-01-05T09:24:53+00:00https://drug.russellpublishing.co.uk/news/7413/amgen-foundation-invests-4-million-in-the-amgen-biotech-experience/2017-01-05T09:24:37+00:00https://drug.russellpublishing.co.uk/news/7419/medlab-to-start-human-trials-using-its-nanocelle-platform/2017-01-04T22:08:28+00:00https://drug.russellpublishing.co.uk/news/7423/gene-discovery-could-lead-to-new-treatments-for-sepsis/2017-01-05T09:24:16+00:00https://drug.russellpublishing.co.uk/news/7427/banlec-the-banana-derived-antiviral-agent/2017-01-05T09:23:51+00:00https://drug.russellpublishing.co.uk/news/7431/ipsc-technology-helps-characterise-healthy-and-diseased-neurons/2017-01-05T09:23:14+00:00https://drug.russellpublishing.co.uk/news/7435/disease-recreated-in-mini-kidney-organoids-in-the-lab/2017-01-05T09:22:40+00:00https://drug.russellpublishing.co.uk/news/7439/celyad-awarded-us-patent-covering-allogeneic-human-primary-t-cells/2017-01-05T09:22:05+00:00https://drug.russellpublishing.co.uk/news/7443/chemical-probe-switches-off-two-cancer-causing-proteins/2017-01-05T09:20:41+00:00https://drug.russellpublishing.co.uk/news/7449/study-shows-immunosuppressive-effects-of-ca125-on-farletuzumab/2017-01-05T09:21:34+00:00https://drug.russellpublishing.co.uk/news/7453/clearpath-establishes-nosocomial-vaccine-corporation-nvc/2017-01-05T09:20:59+00:00https://drug.russellpublishing.co.uk/news/7457/vertex-and-crispr-therapeutics-to-develop-new-treatments-for-genetic-disease/2016-12-16T23:51:28+00:00https://drug.russellpublishing.co.uk/news/7464/scientists-discover-switched-off-gene-in-prostate-cancer-cells/2017-01-05T09:20:26+00:00https://drug.russellpublishing.co.uk/news/7468/ipsen-and-epivax-produce-next-generation-botulinum-toxins/2017-01-05T09:20:13+00:00https://drug.russellpublishing.co.uk/news/7472/scientists-build-protein-cage-cancer-drug-delivery-system/2017-01-05T09:18:36+00:00https://drug.russellpublishing.co.uk/news/7476/scientists-discover-a-switch-associated-with-epileptic-seizures/2017-01-05T09:18:17+00:00https://drug.russellpublishing.co.uk/news/7481/xbiotech-to-develop-antibody-against-c-difficile/2017-01-05T09:18:03+00:00https://drug.russellpublishing.co.uk/news/7485/sri-international-awarded-40m-to-develop-contraceptive-products/2017-01-05T09:17:51+00:00https://drug.russellpublishing.co.uk/news/7489/manipulation-of-primary-cilia-shows-promise-in-osteoarthritis/2017-01-05T09:17:36+00:00https://drug.russellpublishing.co.uk/news/7501/sgk1-identified-as-potential-target-to-reverse-effects-of-ptsd/2017-01-05T09:17:11+00:00https://drug.russellpublishing.co.uk/news/7505/ucla-discovery-could-lead-to-better-recovery-after-stroke/2017-01-05T09:16:57+00:00https://drug.russellpublishing.co.uk/news/7511/domainex-expands-its-drug-discovery-service-business/2017-01-05T09:16:44+00:00https://drug.russellpublishing.co.uk/news/7518/researchers-identify-protein-that-drives-progression-of-ms/2017-01-05T09:16:14+00:00https://drug.russellpublishing.co.uk/news/7527/rna-binding-proteins-play-important-role-in-motor-neurone-disease/2017-01-05T09:15:59+00:00https://drug.russellpublishing.co.uk/news/7545/md-andersons-expands-its-moon-shots-programme/2017-01-05T09:15:28+00:00https://drug.russellpublishing.co.uk/news/7549/tumours-may-seed-cancer-metastases-earlier-than-expected/2017-01-05T09:15:10+00:00https://drug.russellpublishing.co.uk/news/7553/interna-technologies-secures-final-extension-series-a-financing/2017-01-05T09:14:56+00:00https://drug.russellpublishing.co.uk/news/7560/leading-hiv-scientists-launch-project-to-develop-hiv-vaccine/2017-01-05T09:14:41+00:00https://drug.russellpublishing.co.uk/news/7564/merck-and-selvita-announce-oncology-drug-discovery-collaboration/2017-08-24T12:04:05+01:00https://drug.russellpublishing.co.uk/news/7568/lilly-announces-70-million-expansion-of-its-rd-headquarters/2017-01-05T09:13:10+00:00https://drug.russellpublishing.co.uk/news/7575/hercules-receives-eurostars-grant-to-develop-cb7993113-for-breast-cancer/2017-01-05T09:12:52+00:00https://drug.russellpublishing.co.uk/news/7581/sanofi-and-biontech-enter-cancer-immunotherapy-collaboration/2017-01-05T09:12:39+00:00https://drug.russellpublishing.co.uk/news/7585/novo-nordisk-and-uw-to-explore-the-role-of-the-brain-in-obesity/2017-01-05T09:12:28+00:00https://drug.russellpublishing.co.uk/news/7589/researchers-find-way-to-trigger-red-blood-cells-on-demand/2017-01-05T09:12:10+00:00https://drug.russellpublishing.co.uk/news/7594/scientists-develop-3-d-printing-method-for-embryonic-stem-cells/2017-01-05T09:11:56+00:00https://drug.russellpublishing.co.uk/news/7601/eisai-and-ipc-enter-oncology-rd-collaboration/2017-01-05T09:11:43+00:00https://drug.russellpublishing.co.uk/news/7605/mabvax-completes-manufacturing-of-humab-5b1-in-preparation-for-phase-i-trials/2017-01-05T09:11:29+00:00https://drug.russellpublishing.co.uk/news/7611/researchers-harness-brains-immune-system-to-clear-amyloid-plaques/2017-01-05T09:11:15+00:00https://drug.russellpublishing.co.uk/news/7615/researchers-try-to-turn-acid-loving-s-islandicus-into-a-drug-carrier/2017-01-05T09:11:02+00:00https://drug.russellpublishing.co.uk/news/7620/new-collaboration-to-research-probody-enabled-car-nk-cell-therapies/2017-01-05T09:10:47+00:00https://drug.russellpublishing.co.uk/news/7624/scientists-investigate-the-function-of-protein-mhc1/2017-01-05T09:10:33+00:00https://drug.russellpublishing.co.uk/news/7627/national-ms-society-invests-21m-in-78-new-research-projects/2017-01-05T09:10:20+00:00https://drug.russellpublishing.co.uk/news/7637/scientists-identify-compound-that-could-reverse-cataracts/2017-01-05T09:10:06+00:00https://drug.russellpublishing.co.uk/news/7641/possible-solution-for-alzheimers-immunotherapy-side-effect/2017-01-05T09:09:53+00:00https://drug.russellpublishing.co.uk/news/7647/global-and-usa-biosimilar-market-updates-from-hospira-sandoz-merck-teva-boehringer-ingelheim/2017-01-11T16:10:02+00:00https://drug.russellpublishing.co.uk/news/7648/scientists-discover-genetic-cause-and-mechanism-of-noise-induced-hearing-loss/2016-12-09T15:25:16+00:00https://drug.russellpublishing.co.uk/news/7653/sanofi-pasteur-reveals-universal-flu-vaccine-research/2017-01-05T09:08:28+00:00https://drug.russellpublishing.co.uk/news/7657/pharnexts-pxt-864-shows-promise-in-parkinsons-disease/2017-01-05T09:08:15+00:00https://drug.russellpublishing.co.uk/news/7661/boehringer-ingelheim-announces-ibd-research-collaborations/2017-01-05T09:08:01+00:00https://drug.russellpublishing.co.uk/news/7666/cholesterol-lowering-vaccine-shows-promise-in-preclinical-studies/2017-01-05T09:07:48+00:00https://drug.russellpublishing.co.uk/news/7670/e12-7fc-m3-demonstrates-efficacy-as-treatment-for-cocaine-overdose/2017-01-05T09:07:34+00:00https://drug.russellpublishing.co.uk/news/7674/scientists-use-dead-c-sporogenes-bacteria-to-kill-cancer-cells/2017-01-05T09:07:21+00:00https://drug.russellpublishing.co.uk/news/7686/scientists-help-launch-human-dark-proteome-initiative/2017-01-05T09:07:06+00:00https://drug.russellpublishing.co.uk/news/7691/studies-justify-mode-of-delivery-and-dosing-regimen-for-anisina/2017-01-05T09:05:48+00:00https://drug.russellpublishing.co.uk/news/7696/geneone-life-science-and-wrair-to-develop-mers-vaccine/2017-01-05T09:05:21+00:00https://drug.russellpublishing.co.uk/news/7700/boehringer-ingelheim-pledges-eur-11-billion-to-rd/2017-01-05T09:05:04+00:00https://drug.russellpublishing.co.uk/news/7704/study-finds-levodopa-delays-onset-of-macular-degeneration/2017-01-05T09:04:42+00:00https://drug.russellpublishing.co.uk/news/7720/enterome-and-gustave-roussy-in-microbiome-collaboration/2017-01-05T09:03:07+00:00https://drug.russellpublishing.co.uk/news/7743/regen-biopharma-initiates-nr2f6-t-cell-immunotherapy-preclinical-studies/2017-01-05T09:02:52+00:00https://drug.russellpublishing.co.uk/news/7756/experimental-alzheimers-drug-j147-shows-anti-aging-effects/2017-01-05T09:01:55+00:00https://drug.russellpublishing.co.uk/news/7760/ppf-could-limit-the-spread-of-glioblastoma-multiforme/2017-01-05T16:32:55+00:00https://drug.russellpublishing.co.uk/news/7765/researchers-discover-enzyme-critical-to-telomere-length/2017-01-05T08:59:51+00:00https://drug.russellpublishing.co.uk/news/7770/super-natural-killer-cells-destroy-lymph-node-cancer-cells-and-halt-mestastases/2017-01-05T08:59:21+00:00https://drug.russellpublishing.co.uk/news/7775/improved-gene-therapy-shows-promise-in-cystic-fibrosis/2016-12-14T22:57:44+00:00https://drug.russellpublishing.co.uk/news/7782/chemists-turn-bacterial-molecules-into-potential-drug-molecules/2017-01-05T08:58:31+00:00https://drug.russellpublishing.co.uk/news/7787/scientists-use-light-to-treat-alzheimers-disease/2017-01-05T08:58:17+00:00https://drug.russellpublishing.co.uk/news/7792/potential-target-for-reducing-obesity-related-inflammation/2017-01-05T08:58:02+00:00https://drug.russellpublishing.co.uk/news/7797/crucial-cause-of-eczema-during-childhood-discovered/2017-01-05T08:57:47+00:00https://drug.russellpublishing.co.uk/news/7801/tigit-identified-as-new-target-for-immuno-oncology-therapies/2017-01-05T08:57:31+00:00https://drug.russellpublishing.co.uk/news/7805/duchenne-muscular-dystrophy-identified-as-a-stem-cell-disease/2017-01-05T08:57:18+00:00https://drug.russellpublishing.co.uk/news/7810/topical-formulation-mgb-bp-3-completes-feasibility-study/2017-01-05T08:57:05+00:00https://drug.russellpublishing.co.uk/news/7818/ucla-researchers-identify-drug-that-helps-fight-side-effect-of-ovarian-cancer/2017-01-05T08:56:27+00:00https://drug.russellpublishing.co.uk/news/7840/dbv-technologies-presents-data-on-its-viaskin-technology-in-rsv/2017-01-05T08:56:04+00:00https://drug.russellpublishing.co.uk/news/7843/morphotek-and-univeristy-of-gothenburg-to-develop-farletuzumab/2017-01-05T08:54:59+00:00https://drug.russellpublishing.co.uk/news/7846/good-mosquito-virus-could-hold-the-key-to-fighting-disease/2017-01-05T08:51:58+00:00https://drug.russellpublishing.co.uk/news/7850/tsri-scientists-use-trait-of-anti-hiv-antibodies-to-develop-vaccine-candidates/2017-01-05T08:52:58+00:00https://drug.russellpublishing.co.uk/news/7853/mir-124-reduces-tumour-growth-in-advanced-prostate-cancer/2017-01-05T08:52:13+00:00https://drug.russellpublishing.co.uk/news/7859/york-scientists-reveal-structure-heparanase/2017-01-05T08:51:29+00:00https://drug.russellpublishing.co.uk/news/7863/gamma-interferon-protects-mice-ebola/2017-01-05T08:51:14+00:00https://drug.russellpublishing.co.uk/news/7882/presence-protein-aggregates-important-form/2017-01-05T08:50:57+00:00https://drug.russellpublishing.co.uk/news/7887/fda-clears-firr-mers-vaccine/2017-01-05T08:50:42+00:00https://drug.russellpublishing.co.uk/news/7891/sanofi-and-astrazeneca-exchange-210000-chemical-compounds/2017-01-05T08:50:28+00:00https://drug.russellpublishing.co.uk/news/7896/intelligent-biogel-effective-delivering-agents/2017-01-05T08:50:14+00:00https://drug.russellpublishing.co.uk/news/7900/astrazeneca-invests-cambridge-lead-discovery-centre/2017-01-05T08:49:55+00:00https://drug.russellpublishing.co.uk/news/7904/cocktail-mutant-proteins-linked-huntington-disease/2017-01-05T08:49:31+00:00https://drug.russellpublishing.co.uk/news/7910/sheffield-uni-appoints-cobra-growth-hormone/2017-01-05T08:49:07+00:00https://drug.russellpublishing.co.uk/news/7915/evgen-expands-pipeline-novel-compounds/2017-01-05T08:48:44+00:00https://drug.russellpublishing.co.uk/news/7920/1-billion-fund-fight-malaria-infectious-diseases/2017-01-05T08:48:21+00:00https://drug.russellpublishing.co.uk/news/7925/drug-heals-broken-bones-faster-better/2017-01-05T08:47:19+00:00https://drug.russellpublishing.co.uk/news/7929/tsri-scientists-reveal-potential-treatment-viruses/2017-01-04T16:49:00+00:00https://drug.russellpublishing.co.uk/news/7934/lsp-bristol-myers-squibb-life-sciences-innovation/2017-01-04T16:48:13+00:00https://drug.russellpublishing.co.uk/news/7938/ucl-launches-gene-therapy-company-athena-vision/2017-01-04T16:47:50+00:00https://drug.russellpublishing.co.uk/news/7947/scientists-used-x-ray-crystallography-pneumolysin/2017-01-04T16:47:32+00:00https://drug.russellpublishing.co.uk/news/7952/teva-heptares-develop-treatments-migraine/2017-01-04T16:47:05+00:00https://drug.russellpublishing.co.uk/news/7957/ablynx-novo-nordisk-nanobody-drug-discovery/2017-01-04T16:46:43+00:00https://drug.russellpublishing.co.uk/news/7963/reprocell-acquires-scottish-life-sciences-company-biopta/2017-01-04T16:46:09+00:00https://drug.russellpublishing.co.uk/news/7970/allergan-rugen-develop-asd-ocd-therapies/2017-01-04T16:46:27+00:00https://drug.russellpublishing.co.uk/news/7981/gene-map-identifies-genes-unique-different-cancers/2017-01-04T16:45:52+00:00https://drug.russellpublishing.co.uk/news/7985/scientists-create-therapeutic-venom-database/2016-12-09T15:23:38+00:00https://drug.russellpublishing.co.uk/news/7999/scientists-combine-antibody-drug-conjugates-with-immunotherapy/2017-01-04T16:44:59+00:00https://drug.russellpublishing.co.uk/news/8004/pelago-astrazeneca-enter-cetsa-research-collaboration/2017-01-04T16:44:43+00:00https://drug.russellpublishing.co.uk/news/8008/unsw-synapse-discovery-could-lead-to-new-alzheimers-treatments/2017-01-04T16:44:25+00:00https://drug.russellpublishing.co.uk/news/8015/new-data-supports-use-clevegen-immunotherapy/2017-01-04T16:44:07+00:00https://drug.russellpublishing.co.uk/news/8030/sleeping-sickness-project-passes-20-month-milestone/2017-01-04T16:43:44+00:00https://drug.russellpublishing.co.uk/news/8033/heptares-pfizer-focus-gpcr-targets/2017-01-04T16:40:24+00:00https://drug.russellpublishing.co.uk/news/8037/functional-human-hepatocytes-grown-lab/2017-01-04T16:40:05+00:00https://drug.russellpublishing.co.uk/news/8040/cftr-interacts-wrong-partners-cystic-fibrosis/2016-12-16T23:33:22+00:00https://drug.russellpublishing.co.uk/news/8043/daiichi-sankyo-to-close-research-subsidiary-u3-pharma/2017-01-04T16:39:33+00:00https://drug.russellpublishing.co.uk/news/8048/amcure-awarded-bmbf-research-grant-to-advance-lead-candidate/2017-01-04T16:39:17+00:00https://drug.russellpublishing.co.uk/news/8052/adaptimmune-universal-cells-t-cell-collaboration/2017-01-04T16:39:01+00:00https://drug.russellpublishing.co.uk/news/8063/scientists-engineer-crispr-cas9-reduce-errors/2017-01-19T09:47:06+00:00https://drug.russellpublishing.co.uk/news/8090/mabvax-files-ind-fda-humab-5b1/2017-01-04T16:38:28+00:00https://drug.russellpublishing.co.uk/news/8119/boehringer-md-anderson-in-pancreatic-cancer-collaboration/2017-01-04T16:38:10+00:00https://drug.russellpublishing.co.uk/news/8123/oncology-therapeutic-pipeline-boasts-over-6000-products/2017-01-04T16:37:55+00:00https://drug.russellpublishing.co.uk/news/8134/new-class-inhibitory-compounds-aid-melanoma-treatments/2017-01-04T16:37:40+00:00https://drug.russellpublishing.co.uk/news/8139/scientists-engineer-potential-treatment-for-pertussis/2017-01-04T16:37:21+00:00https://drug.russellpublishing.co.uk/news/8151/morphotek-enters-collaboration-investigate-ca125/2017-01-04T16:37:07+00:00https://drug.russellpublishing.co.uk/news/8153/nanobombs-future-cancer-drug-delivery/2017-01-04T16:36:52+00:00https://drug.russellpublishing.co.uk/news/8157/baxalta-opens-rd-global-innovation-centre/2017-01-04T16:36:17+00:00https://drug.russellpublishing.co.uk/news/8160/icr-identify-brf2-as-a-potential-target-for-future-cancer-drugs/2017-01-04T14:42:35+00:00https://drug.russellpublishing.co.uk/news/8164/ucl-researchers-discover-recipe-painlessness/2017-01-04T14:42:34+00:00https://drug.russellpublishing.co.uk/news/8169/nordic-nanovector-presents-preclinical-research-with-betalutin/2017-01-04T14:42:30+00:00https://drug.russellpublishing.co.uk/news/8174/cypralis-collaborates-with-janssen-on-cyclophilin-inhibitors/2017-01-04T14:42:29+00:00https://drug.russellpublishing.co.uk/news/8180/nosopharm-joins-enable-help-combat-antibiotic-resistance/2017-01-04T14:41:28+00:00https://drug.russellpublishing.co.uk/news/8196/researchers-one-step-closer-designer-dopamine-neurons/2017-01-04T14:41:25+00:00https://drug.russellpublishing.co.uk/news/8228/viking-announces-new-preclinical-results-vk5211/2017-01-04T14:41:23+00:00https://drug.russellpublishing.co.uk/news/8231/bioatla-pfizer-cab-antibody-collaboration/2017-01-04T14:42:07+00:00https://drug.russellpublishing.co.uk/news/8234/trial-of-car-t-cell-therapy-head-and-neck-cancer-starts/2017-01-04T14:41:20+00:00https://drug.russellpublishing.co.uk/news/8247/tc24-protein-could-hold-key-fighting-chagas-disease/2017-01-04T14:41:17+00:00https://drug.russellpublishing.co.uk/news/8253/jq1-prevents-reverses-liver-fibrosis-mice/2017-01-04T14:41:14+00:00https://drug.russellpublishing.co.uk/news/8258/gene-therapy-extend-oestrogen-effects-memory/2017-01-04T14:41:03+00:00https://drug.russellpublishing.co.uk/news/8261/gene-therapy-early-stage-pipeline-looks-strong/2017-01-04T14:40:48+00:00https://drug.russellpublishing.co.uk/news/8267/takeda-cour-coeliac-disease-collaboration/2017-01-04T14:40:33+00:00https://drug.russellpublishing.co.uk/news/8274/big-data-unlocks-new-targets-to-treat-influenza/2017-01-04T14:39:31+00:00https://drug.russellpublishing.co.uk/news/8278/sri-and-stanford-cancer-institute-in-first-in-class-collaboration/2017-01-04T14:49:17+00:00https://drug.russellpublishing.co.uk/news/8282/astrazeneca-and-medimmune-harness-power-secretome/2017-01-04T14:49:13+00:00https://drug.russellpublishing.co.uk/news/8286/immbio-initiates-first-in-human-study-of-pnubiovax/2017-01-04T14:48:29+00:00https://drug.russellpublishing.co.uk/news/8289/scientists-show-how-drug-molecules-regulate-%ce%b22ar/2017-01-04T14:48:23+00:00https://drug.russellpublishing.co.uk/news/8296/bellicum-to-develop-psca-cancer-therapies/2017-01-04T14:48:19+00:00https://drug.russellpublishing.co.uk/news/8300/bms-ucla-team-up-immuno-oncology-collaboration/2017-01-04T14:48:14+00:00https://drug.russellpublishing.co.uk/news/8302/abbott-ucsf-discover-human-pegivirus-2-linked-hcv/2017-01-04T14:48:12+00:00https://drug.russellpublishing.co.uk/news/8307/harnessing-antibiotic-resistance-to-find-drugs-for-amyloid-diseases/2017-01-04T14:47:25+00:00https://drug.russellpublishing.co.uk/news/8321/scientists-identify-gene-variant-linked-to-bipolar-disorder/2017-01-04T14:47:22+00:00https://drug.russellpublishing.co.uk/news/8325/construction-starts-at-imperial-college-londons-new-babraham-facility/2017-01-04T14:47:19+00:00https://drug.russellpublishing.co.uk/news/8329/induced-pluripotent-stem-cell-t-cira-programme-begins/2017-01-04T14:47:18+00:00https://drug.russellpublishing.co.uk/news/8334/cap2-study-sheds-light-genetic-cause-heart-disease/2017-01-04T14:47:15+00:00https://drug.russellpublishing.co.uk/news/8339/new-3-4-million-project-to-investigate-protein-protein-interactions/2017-01-04T14:47:14+00:00https://drug.russellpublishing.co.uk/news/8353/immunocore-makes-senior-appointments-opens-us-office/2017-01-04T14:46:55+00:00https://drug.russellpublishing.co.uk/news/8357/reneuron-holds-inaugral-meeting-with-its-new-scientific-advisory-board/2017-01-04T14:45:45+00:00https://drug.russellpublishing.co.uk/news/8360/duel-homing-agent-could-aid-brain-injury-recovery/2017-01-04T14:56:02+00:00https://drug.russellpublishing.co.uk/news/8364/ligand-pharmaceuticals-acquire-omt-for-178-million/2017-01-04T14:55:56+00:00https://drug.russellpublishing.co.uk/news/8412/variant-and-lf-research-team-up-to-develop-var-200/2017-01-04T14:55:54+00:00https://drug.russellpublishing.co.uk/news/8445/janssen-bavarian-nordic-team-up-hpv-infection-vaccine/2017-01-04T14:55:39+00:00https://drug.russellpublishing.co.uk/news/8449/bayer-and-crispr-therapeutics-join-forces-joint-venture/2017-01-04T14:55:25+00:00https://drug.russellpublishing.co.uk/news/8452/mimetas-awarded-organ-on-a-chip-neurotoxicity-models/2017-01-04T14:55:21+00:00https://drug.russellpublishing.co.uk/news/8457/imi-launches-calls-advance-drug-development-in-ebola-alzheimers-amd/2017-01-04T14:55:12+00:00https://drug.russellpublishing.co.uk/news/8461/enhancing-proteasome-activity-may-prevent-dementia/2017-01-04T14:54:53+00:00https://drug.russellpublishing.co.uk/news/8465/study-identifies-mdscs-as-possible-prostate-cancer-target/2017-01-04T14:54:45+00:00https://drug.russellpublishing.co.uk/news/8469/ara-290-improves-islet-cell-transplantation-outcome-type-1-diabetes/2017-01-04T14:54:27+00:00https://drug.russellpublishing.co.uk/news/8473/malat1-aso-generates-exciting-results-in-breast-cancer-models/2017-01-04T14:54:25+00:00https://drug.russellpublishing.co.uk/news/8480/vertex-and-genomics-enter-target-pathway-collaboration/2017-01-04T14:54:09+00:00https://drug.russellpublishing.co.uk/news/8484/memory-drug-bpn14770-moves-into-phase-1-safety-trial/2017-01-19T11:12:42+00:00https://drug.russellpublishing.co.uk/news/8488/baxalta-symphogen-enter-immuno-oncology-collaboration/2017-01-04T14:53:45+00:00https://drug.russellpublishing.co.uk/news/8492/cellectis-files-clinical-trial-application-ucart19-leukaemia/2017-01-04T14:51:56+00:00https://drug.russellpublishing.co.uk/news/8497/cansar-cancer-drug-discovery-database-goes-3d/2017-01-19T10:31:15+00:00https://drug.russellpublishing.co.uk/news/8503/aic649-potential-induce-functional-cure-preclinical-hbv-study/2017-01-04T15:00:17+00:00https://drug.russellpublishing.co.uk/news/8507/nanobiotix-explore-use-nbtxr3-immuno-oncology/2017-01-04T15:00:02+00:00https://drug.russellpublishing.co.uk/news/8513/renova-expands-its-robust-gene-therapy-portfolio/2017-01-04T14:59:59+00:00https://drug.russellpublishing.co.uk/news/8517/oncodesign-bms-enter-drug-discovery-collaboration/2017-01-04T14:59:54+00:00https://drug.russellpublishing.co.uk/news/8521/takeda-enterome-microbiome-drug-discovery-collaboration/2017-01-04T14:59:49+00:00https://drug.russellpublishing.co.uk/news/8524/new-project-car-t-cell-immuno-oncology-therapy-development/2017-01-04T15:00:24+00:00https://drug.russellpublishing.co.uk/news/8528/dasatinib-shows-promise-duchenne-muscular-dystrophy/2017-01-04T14:59:42+00:00https://drug.russellpublishing.co.uk/news/8532/complix-and-msd-team-up-for-cell-penetrating-alphabodies/2017-01-04T14:59:34+00:00https://drug.russellpublishing.co.uk/news/8538/enterome-announces-collaboration-with-johnson-johnson-innovation-focused-on-the-discovery-of-novel-targets-and-therapeutics-for-crohns-disease/2017-01-04T14:59:33+00:00https://drug.russellpublishing.co.uk/news/8541/vaccine-targeting-alzheimers-in-people-with-down-syndrome/2017-01-04T14:59:31+00:00https://drug.russellpublishing.co.uk/news/8554/gtp-energy-sensor-identified-as-potential-cancer-drug-target/2017-01-04T14:59:26+00:00https://drug.russellpublishing.co.uk/news/8559/tiziana-life-sciences-to-drive-its-first-in-class-bcl-3-inhibitor/2017-01-04T14:59:19+00:00https://drug.russellpublishing.co.uk/news/8564/innovate-uk-awards-300k-grant-virtual-laboratory/2017-01-04T14:59:14+00:00https://drug.russellpublishing.co.uk/news/8568/takeda-nsgene-research-encapsulated-cell-therapies-parkinsons/2017-01-04T14:58:26+00:00https://drug.russellpublishing.co.uk/news/8571/sanofi-and-innate-team-up-for-nkp46-bispecific-nk-cell-engagers/2017-01-04T15:04:19+00:00https://drug.russellpublishing.co.uk/news/8575/novartis-surface-oncology-immuno-oncology-alliance/2017-01-04T15:04:14+00:00https://drug.russellpublishing.co.uk/news/8588/aelix-completes-e11-5-m-series-a-funding-therapeutic-hiv-vaccine/2017-01-04T15:04:11+00:00https://drug.russellpublishing.co.uk/news/8594/astrazeneca-and-moderna-enter-mrna-collaboration/2017-01-04T15:04:10+00:00https://drug.russellpublishing.co.uk/news/8597/sanofi-and-warp-drive-bio-team-up-to-discover-oncology-therapeutics/2017-01-04T15:04:09+00:00https://drug.russellpublishing.co.uk/news/8608/preclinical-data-reneurons-exosome-nanomedicine-platform-published/2017-01-04T15:03:58+00:00https://drug.russellpublishing.co.uk/news/8611/vagus-nerve-stimulation-shown-to-suppress-csds/2017-01-04T15:03:55+00:00https://drug.russellpublishing.co.uk/news/8616/merck-acquires-drug-discovery-company-iomet/2018-06-29T13:57:09+01:00https://drug.russellpublishing.co.uk/news/8621/scientists-design-new-car-architecture-with-switch-on-system/2017-01-04T15:03:47+00:00https://drug.russellpublishing.co.uk/news/8626/pfizer-expands-its-rd-investment-strategy/2017-01-04T15:03:46+00:00https://drug.russellpublishing.co.uk/news/8649/boehringer-and-arena-to-advance-research-in-psychiatric-diseases/2017-01-04T15:03:44+00:00https://drug.russellpublishing.co.uk/news/8653/niaid-funds-projects-developing-non-traditional-therapeutics/2017-01-04T15:03:37+00:00https://drug.russellpublishing.co.uk/news/8657/an-interview-with-uwe-gudat-from-merck-serono-speaker-at-the-4th-annual-biosimilars-biobetters-congress-18-19-april-2016-london/2017-01-11T16:19:45+00:00https://drug.russellpublishing.co.uk/news/8659/an-interview-with-elaine-pinheiro-principal-scientist-at-msd-speaker-at-the-advances-in-immuno-oncology-congress-12-13-may-2016-london-uk/2017-01-11T16:18:59+00:00https://drug.russellpublishing.co.uk/news/8661/an-interview-with-bernardo-perez-ramirez-sanofi-speaker-at-the-9th-annual-proteins-antibodies-congress-18-19-april-2016-london-uk/2017-01-11T16:18:13+00:00https://drug.russellpublishing.co.uk/news/8665/antibodies-show-efficacy-against-both-ebov-and-sudv-ebola-strains/2017-01-04T15:11:07+00:00https://drug.russellpublishing.co.uk/news/8668/registration-has-now-opened-for-oxford-globals-17th-annual-drug-discovery-leaders-summit/2017-01-11T16:16:51+00:00https://drug.russellpublishing.co.uk/news/8673/xbp-1-pathway-plays-key-role-in-cf-airway-inflammation/2016-12-16T23:49:16+00:00https://drug.russellpublishing.co.uk/news/8678/researchers-discover-previously-unknown-defect-in-parkinsons-disease/2017-01-04T15:10:56+00:00https://drug.russellpublishing.co.uk/news/8728/sanofi-pasteur-announces-support-human-vaccines-project/2017-01-04T15:10:49+00:00https://drug.russellpublishing.co.uk/news/8737/calibr-and-pfizer-to-develop-heart-failure-therapies/2017-01-04T15:10:48+00:00https://drug.russellpublishing.co.uk/news/8740/channel-blocker-drug-helps-restore-vision-in-mice-with-optic-nerve-injury/2017-01-04T15:10:45+00:00https://drug.russellpublishing.co.uk/news/8802/centauri-acquires-alphamer-technology-from-altermune/2017-01-04T15:10:34+00:00https://drug.russellpublishing.co.uk/news/8806/f-star-and-abbvie-to-develop-bispecific-antibodies-in-immuno-oncology/2017-01-04T15:10:31+00:00https://drug.russellpublishing.co.uk/news/8810/ucl-announces-new-50-million-fund-to-commercialise-research/2017-01-04T15:10:22+00:00https://drug.russellpublishing.co.uk/news/8813/time-to-renew-the-antibiotic-arsenal/2017-01-19T11:30:44+00:00https://drug.russellpublishing.co.uk/news/8815/breast-cancer-study-reveals-new-drug-targets-combinations/2017-01-04T15:10:14+00:00https://drug.russellpublishing.co.uk/news/8818/rapastinel-demonstrates-pro-cognitive-benefits-cognitive-impairment/2017-01-04T15:10:12+00:00https://drug.russellpublishing.co.uk/news/8834/neurodegenerative-diseases-the-potential-of-cyclophilin-inhibition/2017-01-04T15:18:53+00:00https://drug.russellpublishing.co.uk/news/8841/new-study-finds-laws-of-nature-predict-cancer-evolution/2017-01-04T15:10:00+00:00https://drug.russellpublishing.co.uk/news/8861/mucosis-secures-e3-7m-to-advance-its-rsv-vaccine-syngem/2017-01-04T15:08:44+00:00https://drug.russellpublishing.co.uk/news/8907/regen-biopharma-and-ncats-to-research-nr2f6/2017-01-04T15:20:47+00:00https://drug.russellpublishing.co.uk/news/8922/researchers-freeze-ebv-by-disrupting-the-cell-supply-chain/2017-01-04T15:20:49+00:00https://drug.russellpublishing.co.uk/news/8945/microptosis-could-present-an-antimicrobial-drug-development-opportunity/2017-01-19T11:24:58+00:00https://drug.russellpublishing.co.uk/news/8952/pdi-launched-to-translate-of-phenotypic-biology-to-therapeutics/2017-01-04T15:20:45+00:00https://drug.russellpublishing.co.uk/news/9037/uc-berkeley-researchers-improve-crispr-cas9-gene-editing/2017-01-04T15:19:07+00:00https://drug.russellpublishing.co.uk/news/9209/ldc-enters-new-industry-partnership-with-roche/2017-01-04T15:19:07+00:00https://drug.russellpublishing.co.uk/news/9432/mrct-and-the-alzheimers-association-enter-collaboration/2017-01-04T15:19:01+00:00https://drug.russellpublishing.co.uk/news/9472/asterias-ast-vac2-manufacturing-processes-cancer-research-uk/2017-01-04T15:18:57+00:00https://drug.russellpublishing.co.uk/news/9550/scientists-discover-method-to-potentially-repair-injured-nerve-cells/2017-01-04T15:18:30+00:00https://drug.russellpublishing.co.uk/news/9580/new-biomarkers-may-influence-cancer-drug-design/2017-01-04T15:18:08+00:00https://drug.russellpublishing.co.uk/news/9590/researchers-isolate-antibodies-that-neutralise-multiple-species-of-ebola/2017-01-04T15:17:44+00:00https://drug.russellpublishing.co.uk/news/9675/domainex-and-cresset-form-drug-discovery-services-alliance/2017-01-04T15:17:28+00:00https://drug.russellpublishing.co.uk/news/9686/apollo-therapeutics-fund-launched-to-drive-therapeutic-innovation/2017-01-04T15:16:34+00:00https://drug.russellpublishing.co.uk/news/9692/institut-pasteur-sequences-genome-of-the-zika-virus/2017-01-04T15:15:46+00:00https://drug.russellpublishing.co.uk/news/9696/abtl0812-study-identifies-new-mechanism-anti-tumour-action/2017-01-04T15:27:22+00:00https://drug.russellpublishing.co.uk/news/9700/md-anderson-and-abbvie-join-forces-to-fight-cancer/2017-01-04T15:27:17+00:00https://drug.russellpublishing.co.uk/news/9704/laser-cut-microwells-could-lower-the-cost-of-cancer-research/2017-01-04T15:27:15+00:00https://drug.russellpublishing.co.uk/news/9708/nanoparticles-inhibit-liver-cancer-tumour-growth-in-study/2017-01-04T15:27:12+00:00https://drug.russellpublishing.co.uk/news/9728/crispr-used-to-repair-genetic-mutation-in-retinitis-pigmentosa/2017-01-04T15:27:12+00:00https://drug.russellpublishing.co.uk/news/9733/uw-madison-researchers-look-for-ways-to-stop-zika-virus/2017-01-04T15:26:59+00:00https://drug.russellpublishing.co.uk/news/9740/myeloma-uk-and-the-sgc-in-first-of-its-kind-collaboration/2017-01-04T15:27:00+00:00https://drug.russellpublishing.co.uk/news/9749/abcellera-and-merck-enter-antibody-collaboration/2018-06-29T14:01:19+01:00https://drug.russellpublishing.co.uk/news/9778/addopt-project-set-to-transform-the-uk-pharma-industry/2017-01-04T15:26:30+00:00https://drug.russellpublishing.co.uk/news/9787/who-emergency-team-to-convene-to-discuss-the-zika-virus/2017-01-04T15:25:43+00:00https://drug.russellpublishing.co.uk/news/9799/karolinska-institutet-and-biovica-to-evaluate-promising-cancer-treatments/2017-01-04T15:25:08+00:00https://drug.russellpublishing.co.uk/news/9803/new-therapy-halts-progression-of-als-in-mice/2017-01-04T15:25:05+00:00https://drug.russellpublishing.co.uk/news/9815/adc-summit-2016-to-highlight-the-developments-for-next-wave-of-antibody-drug-conjugates/2017-01-11T16:22:38+00:00https://drug.russellpublishing.co.uk/news/9818/pfizer-to-give-a-keynote-address-on-reviving-covalent-drug-design-in-oncology-at-smis-15th-annual-event-this-february/2017-01-11T16:22:10+00:00https://drug.russellpublishing.co.uk/news/9820/epigenome-mining-leads-to-medulloblastoma-discovery/2017-01-04T15:43:22+00:00https://drug.russellpublishing.co.uk/news/9824/nordic-nanovector-awarded-grant-to-develop-novel-therapeutics/2017-01-04T15:43:19+00:00https://drug.russellpublishing.co.uk/news/9828/astellas-and-clino-team-up-for-retinitis-pigmentosa-gene-therapy/2017-01-04T15:43:17+00:00https://drug.russellpublishing.co.uk/news/9832/stem-cells-that-can-repair-the-skull-and-face-bones/2017-01-04T15:43:15+00:00https://drug.russellpublishing.co.uk/news/9839/hfea-approves-embryo-gene-editing/2017-01-04T15:42:54+00:00https://drug.russellpublishing.co.uk/news/9846/cell-therapy-catapult-becomes-cell-and-gene-therapy-catapult/2017-01-04T15:42:51+00:00https://drug.russellpublishing.co.uk/news/9851/non-coding-rna-helps-suppress-breast-cancer/2017-01-04T15:42:17+00:00https://drug.russellpublishing.co.uk/news/9854/mission-therapeutics-raises-60m-to-advance-dub-inhibitors/2017-01-04T15:42:14+00:00https://drug.russellpublishing.co.uk/news/9869/leicesters-dr-echalier-awarded-domainexs-discovery-star-award/2017-01-04T15:41:41+00:00https://drug.russellpublishing.co.uk/news/9876/adaptimmune-and-gsk-expand-cancer-immunotherapy-collaboration/2017-01-04T15:40:34+00:00https://drug.russellpublishing.co.uk/news/9882/teva-and-abcellera-team-up-to-discover-monoclonal-antibodies/2017-01-04T15:40:34+00:00https://drug.russellpublishing.co.uk/news/9885/london-cancer-hub-to-accelerate-the-discovery-of-treatments/2017-01-04T15:40:29+00:00https://drug.russellpublishing.co.uk/news/9889/mersana-and-takeda-expand-partnership-to-advance-xmt-1522/2017-01-04T15:40:26+00:00https://drug.russellpublishing.co.uk/news/9892/selvita-opens-new-research-site-in-poland/2017-01-04T15:40:20+00:00https://drug.russellpublishing.co.uk/news/9908/vaccines-carried-in-hepatitis-e-virus-shells/2017-01-04T15:40:12+00:00https://drug.russellpublishing.co.uk/news/9921/potential-new-approaches-to-treating-amd/2017-01-04T15:50:58+00:00https://drug.russellpublishing.co.uk/news/9924/mice-with-increased-levels-of-ttp-resistant-to-inflammation/2017-01-04T15:50:54+00:00https://drug.russellpublishing.co.uk/news/9929/quantum-genomics-expands-its-us-presence/2017-01-04T15:50:38+00:00https://drug.russellpublishing.co.uk/news/9932/inhibiting-cell-death-may-prevent-the-spread-of-cancer/2017-01-04T15:50:31+00:00https://drug.russellpublishing.co.uk/news/9939/nih-seeks-research-applications-to-study-zika-in-pregnancy/2017-01-04T15:50:29+00:00https://drug.russellpublishing.co.uk/news/9961/researchers-uncover-the-role-of-pad4-in-cancers/2017-01-19T09:46:25+00:00https://drug.russellpublishing.co.uk/news/9964/biogen-joins-the-centre-for-therapeutic-target-validation/2017-01-04T15:50:12+00:00https://drug.russellpublishing.co.uk/news/9968/the-practicalities-of-targeted-cell-delivery-senior-scientists-gather-in-london-to-explore-the-latest-in-rna-therapeutics/2017-01-11T16:24:06+00:00https://drug.russellpublishing.co.uk/news/9978/ucb-baylor-neurodegenerative-disease-research-alliance/2017-01-04T15:49:58+00:00https://drug.russellpublishing.co.uk/news/10005/escmid-experts-gather-data-on-the-zika-virus/2017-01-04T15:49:54+00:00https://drug.russellpublishing.co.uk/news/10012/breast-cancer-now-catalyst-programme-aims-to-stop-breast-cancer/2017-01-04T15:49:44+00:00https://drug.russellpublishing.co.uk/news/10040/researchers-successfully-use-laser-to-weld-neurons-together/2017-01-04T15:49:41+00:00https://drug.russellpublishing.co.uk/news/10047/healing-microbes-could-be-exploited-as-treatments-for-ibd/2017-01-04T15:49:12+00:00https://drug.russellpublishing.co.uk/news/10051/regeneron-joins-the-human-vaccines-project/2017-01-04T15:57:22+00:00https://drug.russellpublishing.co.uk/news/10062/winners-of-innovative-cardiovascular-research-grant-programme-announced/2017-01-04T15:57:08+00:00https://drug.russellpublishing.co.uk/news/10072/fgf21-discovery-could-lead-to-new-treatments-for-type-2-diabetes/2017-01-04T15:57:07+00:00https://drug.russellpublishing.co.uk/news/10088/nimbolide-shows-potential-as-pancreatic-cancer-treatment/2017-01-04T15:57:07+00:00https://drug.russellpublishing.co.uk/news/10095/vaccines-alternatives-tackling-drug-resistant-infections/2017-01-04T15:56:59+00:00https://drug.russellpublishing.co.uk/news/10114/herpesvirus-cmv-based-vaccine-shown-to-be-effective-against-ebola/2017-01-04T15:56:44+00:00https://drug.russellpublishing.co.uk/news/10121/eisai-and-charles-river-announce-drug-discovery-collaboration/2017-05-30T15:17:50+01:00https://drug.russellpublishing.co.uk/news/10124/drug-discovery-crisis-linked-to-bad-technology-choices/2017-01-04T15:56:21+00:00https://drug.russellpublishing.co.uk/news/10128/abbvie-joins-the-dementia-consortium/2017-01-04T15:56:12+00:00https://drug.russellpublishing.co.uk/news/10131/mgb-biopharma-strathclyde-develop-new-mgb-anti-infectives/2017-01-19T10:15:26+00:00https://drug.russellpublishing.co.uk/news/10135/bms-and-dana-farber-cancer-institute-enter-i-o-rpm-collaboration/2017-01-04T15:56:02+00:00https://drug.russellpublishing.co.uk/news/10138/extraordinary-t-cell-therapy-results-change-face-cancer-treatment/2017-01-04T15:55:52+00:00https://drug.russellpublishing.co.uk/news/10144/forbion-invests-in-akarna-therapeutics-15-million-series-b-financing/2017-01-04T15:55:12+00:00https://drug.russellpublishing.co.uk/news/10147/zika-virus-must-be-addressed-using-a-multi-pronged-approach-says-globaldata/2017-01-04T15:53:39+00:00https://drug.russellpublishing.co.uk/news/10149/scientists-discover-dual-role-of-il-36-in-ibd/2017-01-04T16:07:27+00:00https://drug.russellpublishing.co.uk/news/10152/taxi-holds-promise-as-a-carrier-for-spinal-cord-treatments/2017-01-19T10:37:08+00:00https://drug.russellpublishing.co.uk/news/10157/inovios-dna-vaccine-for-zika-virus-induces-robust-responses/2017-01-04T16:07:18+00:00https://drug.russellpublishing.co.uk/news/10167/bird-blood-cell-destroys-cryptococcus-neoformans/2017-01-04T16:07:11+00:00https://drug.russellpublishing.co.uk/news/10210/studies-suggest-major-role-for-regens-nr2f6-target/2017-01-04T16:07:11+00:00https://drug.russellpublishing.co.uk/news/10316/mers-treatment-demonstrates-promising-results/2017-01-04T16:07:05+00:00https://drug.russellpublishing.co.uk/news/10325/discover-the-latest-developments-in-organ-on-a-chip/2017-01-11T16:28:20+00:00https://drug.russellpublishing.co.uk/news/10327/select-biosciences-second-annual-organ-on-a-chip-world-congress-and-3d-culture-july-7-8-2016-boston-usa/2017-01-04T16:06:55+00:00https://drug.russellpublishing.co.uk/news/10339/nanoparticle-has-potential-to-treat-ocular-cancer/2017-01-04T16:06:55+00:00https://drug.russellpublishing.co.uk/news/10343/suppressing-jnk3-could-reduce-severity-of-spinal-muscular-atrophy/2017-01-04T16:06:47+00:00https://drug.russellpublishing.co.uk/news/10355/researchers-use-key-mechanism-to-treat-autoimmune-diseases/2017-01-04T16:06:47+00:00https://drug.russellpublishing.co.uk/news/10379/pherecydes-pharma-appoints-fanneau-de-la-horie-as-ceo/2017-01-19T10:36:56+00:00https://drug.russellpublishing.co.uk/news/10428/desktop-genetics-grant-site-specific-epigenetic-crispr-editing/2017-01-04T16:06:36+00:00https://drug.russellpublishing.co.uk/news/10463/plasticell-and-pierre-fabre-in-brown-fat-enhancement-collaboration/2017-01-04T16:06:28+00:00https://drug.russellpublishing.co.uk/news/10468/tyg100-induces-strong-immune-response-in-pancreatic-cancer/2017-01-04T16:31:13+00:00https://drug.russellpublishing.co.uk/news/10473/dna-origami-successfully-used-to-kill-leukaemia-cells/2017-01-04T16:30:51+00:00https://drug.russellpublishing.co.uk/news/10479/avacta-awarded-grant-to-develop-novel-affirmer-reagents/2017-09-21T12:18:22+01:00https://drug.russellpublishing.co.uk/news/10485/bacteria-killing-protein-could-lead-new-treatment-diabetes/2017-01-04T16:29:53+00:00https://drug.russellpublishing.co.uk/news/10490/scientists-engineer-calcium-receptors-to-tune-heartbeat-strength/2017-01-04T16:28:54+00:00https://drug.russellpublishing.co.uk/news/10496/pancreatic-cancer-identified-as-four-separate-diseases/2017-01-04T16:28:34+00:00https://drug.russellpublishing.co.uk/news/10510/gilead-announces-preclinical-results-for-tlr7-agonist-gs-9620/2017-01-19T10:19:33+00:00https://drug.russellpublishing.co.uk/news/10517/adaptive-therapy-inhibits-chemo-resistance-in-study/2017-01-04T16:27:22+00:00https://drug.russellpublishing.co.uk/news/10525/single-antibody-protects-non-human-primates-from-ebola-virus/2017-01-04T16:27:01+00:00https://drug.russellpublishing.co.uk/news/10529/targeted-substance-selectively-blocks-alzheimers-disease-enzyme/2016-12-14T22:52:26+00:00https://drug.russellpublishing.co.uk/news/10532/regen-completes-preclinical-experimentation-for-its-nr2f6-checkpoint-inhibitor/2017-01-04T16:26:33+00:00https://drug.russellpublishing.co.uk/news/10543/tarantula-toxin-protx-ii-shows-promise-as-a-painkiller/2017-01-04T16:26:18+00:00https://drug.russellpublishing.co.uk/news/10579/peptimimesis-to-develop-next-generation-therapeutic-peptides/2017-01-04T16:25:18+00:00https://drug.russellpublishing.co.uk/news/10608/lamellar-teams-up-with-ecfp-to-create-novel-lamellasomes/2017-01-04T16:25:03+00:00https://drug.russellpublishing.co.uk/news/10614/electron-microscopy-detail-infection-mechanisms-of-coronaviruses/2017-01-04T16:24:13+00:00https://drug.russellpublishing.co.uk/news/10620/ache-peptide-key-driver-for-neuronal-death-in-alzheimers/2017-01-04T16:23:46+00:00https://drug.russellpublishing.co.uk/news/10623/fda-makes-2-million-available-to-fund-natural-history-studies-in-rare-diseases/2017-01-04T16:23:19+00:00https://drug.russellpublishing.co.uk/news/10627/uci-study-points-to-new-treatments-to-limit-effects-of-alzheimers/2017-01-04T16:23:07+00:00https://drug.russellpublishing.co.uk/news/10632/celyad-patent-tcr-deficient-car-t-cells-method/2017-01-04T16:22:50+00:00https://drug.russellpublishing.co.uk/news/10638/cypralis-appoints-new-chief-scientific-officer/2017-01-19T10:15:20+00:00https://drug.russellpublishing.co.uk/news/10656/researchers-investigate-defects-dj1-gene-parkinsons/2017-01-04T16:22:03+00:00https://drug.russellpublishing.co.uk/news/10659/researchers-find-achilles-heel-of-acute-lymphoblastic-leukaemia/2017-01-04T16:21:32+00:00https://drug.russellpublishing.co.uk/news/10701/fighting-proteus-mirabilis-infections-viruses/2017-01-04T16:21:02+00:00https://drug.russellpublishing.co.uk/news/10704/angptl4-inhibition-coronary-artery-disease/2017-01-04T16:20:44+00:00https://drug.russellpublishing.co.uk/news/10707/why-pharma-may-prefer-invest-drugs-vaccines/2017-01-04T16:20:30+00:00https://drug.russellpublishing.co.uk/news/10711/immunotherapy-shows-promise-treating-high-grade-glioma/2017-01-04T16:20:05+00:00https://drug.russellpublishing.co.uk/news/10717/researchers-make-groundbreaking-cancer-immunotherapy-discovery/2017-01-04T16:19:44+00:00https://drug.russellpublishing.co.uk/news/10723/likely-link-zika-virus-microcephaly/2017-01-04T16:17:27+00:00https://drug.russellpublishing.co.uk/news/10727/oxford-globals-free-webinars-drug-discovery-will-future-hold-registration-open/2017-01-11T16:30:55+00:00https://drug.russellpublishing.co.uk/news/10730/vaxart-initiates-preclinical-testing-of-its-oral-zika-virus-vaccine/2017-01-04T16:18:57+00:00https://drug.russellpublishing.co.uk/news/10734/naive-pluripotent-stem-cells-human-embryos/2017-01-04T16:17:43+00:00https://drug.russellpublishing.co.uk/news/10740/new-insights-brca1-breast-cancer/2017-01-04T16:16:55+00:00https://drug.russellpublishing.co.uk/news/10745/bristol-myers-squibb-labcentral/2017-01-04T16:16:35+00:00https://drug.russellpublishing.co.uk/news/10748/urine-premature-babies-source-kidney-stem-cells/2017-01-04T16:15:59+00:00https://drug.russellpublishing.co.uk/news/10752/spotted-gar-help-advance-biomedical-research/2017-01-04T16:15:39+00:00https://drug.russellpublishing.co.uk/news/10756/researchers-grow-3-d-heart-liver-tissues-using-angiochip/2017-01-04T16:15:09+00:00https://drug.russellpublishing.co.uk/news/10760/bh3-mimetic-drugs-legionella/2017-01-04T16:14:37+00:00https://drug.russellpublishing.co.uk/news/10770/phgdh-inhibitor-cancer/2017-01-04T16:14:20+00:00https://drug.russellpublishing.co.uk/news/10791/collaboration-treatments-tuberculosis/2017-01-04T16:13:48+00:00https://drug.russellpublishing.co.uk/news/10798/new-target-identified-treatment-asthma/2017-01-04T16:12:51+00:00https://drug.russellpublishing.co.uk/news/10805/silico-prediction-drug-side-effects/2017-01-04T16:12:12+00:00https://drug.russellpublishing.co.uk/news/10811/injectible-gel-critical-limb-ischemia/2017-01-04T16:11:26+00:00https://drug.russellpublishing.co.uk/news/10817/ipsen-peptimimesis-oncology-peptide-partnership/2017-01-04T16:09:53+00:00https://drug.russellpublishing.co.uk/news/10821/phoremost-wistar-identify-target/2017-01-04T16:03:36+00:00https://drug.russellpublishing.co.uk/news/10824/research-first-step-anti-cancer-drugs/2017-01-04T16:03:20+00:00https://drug.russellpublishing.co.uk/news/10827/psaptides-attack-ovarian-cancer-on-two-fronts/2017-01-19T09:45:22+00:00https://drug.russellpublishing.co.uk/news/10831/genetic-variations-bipolar-disorder/2017-01-04T16:02:24+00:00https://drug.russellpublishing.co.uk/news/10835/reduce-brain-damage-stroke-victims/2017-01-04T16:02:06+00:00https://drug.russellpublishing.co.uk/news/10843/blood-stem-cells-leukaemia/2017-01-04T16:01:39+00:00https://drug.russellpublishing.co.uk/news/10846/trioxacarcins-synthesised-as-a-potent-anti-cancer-agent/2017-01-04T16:01:03+00:00https://drug.russellpublishing.co.uk/news/10850/male-contraceptive-pill/2017-01-04T16:00:03+00:00https://drug.russellpublishing.co.uk/news/10853/citrullinated-proteins-cancer/2017-01-04T16:00:34+00:00https://drug.russellpublishing.co.uk/news/10860/cegx-series-b-financing-ceo/2017-01-04T15:59:36+00:00https://drug.russellpublishing.co.uk/news/10863/dr-david-b-weiner-inovio/2017-01-04T15:59:04+00:00https://drug.russellpublishing.co.uk/news/10866/hrx9-treatment-mesothelioma/2017-01-04T15:58:48+00:00https://drug.russellpublishing.co.uk/news/10888/takeda-outpost-medicine/2017-01-04T15:58:00+00:00https://drug.russellpublishing.co.uk/news/10891/parkinsons-proteins-toxic/2017-01-04T15:57:24+00:00https://drug.russellpublishing.co.uk/news/10894/blueprint-medicines-immunokinases/2017-01-04T15:56:33+00:00https://drug.russellpublishing.co.uk/news/10897/sri-international-cancer-vaccines/2017-01-04T15:55:02+00:00https://drug.russellpublishing.co.uk/news/10918/johnson-johnson-innovation-launches-jlinx/2017-01-04T15:54:20+00:00https://drug.russellpublishing.co.uk/news/10928/sanofi-dice-molecules-collaboration/2017-01-04T15:51:36+00:00https://drug.russellpublishing.co.uk/news/10931/inovio-wistar-dna-based-immunotherapies/2017-01-04T15:50:47+00:00https://drug.russellpublishing.co.uk/news/10934/antimicrobial-high-throughput-screening/2017-01-19T11:24:47+00:00https://drug.russellpublishing.co.uk/news/10938/cellectis-mabquest-new-class-anti-pd-1-mabs/2017-01-04T15:47:24+00:00https://drug.russellpublishing.co.uk/news/10970/iprove-roadmap-vaccine-innovation/2017-01-04T15:46:54+00:00https://drug.russellpublishing.co.uk/news/10983/implant-alzheimers-disease/2017-01-04T15:46:29+00:00https://drug.russellpublishing.co.uk/news/11010/interview-with-michael-springer-associate-professor-of-systems-biology-harvard-medical-school/2017-08-24T11:21:54+01:00https://drug.russellpublishing.co.uk/news/11021/abhd2-compound-sperm-activation/2017-01-04T15:44:44+00:00https://drug.russellpublishing.co.uk/news/11025/viewing-cells-3d-skin-nanorods/2017-01-04T15:43:34+00:00https://drug.russellpublishing.co.uk/news/11037/ethris-mrna-therapy-regeneration/2016-12-16T23:47:05+00:00https://drug.russellpublishing.co.uk/news/11040/researchers-identify-achilles-heel-bacteria/2017-01-04T15:42:20+00:00https://drug.russellpublishing.co.uk/news/11048/celyad-institut-curie/2017-01-04T15:39:01+00:00https://drug.russellpublishing.co.uk/news/11051/dmab-antibody-dna-vaccine-chikv/2017-01-04T15:38:33+00:00https://drug.russellpublishing.co.uk/news/11054/prostate-cancer-treatment-efficacy/2017-01-04T15:37:48+00:00https://drug.russellpublishing.co.uk/news/11057/secret-antibiotic-resistance/2017-01-04T15:36:54+00:00https://drug.russellpublishing.co.uk/news/11060/pfizer-human-vaccines-project/2017-01-04T15:37:10+00:00https://drug.russellpublishing.co.uk/news/11071/bms-padlock-therapeutics/2017-01-04T15:36:12+00:00https://drug.russellpublishing.co.uk/news/11079/genetic-target-nsclc/2017-01-04T15:35:46+00:00https://drug.russellpublishing.co.uk/news/11082/mir-155-deletion-obesity/2017-01-04T15:35:18+00:00https://drug.russellpublishing.co.uk/news/11114/iterum-anti-infective-compound/2017-01-04T15:34:27+00:00https://drug.russellpublishing.co.uk/news/11117/apg101-mds-study/2017-01-04T15:33:32+00:00https://drug.russellpublishing.co.uk/news/11140/dr-lui-sanofi-research/2017-01-04T15:33:31+00:00https://drug.russellpublishing.co.uk/news/11144/drug-combination-tuberculosis/2017-01-04T15:33:29+00:00https://drug.russellpublishing.co.uk/news/11148/ino-3112-hpv-immunotherapy/2017-01-04T15:33:28+00:00https://drug.russellpublishing.co.uk/news/11152/vaccine-h1n1-influenza/2017-01-04T15:29:28+00:00https://drug.russellpublishing.co.uk/news/11155/acute-myeloid-leukaemia-clue/2017-01-04T15:26:46+00:00https://drug.russellpublishing.co.uk/news/11163/amal-therapeutics-financing/2017-01-04T15:25:59+00:00https://drug.russellpublishing.co.uk/news/11172/aig1-and-adtrp-diabetes/2017-01-04T15:25:32+00:00https://drug.russellpublishing.co.uk/news/11176/axl-neural-zika/2017-01-13T10:28:23+00:00https://drug.russellpublishing.co.uk/news/11190/new-aml-mouse-model/2017-01-04T15:24:00+00:00https://drug.russellpublishing.co.uk/news/11195/children-with-cancer-gene-testing/2017-01-04T15:23:33+00:00https://drug.russellpublishing.co.uk/news/11211/commense-microbiome-platform/2017-01-04T15:23:08+00:00https://drug.russellpublishing.co.uk/news/11224/zika-virus-structure/2017-01-19T09:41:59+00:00https://drug.russellpublishing.co.uk/news/11236/prosthetic-ovary-implant/2017-01-04T15:19:40+00:00https://drug.russellpublishing.co.uk/news/11239/astellas-aist-chagas/2017-01-04T15:19:02+00:00https://drug.russellpublishing.co.uk/news/11251/niaid-vaccine-adjuvants/2017-01-04T15:18:09+00:00https://drug.russellpublishing.co.uk/news/11254/mouse-model-for-zika/2017-01-04T15:16:28+00:00https://drug.russellpublishing.co.uk/news/11260/method-inhibits-tb-bacteria/2017-01-04T15:17:38+00:00https://drug.russellpublishing.co.uk/news/11265/tsri-scientists-grant-addiction/2017-01-04T15:15:53+00:00https://drug.russellpublishing.co.uk/news/11269/immature-hiv-antibody/2017-01-04T15:12:36+00:00https://drug.russellpublishing.co.uk/news/11276/allergan-pfizer-merger/2017-01-04T15:11:43+00:00https://drug.russellpublishing.co.uk/news/11284/mrc-technology-ips-cas/2017-01-04T15:10:31+00:00https://drug.russellpublishing.co.uk/news/11303/allergan-alzheimers-heptares/2017-01-04T15:09:45+00:00https://drug.russellpublishing.co.uk/news/11310/mrc-technology-trustees/2017-01-04T15:09:16+00:00https://drug.russellpublishing.co.uk/news/11317/nanoparticles-inflammatory-bowel-disease/2017-01-04T15:08:09+00:00https://drug.russellpublishing.co.uk/news/11320/cancer-blood-vessels/2017-01-13T10:29:23+00:00https://drug.russellpublishing.co.uk/news/11338/epiregulin-lung-cancer/2017-01-04T15:06:21+00:00https://drug.russellpublishing.co.uk/news/11343/genes-stroke-small-vessel-disease/2016-12-14T22:49:44+00:00https://drug.russellpublishing.co.uk/news/11350/nordic-nanovector-psi-arcs/2017-01-04T15:05:51+00:00https://drug.russellpublishing.co.uk/news/11355/protect-neurons-amyloid-beta/2017-01-04T14:59:44+00:00https://drug.russellpublishing.co.uk/news/11358/mymetics-hiv-vaccine-candidate/2017-01-04T14:57:39+00:00https://drug.russellpublishing.co.uk/news/11364/anti-diabetic-light/2017-01-04T14:56:56+00:00https://drug.russellpublishing.co.uk/news/11374/genetic-link-dcis-breast-cancer/2017-01-04T14:01:13+00:00https://drug.russellpublishing.co.uk/news/11377/symptoms-post-ebola-syndrome/2017-01-04T14:01:12+00:00https://drug.russellpublishing.co.uk/news/11381/biomarkers-tb-vaccines-bcg/2017-01-04T14:00:39+00:00https://drug.russellpublishing.co.uk/news/11385/regeneron-intellia-therapeutics-crisprcas/2017-01-04T14:00:26+00:00https://drug.russellpublishing.co.uk/news/11399/salk-insulin-producing-cells-diabetes/2017-01-04T14:00:14+00:00https://drug.russellpublishing.co.uk/news/11410/clue-lupus-autoantibody/2017-01-04T14:00:15+00:00https://drug.russellpublishing.co.uk/news/11414/quotient-clinical-celebrates-100th-rapidfact-program/2017-06-07T16:44:32+01:00https://drug.russellpublishing.co.uk/news/11420/sanofi-stevenage-bioscience-catalyst/2017-01-04T13:59:38+00:00https://drug.russellpublishing.co.uk/news/11424/lsd-treatments-psychiatric-disorders/2017-01-04T13:59:33+00:00https://drug.russellpublishing.co.uk/news/11429/mathematics-bonn-cancer/2017-01-04T13:59:29+00:00https://drug.russellpublishing.co.uk/news/11438/cdc-zika-microcephaly/2017-01-04T13:59:27+00:00https://drug.russellpublishing.co.uk/news/11450/dr-richard-butt-apollo-therapeutics/2017-01-04T13:59:00+00:00https://drug.russellpublishing.co.uk/news/11454/cancer-cells-persuade-healthy-cells/2017-01-04T13:58:44+00:00https://drug.russellpublishing.co.uk/news/11458/pain-therapeutics-new-interview-released-centre-human-drug-research-chdr/2017-01-11T16:37:03+00:00https://drug.russellpublishing.co.uk/news/11465/bat-activity-obesity/2017-01-04T13:57:15+00:00https://drug.russellpublishing.co.uk/news/11468/implantable-film-pancreatic-cancer/2017-01-04T14:03:30+00:00https://drug.russellpublishing.co.uk/news/11474/evolution-zika-virus/2017-01-19T09:39:46+00:00https://drug.russellpublishing.co.uk/news/11484/heptares-kymab-antibodies/2017-01-04T14:05:57+00:00https://drug.russellpublishing.co.uk/news/11499/selvita-ind-sel24/2017-01-04T14:05:20+00:00https://drug.russellpublishing.co.uk/news/11509/infinity-preclinical-ipi-549-aacr/2017-01-04T14:04:58+00:00https://drug.russellpublishing.co.uk/news/11512/using-nanoparticles-halt-asthma/2017-01-04T14:04:56+00:00https://drug.russellpublishing.co.uk/news/11515/enterome-vertex-ibd/2017-01-04T14:04:43+00:00https://drug.russellpublishing.co.uk/news/11518/lenvatinib-everolimus-kidney-cancer/2017-01-04T14:04:32+00:00https://drug.russellpublishing.co.uk/news/11522/resurrection-pancreatic-cancer/2017-01-04T14:04:17+00:00https://drug.russellpublishing.co.uk/news/11534/johnson-matthey-domainex/2017-01-04T14:04:14+00:00https://drug.russellpublishing.co.uk/news/11537/lab-mice-cold/2017-01-04T14:03:58+00:00https://drug.russellpublishing.co.uk/news/11547/enterome-series-c-funding/2017-01-04T14:03:56+00:00https://drug.russellpublishing.co.uk/news/11553/emergent-data-es425/2017-01-04T14:03:54+00:00https://drug.russellpublishing.co.uk/news/11572/abbvie-argenx-argx-115/2017-01-04T14:02:41+00:00https://drug.russellpublishing.co.uk/news/11575/neurons-map-parkinsons/2017-01-04T14:11:44+00:00https://drug.russellpublishing.co.uk/news/11582/medimmune-explores-therapeutic-lead-treatment-type-2-diabetes-obesity/2017-01-11T16:38:08+00:00https://drug.russellpublishing.co.uk/news/11585/als-mouse-model/2017-01-04T14:11:04+00:00https://drug.russellpublishing.co.uk/news/11594/mini-brain-zika-cortex/2017-01-04T14:10:48+00:00https://drug.russellpublishing.co.uk/news/11599/merrimack-mm-310/2017-01-04T14:10:57+00:00https://drug.russellpublishing.co.uk/news/11602/abbvie-cytomx-probody-therapeutics/2017-01-04T14:10:54+00:00https://drug.russellpublishing.co.uk/news/11605/astrazeneca-genomics/2017-01-04T14:10:52+00:00https://drug.russellpublishing.co.uk/news/11611/innova-biosciences-expansion/2017-01-04T14:10:46+00:00https://drug.russellpublishing.co.uk/news/11614/cell-death-pancreatic-cancer/2017-01-04T14:10:27+00:00https://drug.russellpublishing.co.uk/news/11618/psoriasis-card14/2017-01-04T14:10:10+00:00https://drug.russellpublishing.co.uk/news/11625/t-cell-disease-breakthrough/2017-01-04T14:09:43+00:00https://drug.russellpublishing.co.uk/news/11633/heptares-glp-1-glucagon/2017-01-04T14:09:30+00:00https://drug.russellpublishing.co.uk/news/11637/domainex-flip-inhibitor/2017-01-04T14:08:39+00:00https://drug.russellpublishing.co.uk/news/11640/mrc-debra-austria-epidermolysis-bullosa/2017-01-04T14:22:27+00:00https://drug.russellpublishing.co.uk/news/11649/vtu-technology-boehringer-ingelheim/2017-01-04T14:22:22+00:00https://drug.russellpublishing.co.uk/news/11652/protein-synthesis-neurodegeneration/2017-01-04T14:22:07+00:00https://drug.russellpublishing.co.uk/news/11656/blood-stem-cells/2017-01-04T14:21:53+00:00https://drug.russellpublishing.co.uk/news/11660/nutlin-3-fragile-x/2017-01-04T14:21:30+00:00https://drug.russellpublishing.co.uk/news/11664/nanoparticles-genital-herpes/2017-10-27T15:17:54+01:00https://drug.russellpublishing.co.uk/news/11667/cell-transplant-parkinsons/2017-01-04T14:21:01+00:00https://drug.russellpublishing.co.uk/news/11670/diabetes-related-blindness-project/2017-01-04T14:21:08+00:00https://drug.russellpublishing.co.uk/news/11680/hsp90-inhibitors-prostate-cancer/2017-01-04T14:20:58+00:00https://drug.russellpublishing.co.uk/news/11685/target-bacterial-infections/2017-01-04T14:21:06+00:00https://drug.russellpublishing.co.uk/news/11699/nerve-agent-antidote/2017-01-04T14:20:47+00:00https://drug.russellpublishing.co.uk/news/11702/nmda-receptor-cshl/2017-10-27T15:16:16+01:00https://drug.russellpublishing.co.uk/news/11705/genetic-risk-factors-endometrial-cancer/2017-01-04T14:20:20+00:00https://drug.russellpublishing.co.uk/news/11708/breast-cancer-tsri/2017-01-04T14:20:00+00:00https://drug.russellpublishing.co.uk/news/11712/jakinibs-parkinsons-disease/2017-01-04T12:21:49+00:00https://drug.russellpublishing.co.uk/news/11715/orchard-therapeutics/2017-01-04T12:20:53+00:00https://drug.russellpublishing.co.uk/news/11721/bristol-pleuromutilin/2017-01-04T12:20:32+00:00https://drug.russellpublishing.co.uk/news/11726/cholesterol-pancreatic-cancer/2017-01-04T12:20:00+00:00https://drug.russellpublishing.co.uk/news/11729/cambridge-embryos-post-implantation/2017-01-04T12:19:15+00:00https://drug.russellpublishing.co.uk/news/11732/wellcome-sanger-microbiome/2017-01-04T12:18:51+00:00https://drug.russellpublishing.co.uk/news/11737/antidepressant-hydroxynorketamine/2017-01-04T12:17:32+00:00https://drug.russellpublishing.co.uk/news/11750/relmada-in-vivo-d-methadone/2017-01-04T12:16:49+00:00https://drug.russellpublishing.co.uk/news/11762/tsri-appetite-illness/2017-01-04T12:15:35+00:00https://drug.russellpublishing.co.uk/news/11766/mir551b-ovarian-cancer/2017-01-04T12:15:04+00:00https://drug.russellpublishing.co.uk/news/11770/multiple-myeloma-model/2017-01-04T12:14:35+00:00https://drug.russellpublishing.co.uk/news/11774/zika-microcephaly-tlr3/2017-01-03T16:49:47+00:00https://drug.russellpublishing.co.uk/news/11787/manchester-drug-delivery-placenta/2017-01-04T12:13:59+00:00https://drug.russellpublishing.co.uk/news/11792/gut-microbes-neurodegeneration/2017-01-04T12:11:08+00:00https://drug.russellpublishing.co.uk/news/11795/skin-polymer-xpl/2017-01-04T12:10:34+00:00https://drug.russellpublishing.co.uk/news/11798/cincinnati-gliomas-therapy/2017-01-05T16:32:41+00:00https://drug.russellpublishing.co.uk/news/11802/intraocular-diabetic-retinopathy/2017-01-04T12:06:27+00:00https://drug.russellpublishing.co.uk/news/11814/autism-model-duke/2017-01-13T10:27:37+00:00https://drug.russellpublishing.co.uk/news/11821/tsri-warheads-cancer/2017-01-04T12:04:09+00:00https://drug.russellpublishing.co.uk/news/11825/targaprimir-96-tsri-breast-cancer/2017-01-04T12:03:01+00:00https://drug.russellpublishing.co.uk/news/11833/ldc-boehringer-ingelheim-schizophrenia/2017-01-04T12:02:11+00:00https://drug.russellpublishing.co.uk/news/11839/washington-zika-placenta/2017-01-03T16:47:50+00:00https://drug.russellpublishing.co.uk/news/11842/humix-microbiome/2017-01-04T12:00:29+00:00https://drug.russellpublishing.co.uk/news/11846/pfizer-metastatic-breast-cancer/2017-01-04T11:59:38+00:00https://drug.russellpublishing.co.uk/news/11864/myc-targets-triple-negative-breast-cancer/2017-01-04T11:59:02+00:00https://drug.russellpublishing.co.uk/news/11872/ptsd-adiponectin/2017-01-04T11:58:38+00:00https://drug.russellpublishing.co.uk/news/11893/seizures-breast-cancer-drug/2017-01-04T11:57:02+00:00https://drug.russellpublishing.co.uk/news/11896/mcgill-brain-appetite-ng2-glia/2017-01-13T10:26:41+00:00https://drug.russellpublishing.co.uk/news/11912/hepatitis-c-drug-slows-zika-virus/2017-01-03T16:46:26+00:00https://drug.russellpublishing.co.uk/news/11928/magic-mushroom-drug-psilocybin-reduced-depressive-symptoms-trial/2017-01-04T11:55:42+00:00https://drug.russellpublishing.co.uk/news/11938/nibsc-mhra-go-microscope-run-opening-keynote-allergies-2016/2017-01-11T16:45:03+00:00https://drug.russellpublishing.co.uk/news/11943/chugai-ifrec-collaboration-immunology/2017-01-04T11:55:17+00:00https://drug.russellpublishing.co.uk/news/11973/crowdsourcing-psychiatric-diseases/2017-01-04T11:54:56+00:00https://drug.russellpublishing.co.uk/news/11976/definingen-raises-1-5m/2016-12-16T23:44:20+00:00https://drug.russellpublishing.co.uk/news/11979/loss-y-chromosome-associated-alzheimers-disease/2017-01-04T11:51:56+00:00https://drug.russellpublishing.co.uk/news/11982/switch-natural-killer-cells/2017-01-04T11:52:56+00:00https://drug.russellpublishing.co.uk/news/11986/antibiotic-discovery-platform/2017-01-04T11:54:30+00:00https://drug.russellpublishing.co.uk/news/11991/delamanid-visceral-leishmaniasis/2017-01-04T11:51:01+00:00https://drug.russellpublishing.co.uk/news/11994/zika-conspiracy-theories/2017-01-03T16:43:21+00:00https://drug.russellpublishing.co.uk/news/12001/iceni-pharmaceuticals-cilengitide/2017-01-05T16:36:49+00:00https://drug.russellpublishing.co.uk/news/12004/breast-cancer-cells-bone/2017-01-04T11:46:37+00:00https://drug.russellpublishing.co.uk/news/12010/thunderbolt-baffapril/2017-01-04T11:49:42+00:00https://drug.russellpublishing.co.uk/news/12013/amyloid-beta-antibiotic-alzheimers/2017-01-19T11:25:58+00:00https://drug.russellpublishing.co.uk/news/12018/twoxar-chicago-atherosclerosis/2017-01-04T11:48:00+00:00https://drug.russellpublishing.co.uk/news/12022/mjff-stem-cells-parkinsons/2017-01-04T11:47:37+00:00https://drug.russellpublishing.co.uk/news/12026/antibiotic-bacteriophage-pond/2016-12-16T23:42:11+00:00https://drug.russellpublishing.co.uk/news/12029/celecoxib-tsri-cancer/2017-01-04T11:44:48+00:00https://drug.russellpublishing.co.uk/news/12032/dmd-johns-hopkins-cells/2017-01-04T11:42:35+00:00https://drug.russellpublishing.co.uk/news/12036/proteogenomic-breast-cancer-study/2017-01-04T11:44:13+00:00https://drug.russellpublishing.co.uk/news/12040/faron-expands-strategy-clevegen/2017-01-04T11:42:57+00:00https://drug.russellpublishing.co.uk/news/12055/mirnas-resistant-pancreatic-cancer/2017-01-04T11:38:23+00:00https://drug.russellpublishing.co.uk/news/12060/leicester-bacteriophages/2017-01-04T11:40:33+00:00https://drug.russellpublishing.co.uk/news/12071/boehringer-inventiva-ipf/2017-01-04T11:37:50+00:00https://drug.russellpublishing.co.uk/news/12074/genetic-drivers-adrenal-cancer/2017-01-04T11:36:57+00:00https://drug.russellpublishing.co.uk/news/12077/contrast-agent-stem-cell/2017-01-04T11:36:23+00:00https://drug.russellpublishing.co.uk/news/12082/tsri-rna-sca10/2017-01-04T11:33:55+00:00https://drug.russellpublishing.co.uk/news/12085/acrolein-alzheimers-disease/2017-01-04T11:33:34+00:00https://drug.russellpublishing.co.uk/news/12088/duke-pain-relief/2017-01-04T11:33:14+00:00https://drug.russellpublishing.co.uk/news/12091/incyte-moffitt-blood-cancer/2017-01-04T11:32:22+00:00https://drug.russellpublishing.co.uk/news/12094/muscular-dystrophy-target/2017-01-04T11:31:58+00:00https://drug.russellpublishing.co.uk/news/12097/scancell-glioblastoma-multiforme/2017-01-04T11:31:37+00:00https://drug.russellpublishing.co.uk/news/12100/toulouse-oncopole-immuno-oncology/2017-01-04T11:31:14+00:00https://drug.russellpublishing.co.uk/news/12104/bellicum-lumc-tcr/2017-01-04T11:30:50+00:00https://drug.russellpublishing.co.uk/news/12107/fasnall-breast-cancer/2017-01-04T11:30:19+00:00https://drug.russellpublishing.co.uk/news/12121/breast-cancer-zurich/2017-01-04T11:29:54+00:00https://drug.russellpublishing.co.uk/news/12124/dna-diabetic-kidney-disease/2017-01-04T11:29:19+00:00https://drug.russellpublishing.co.uk/news/12127/nek1-cancer/2017-01-04T11:28:19+00:00https://drug.russellpublishing.co.uk/news/12132/bbc-uc-davis-chimeras/2017-01-04T11:27:58+00:00https://drug.russellpublishing.co.uk/news/12136/babesiosis-mice/2017-01-04T11:27:21+00:00https://drug.russellpublishing.co.uk/news/12142/tmem230-parkinsons/2017-01-04T11:18:12+00:00https://drug.russellpublishing.co.uk/news/12145/genomic-data-commons/2017-01-04T11:26:54+00:00https://drug.russellpublishing.co.uk/news/12150/gfe3-brain-function/2017-01-04T11:17:39+00:00https://drug.russellpublishing.co.uk/news/12153/ldc-mcgill-drug-discovery/2017-01-04T11:15:56+00:00https://drug.russellpublishing.co.uk/news/12157/tst-gene-diabetes/2017-01-04T11:15:32+00:00https://drug.russellpublishing.co.uk/news/12162/chemofilter-berkeley/2017-01-04T11:13:43+00:00https://drug.russellpublishing.co.uk/news/12166/glia-cell-transplants-huntingtons/2017-01-04T11:13:09+00:00https://drug.russellpublishing.co.uk/news/12172/relmadas-d-methadone/2017-01-04T11:08:57+00:00https://drug.russellpublishing.co.uk/news/12175/agtc-xlrp-gene-therapy/2017-01-04T11:08:37+00:00https://drug.russellpublishing.co.uk/news/12178/microbiota-obesity-yale/2017-01-04T11:02:01+00:00https://drug.russellpublishing.co.uk/news/12181/mitochondria-neuronal-axons/2017-01-04T11:07:33+00:00https://drug.russellpublishing.co.uk/news/12184/hpnscs-parkinsons-disease/2017-01-04T11:05:19+00:00https://drug.russellpublishing.co.uk/news/12194/reneuron-gbm-exosome/2017-01-04T11:01:36+00:00https://drug.russellpublishing.co.uk/news/12199/biomarkers-survival-times-ucla/2017-01-05T16:35:14+00:00https://drug.russellpublishing.co.uk/news/12207/southampton-cystic-fibrosis/2016-12-16T23:32:20+00:00https://drug.russellpublishing.co.uk/news/12210/meso-brain-funding/2017-01-04T10:58:37+00:00https://drug.russellpublishing.co.uk/news/12214/uck-kcl-uveitis/2017-01-04T10:57:04+00:00https://drug.russellpublishing.co.uk/news/12219/lilly-american-migraine-foundation/2017-01-04T10:56:44+00:00https://drug.russellpublishing.co.uk/news/12223/acute-myeloid-leukaemia-brake/2017-01-04T10:54:05+00:00https://drug.russellpublishing.co.uk/news/12226/molecular-protection-kennedys-disease/2017-01-19T09:39:19+00:00https://drug.russellpublishing.co.uk/news/12231/jq1-breast-cancer/2017-01-04T10:51:17+00:00https://drug.russellpublishing.co.uk/news/12235/psoriasis-target-stanford-rac1/2017-01-04T10:49:21+00:00https://drug.russellpublishing.co.uk/news/12238/radioimmunotherapy-colorectal-cancer/2016-12-09T15:19:35+00:00https://drug.russellpublishing.co.uk/news/12244/quotient-clinical-extends-spray-drying-capabilities-poorly-soluble-molecules/2017-01-11T16:47:34+00:00https://drug.russellpublishing.co.uk/news/12249/reclaim-immune-cells-cancer/2017-01-04T10:50:39+00:00https://drug.russellpublishing.co.uk/news/12252/lrh-1-liver-cancer-epfl/2017-01-04T10:48:01+00:00https://drug.russellpublishing.co.uk/news/12267/txa709-mrsa-cefdinir/2017-01-04T10:47:10+00:00https://drug.russellpublishing.co.uk/news/12292/darapladib-diabetic-macular-oedema/2017-01-04T10:45:38+00:00https://drug.russellpublishing.co.uk/news/12336/hypopituitarism-stem-cells/2017-01-04T10:40:57+00:00https://drug.russellpublishing.co.uk/news/12338/gbi-research-identifies-first-class/2017-01-04T10:42:43+00:00https://drug.russellpublishing.co.uk/news/12345/alzheimers-disease-dish-babraham/2017-01-04T10:45:16+00:00https://drug.russellpublishing.co.uk/news/12368/parkinsons-ziram-ucla/2017-01-04T10:38:36+00:00https://drug.russellpublishing.co.uk/news/12373/respiratory-disease-mrct-astrazeneca/2017-01-16T15:46:21+00:00https://drug.russellpublishing.co.uk/news/12376/prospective-biobank-studies/2017-01-04T10:37:19+00:00https://drug.russellpublishing.co.uk/news/12381/drug-candidates-method-tsri/2017-01-04T10:36:48+00:00https://drug.russellpublishing.co.uk/news/12384/globaldata-zika-virus/2017-01-03T16:42:28+00:00https://drug.russellpublishing.co.uk/news/12387/impact-antibiotic-infant-microbiome/2017-01-04T10:36:02+00:00https://drug.russellpublishing.co.uk/news/12393/t-cells-surface-salk/2017-10-27T15:11:28+01:00https://drug.russellpublishing.co.uk/news/12398/bacteria-autism-baylor/2017-01-04T10:33:30+00:00https://drug.russellpublishing.co.uk/news/12402/cancer-resistance-mole-rats/2017-01-04T10:35:15+00:00https://drug.russellpublishing.co.uk/news/12417/tri-i-tdi-antibody-drug-discovery/2017-01-04T10:31:54+00:00https://drug.russellpublishing.co.uk/news/12422/immune-system-pathways/2017-01-04T10:31:24+00:00https://drug.russellpublishing.co.uk/news/12426/cell-medica-baylor-collaboration/2017-01-04T10:30:04+00:00https://drug.russellpublishing.co.uk/news/12429/tum-thalidomide-mechanism/2017-01-04T10:28:54+00:00https://drug.russellpublishing.co.uk/news/12445/mironid-series-a-funding/2017-01-04T10:27:47+00:00https://drug.russellpublishing.co.uk/news/12448/f2g-funding-antifungal-therapies/2017-01-04T10:27:07+00:00https://drug.russellpublishing.co.uk/news/12465/rnai-nanoparticles-atc/2017-01-04T10:23:46+00:00https://drug.russellpublishing.co.uk/news/12495/methanobactin-wilsons-disease/2017-01-04T10:23:03+00:00https://drug.russellpublishing.co.uk/news/12523/mosquito-bites-inflammation-leeds/2017-01-03T16:41:05+00:00https://drug.russellpublishing.co.uk/news/12538/tobin-eu-leicester/2017-01-04T10:22:17+00:00https://drug.russellpublishing.co.uk/news/12547/car-t-cell-therapy-perelman/2017-01-04T10:21:35+00:00https://drug.russellpublishing.co.uk/news/12552/zika-study-pregnancy-nih/2017-01-03T16:41:43+00:00https://drug.russellpublishing.co.uk/news/12572/tb-alliance-takeda-tuberculosis/2017-01-04T10:20:55+00:00https://drug.russellpublishing.co.uk/news/12587/plx-pad-duchenne-muscular-dystrophy/2017-01-04T10:20:12+00:00https://drug.russellpublishing.co.uk/news/12590/cancer-therapeutics-celgene/2017-01-04T10:19:10+00:00https://drug.russellpublishing.co.uk/news/12597/mait-cells-oxford/2017-01-04T10:17:02+00:00https://drug.russellpublishing.co.uk/news/12600/amgen-qb3at953-golden-ticket/2017-01-04T10:18:45+00:00https://drug.russellpublishing.co.uk/news/12603/itmo-magnetic-drug-clot/2017-01-04T10:16:35+00:00https://drug.russellpublishing.co.uk/news/12614/bristol-bio-ink-3d-printing/2017-01-04T10:14:10+00:00https://drug.russellpublishing.co.uk/news/12625/pharma-cold-chain-distribution-updates-mhra-iata-danish-medicines-agency-world-courier-finnair-sanofi-rd/2017-01-11T16:47:55+00:00https://drug.russellpublishing.co.uk/news/12628/reactions-eu-referendum/2017-01-04T10:13:35+00:00https://drug.russellpublishing.co.uk/news/12634/antibodies-zika-dengue/2017-01-03T16:40:25+00:00https://drug.russellpublishing.co.uk/news/12637/pilot-screening-pancreatic-cancer/2017-01-04T10:13:08+00:00https://drug.russellpublishing.co.uk/news/12642/eisai-ucl-neurodegenerative-disease/2017-01-04T10:12:37+00:00https://drug.russellpublishing.co.uk/news/12645/parkinsons-autoimmune-disease/2017-01-04T10:12:15+00:00https://drug.russellpublishing.co.uk/news/12649/escmid-asm-antimicrobial/2017-01-19T11:24:11+00:00https://drug.russellpublishing.co.uk/news/12652/glyrs-tsri-breast-cancer-target/2017-01-04T10:11:15+00:00https://drug.russellpublishing.co.uk/news/12657/pepducin-heart-failure-jefferson/2017-01-04T10:10:49+00:00https://drug.russellpublishing.co.uk/news/12663/anthrax-toxin-proteins-nih-cancer/2017-01-19T10:00:18+00:00https://drug.russellpublishing.co.uk/news/12668/target-polycystic-kidney-disease/2017-01-04T10:03:24+00:00https://drug.russellpublishing.co.uk/news/12677/storm-therapeutics-rna-modifying-enzymes/2017-01-04T10:02:44+00:00https://drug.russellpublishing.co.uk/news/12680/nordic-nanovector-areva-212pb-arc/2017-01-04T10:01:26+00:00https://drug.russellpublishing.co.uk/news/12685/heptares-leadxpro-gpcr/2017-01-04T10:01:06+00:00https://drug.russellpublishing.co.uk/news/12688/tsri-hiv-metastability-trimer-vaccine/2017-01-04T10:00:35+00:00https://drug.russellpublishing.co.uk/news/12693/efavirenz-alzheimers-hiv-nist/2017-01-04T09:59:47+00:00https://drug.russellpublishing.co.uk/news/12703/merck-moderna-personalised-cancer-vaccines/2018-06-29T13:52:25+01:00https://drug.russellpublishing.co.uk/news/12706/proteogenomics-ovarian-cancer/2017-01-04T09:58:17+00:00https://drug.russellpublishing.co.uk/news/12711/probiodrug-crossbeta-alzheimers/2017-01-04T09:57:56+00:00https://drug.russellpublishing.co.uk/news/12723/pathway-obesity-n-acyl-amino-acids/2017-01-19T09:37:50+00:00https://drug.russellpublishing.co.uk/news/12726/zika-virus-vaccine/2017-01-03T16:39:25+00:00https://drug.russellpublishing.co.uk/news/12740/novo-nordisk-aarhus-university-protein/2017-01-04T09:56:56+00:00https://drug.russellpublishing.co.uk/news/12755/e-coli-vaccine-buffalo/2017-01-04T09:56:04+00:00https://drug.russellpublishing.co.uk/news/12767/alzheimers-dementia-johns-hopkins/2017-01-04T09:54:44+00:00https://drug.russellpublishing.co.uk/news/12777/immunotherapy-pancreatic-cancer/2017-01-04T09:53:17+00:00https://drug.russellpublishing.co.uk/news/12785/neat1-target-non-coding-rna/2017-01-04T09:54:21+00:00https://drug.russellpublishing.co.uk/news/12788/programmable-rna-vaccines-effective-ebola-influenza/2017-01-04T09:52:37+00:00https://drug.russellpublishing.co.uk/news/12791/genetic-mutations-colorectal-cancer/2017-01-04T09:51:17+00:00https://drug.russellpublishing.co.uk/news/12794/biopta-reinnervate-reprocell-europe/2017-01-04T09:50:25+00:00https://drug.russellpublishing.co.uk/news/12802/zika-virus-us-olympic-team/2017-01-03T16:38:22+00:00https://drug.russellpublishing.co.uk/news/12806/sanofi-pasteur-wrair-zika-vaccine/2017-01-03T16:33:46+00:00https://drug.russellpublishing.co.uk/news/12815/vertex-moderna-cf-mrna-therapeutics/2016-12-16T23:28:06+00:00https://drug.russellpublishing.co.uk/news/12818/cold-harbor-boehringer-ingelheim-aml/2017-01-04T09:48:20+00:00https://drug.russellpublishing.co.uk/news/12833/metformin-msud/2017-01-04T09:44:54+00:00https://drug.russellpublishing.co.uk/news/12836/big-data-cancer-cell-lines/2017-01-20T09:25:03+00:00https://drug.russellpublishing.co.uk/news/12842/adalta-ipo-ad-114/2017-01-04T09:41:33+00:00https://drug.russellpublishing.co.uk/news/12846/let-7-neuroblastoma/2017-01-04T09:41:03+00:00https://drug.russellpublishing.co.uk/news/12850/autism-stem-cells/2017-01-04T09:40:26+00:00https://drug.russellpublishing.co.uk/news/12860/basal-cell-carcinoma-origin/2017-01-04T09:39:24+00:00https://drug.russellpublishing.co.uk/news/12866/ovarian-cancer-cold-spring-harbor/2016-12-09T15:19:17+00:00https://drug.russellpublishing.co.uk/news/12872/wars2-duke-nus/2017-01-13T10:24:52+00:00https://drug.russellpublishing.co.uk/news/12878/human-cancer-models-initiative/2017-01-04T09:38:06+00:00https://drug.russellpublishing.co.uk/news/12885/myeloma-birmingham-mgus/2017-01-04T09:37:02+00:00https://drug.russellpublishing.co.uk/news/12896/sorrento-servier-sti-a1110/2017-01-04T09:36:38+00:00https://drug.russellpublishing.co.uk/news/12899/northwestern-depression/2017-01-04T09:36:19+00:00https://drug.russellpublishing.co.uk/news/12902/bayer-x-chem/2017-01-04T09:36:00+00:00https://drug.russellpublishing.co.uk/news/12908/enzyvant-farber-disease/2017-01-04T09:35:40+00:00https://drug.russellpublishing.co.uk/news/12912/redhill-niaid-ebola/2017-01-04T09:35:21+00:00https://drug.russellpublishing.co.uk/news/12916/nih-hiv-cure/2017-01-19T10:18:47+00:00https://drug.russellpublishing.co.uk/news/12924/f-star-cd-laboratory/2017-01-04T09:34:34+00:00https://drug.russellpublishing.co.uk/news/12928/mkx-tendons-tsri/2017-01-04T09:34:08+00:00https://drug.russellpublishing.co.uk/news/12965/nanoracks-plate-reader-2/2017-06-07T16:33:35+01:00https://drug.russellpublishing.co.uk/news/12973/tau-alzheimers-columbia/2017-01-04T09:32:49+00:00https://drug.russellpublishing.co.uk/news/12979/astar-msd-peptide-therapeutics/2017-01-19T11:05:19+00:00https://drug.russellpublishing.co.uk/news/12992/hepatic-cirrhosis-bonn/2017-01-04T09:31:09+00:00https://drug.russellpublishing.co.uk/news/12995/schizophrenia-immune-system/2017-01-04T09:30:47+00:00https://drug.russellpublishing.co.uk/news/13009/research-funding-pancreatic-cancer/2017-01-04T09:28:10+00:00https://drug.russellpublishing.co.uk/news/13035/chlamydia-vaccine/2017-01-04T09:27:16+00:00https://drug.russellpublishing.co.uk/news/13047/stop-parkinsons-diesease/2017-01-04T09:25:30+00:00https://drug.russellpublishing.co.uk/news/13061/itch-signals-washington-university/2017-01-04T09:24:57+00:00https://drug.russellpublishing.co.uk/news/13070/drugs-block-bowel-cancer-tumour/2017-01-04T09:24:22+00:00https://drug.russellpublishing.co.uk/news/13088/sandoz-give-insight-european-biosimilar-trends-7th-annual-congress/2017-08-24T12:01:58+01:00https://drug.russellpublishing.co.uk/news/13094/targeting-cancer-5-key-spotlight-sessions-latest-therapy-breakthroughs/2017-01-11T16:48:30+00:00https://drug.russellpublishing.co.uk/news/13095/antibiotics-weaken-alzheimers-disease-progression/2017-01-19T10:02:18+00:00https://drug.russellpublishing.co.uk/news/13127/retinal-progenitor-stem-cell-data-paves-way-for-clinical-research/2017-01-04T09:22:40+00:00https://drug.russellpublishing.co.uk/news/13139/new-compounds-prevent-epilepsy/2017-01-04T09:22:03+00:00https://drug.russellpublishing.co.uk/news/13157/prokarium-vaccines-emerging-diseases-bioterrorist/2017-01-04T09:21:38+00:00https://drug.russellpublishing.co.uk/news/13170/abbvie-bristol-myers-collaborate/2017-01-04T09:21:09+00:00https://drug.russellpublishing.co.uk/news/13181/inducing-antibodies-flu-vaccine/2017-01-04T09:20:21+00:00https://drug.russellpublishing.co.uk/news/13192/glaxosmithkline-invest-275-million-uk/2017-01-04T09:19:14+00:00https://drug.russellpublishing.co.uk/news/13242/leukaemia-study-therapy-resistant-proteins/2017-01-04T09:18:34+00:00https://drug.russellpublishing.co.uk/news/13252/epidarex-creates-nodthera-limited/2017-01-04T09:17:55+00:00https://drug.russellpublishing.co.uk/news/13343/study-inherited-parkinsons/2017-01-04T09:17:15+00:00https://drug.russellpublishing.co.uk/news/13462/cancer-stem-cell-plasticell-nui/2017-01-04T09:16:44+00:00https://drug.russellpublishing.co.uk/news/13466/chronos-therapeutics-new-research-vp/2018-06-29T13:55:03+01:00https://drug.russellpublishing.co.uk/news/13475/nih-depression-genes-crowd-sourced/2017-01-04T09:15:56+00:00https://drug.russellpublishing.co.uk/news/13483/signalling-regeneration-zebrafish/2017-01-04T09:15:23+00:00https://drug.russellpublishing.co.uk/news/13588/scientists-find-genetic-code-alcoholism/2017-01-04T09:14:55+00:00https://drug.russellpublishing.co.uk/news/13601/mexican-salamander-growing-new-limbs/2017-01-04T09:14:22+00:00https://drug.russellpublishing.co.uk/news/13619/flu-vaccines-fail-protect-obese-mice/2017-01-04T09:13:19+00:00https://drug.russellpublishing.co.uk/news/13630/snakes-gene-spinal-cord-regeneration/2017-01-04T09:12:18+00:00https://drug.russellpublishing.co.uk/news/13640/killing-diseases-one-compound/2017-01-04T09:11:31+00:00https://drug.russellpublishing.co.uk/news/13657/charles-river-laboratories-announces-partnership-milner-therapeutics-institute-consortium/2016-12-19T14:19:54+00:00https://drug.russellpublishing.co.uk/news/13659/veritas-cannabis-chemotherapy-effects/2017-01-04T09:10:32+00:00https://drug.russellpublishing.co.uk/news/13668/cancer-cells-blood-vessels-metastases/2017-01-04T09:09:30+00:00https://drug.russellpublishing.co.uk/news/13675/discovery-hiv-virus-new-drug-target/2017-01-04T09:09:05+00:00https://drug.russellpublishing.co.uk/news/13681/pain-killer-alzheimers-memory-loss/2017-01-04T09:07:38+00:00https://drug.russellpublishing.co.uk/news/13707/protein-expansion-target-als/2017-01-04T09:07:08+00:00https://drug.russellpublishing.co.uk/news/13734/crispr-gene-editing-sickle-cell/2016-12-14T22:46:37+00:00https://drug.russellpublishing.co.uk/news/13745/vedanta-microbiome-cancer/2017-01-04T09:02:23+00:00https://drug.russellpublishing.co.uk/news/13755/ptsd-military-sleep-optimisation-device/2017-01-04T09:01:54+00:00https://drug.russellpublishing.co.uk/news/13760/leukaemia-blood-testing/2017-01-04T09:00:40+00:00https://drug.russellpublishing.co.uk/news/13765/lsd-psychotherapy-mental-health/2017-01-04T09:00:12+00:00https://drug.russellpublishing.co.uk/news/13770/sea-sponge-pancreatic-tumour/2017-01-05T16:34:01+00:00https://drug.russellpublishing.co.uk/news/13775/gene-age-related-hearing-loss/2017-01-04T08:58:24+00:00https://drug.russellpublishing.co.uk/news/13817/nice-nhs-mental-health-initiative/2017-01-04T08:56:24+00:00https://drug.russellpublishing.co.uk/news/13862/stria-vascularis-hearing-treatment/2017-01-04T08:54:46+00:00https://drug.russellpublishing.co.uk/news/13866/nih-health-disparities-chronic-diseases/2017-01-04T08:52:34+00:00https://drug.russellpublishing.co.uk/news/13870/brain-protein-allays-alzheimers/2017-05-16T10:32:22+01:00https://drug.russellpublishing.co.uk/news/13893/mice-model-market-2023/2017-01-04T08:51:38+00:00https://drug.russellpublishing.co.uk/news/13898/novel-inhibitory-brain-receptor-puts-epilepsy-remission-adolescence/2017-01-04T08:51:04+00:00https://drug.russellpublishing.co.uk/news/13912/alcohol-dependency-enzyme/2017-01-04T08:49:57+00:00https://drug.russellpublishing.co.uk/news/13917/animal-model-metastasis-sarcoma/2017-01-04T08:48:16+00:00https://drug.russellpublishing.co.uk/news/13926/targeting-nicotine-receptors-prevent-alzheimers-memory-loss/2016-12-21T16:21:51+00:00https://drug.russellpublishing.co.uk/news/13933/bone-marrow-cells-miscarriage-mice/2016-12-21T16:21:29+00:00https://drug.russellpublishing.co.uk/news/13939/stem-cell-heart-condition/2017-08-03T14:34:52+01:00https://drug.russellpublishing.co.uk/news/13950/crispr-technology-cancer-mutations/2016-12-21T16:19:19+00:00https://drug.russellpublishing.co.uk/news/13954/takeda-giant-multiple-myeloma-trial/2016-12-21T16:18:54+00:00https://drug.russellpublishing.co.uk/news/13960/mrc-astrazeneca-asthma-collaboration/2017-01-16T15:45:32+00:00https://drug.russellpublishing.co.uk/news/13968/blood-test-breast-cancer/2016-12-21T16:15:47+00:00https://drug.russellpublishing.co.uk/news/13989/gene-defect-biomarker-prostate/2016-12-21T16:15:08+00:00https://drug.russellpublishing.co.uk/news/13993/infra-red-oesophageal-cancer/2016-12-21T16:14:43+00:00https://drug.russellpublishing.co.uk/news/13996/rignotec-rig-therapeutics/2016-12-21T16:14:26+00:00https://drug.russellpublishing.co.uk/news/14000/biomed-johnson-research/2016-12-21T16:13:55+00:00https://drug.russellpublishing.co.uk/news/14019/hsrx-zika-virus/2017-01-03T16:32:45+00:00https://drug.russellpublishing.co.uk/news/14029/pancreatic-tumour-vitamin/2016-12-21T16:12:46+00:00https://drug.russellpublishing.co.uk/news/14037/jdrf-t1d-diabetes-sernova/2016-12-21T16:12:20+00:00https://drug.russellpublishing.co.uk/news/14043/probiodrugs-glutaminyl-cyclase-inhibitor/2016-12-21T16:11:54+00:00https://drug.russellpublishing.co.uk/news/14046/chemotherapy-chinese-cancer-cells/2016-12-21T16:11:29+00:00https://drug.russellpublishing.co.uk/news/14066/attendee-list-released-orphan-drugs-rare-diseases-2016/2016-12-09T15:18:20+00:00https://drug.russellpublishing.co.uk/news/14089/intercontinental-imaging-breast/2016-12-21T08:46:18+00:00https://drug.russellpublishing.co.uk/news/14093/belgian-scientists-sepsis/2016-12-21T16:11:03+00:00https://drug.russellpublishing.co.uk/news/14096/immunological-vaccine-research/2016-12-21T16:09:47+00:00https://drug.russellpublishing.co.uk/news/14100/library-pharma-compounds/2018-01-08T21:45:02+00:00https://drug.russellpublishing.co.uk/news/14104/protein-kinase-ms-treatment/2016-12-21T16:02:25+00:00https://drug.russellpublishing.co.uk/news/14149/faron-placing-subscription/2016-12-21T16:02:00+00:00https://drug.russellpublishing.co.uk/news/14154/globaldata-osteoarthritis-market/2016-12-21T16:01:44+00:00https://drug.russellpublishing.co.uk/news/14156/gsk-emma-walmsley-succeeds-andrew-witty/2016-12-21T16:01:15+00:00https://drug.russellpublishing.co.uk/news/14162/ge-irish-biopharma-jobs/2016-12-21T16:00:24+00:00https://drug.russellpublishing.co.uk/news/14190/using-pd-l1-immunotherapy/2016-12-21T16:00:45+00:00https://drug.russellpublishing.co.uk/news/14211/130-new-treatments-corneal-disorders-cause-still-not-yet-known/2016-12-21T15:59:41+00:00https://drug.russellpublishing.co.uk/news/14221/charles-river-laboratories-tri-insitutional-therapeutics-discovery-institute-announce-strategic-partnership/2016-12-19T14:22:18+00:00https://drug.russellpublishing.co.uk/news/14227/roche-fda-assay-syphilis/2016-12-21T15:58:18+00:00https://drug.russellpublishing.co.uk/news/14230/viking-adrenoleukodystrophy-model-study/2016-12-21T15:57:58+00:00https://drug.russellpublishing.co.uk/news/14234/quotient-clinical-expands-data-sciences-capability/2017-01-11T16:49:38+00:00https://drug.russellpublishing.co.uk/news/14244/envigo-invests-non-animal-assays-research-development/2016-12-21T15:56:45+00:00https://drug.russellpublishing.co.uk/news/14302/anthrax-toxin-protein/2017-10-27T15:16:15+01:00https://drug.russellpublishing.co.uk/news/14306/pycnogenol-research-antioxidant-ageing/2016-12-21T15:53:51+00:00https://drug.russellpublishing.co.uk/news/14313/antibiotics-tuberculosis-therapy/2016-12-21T15:53:21+00:00https://drug.russellpublishing.co.uk/news/14342/inflammasomes-signal-protein/2016-12-21T15:52:55+00:00https://drug.russellpublishing.co.uk/news/14346/healthcare-technologies-research/2016-12-21T15:52:27+00:00https://drug.russellpublishing.co.uk/news/14356/idf-cardiovascular-disease-diabetics/2016-12-21T15:52:05+00:00https://drug.russellpublishing.co.uk/news/14363/toys-enriched-surroundings-help-fight-infection-mice/2016-12-21T15:51:29+00:00https://drug.russellpublishing.co.uk/news/14368/advancing-non-animal-testing/2016-12-21T15:50:54+00:00https://drug.russellpublishing.co.uk/news/14379/support-health-needs-older-people/2016-12-21T15:50:22+00:00https://drug.russellpublishing.co.uk/news/14384/active-motif-swift-epigenetics/2016-12-21T15:49:55+00:00https://drug.russellpublishing.co.uk/news/14390/il-34-chemo-resistant-cells/2016-12-21T15:49:27+00:00https://drug.russellpublishing.co.uk/news/14396/reviral-appoints-new-ceo/2016-12-21T15:49:05+00:00https://drug.russellpublishing.co.uk/news/14415/superantigen-toxins-blocked/2016-12-21T15:48:34+00:00https://drug.russellpublishing.co.uk/news/14422/key-molecule-psoriasis-development/2016-12-21T15:48:05+00:00https://drug.russellpublishing.co.uk/news/14442/rare-diseases-repurposing-drugs/2016-12-21T15:47:20+00:00https://drug.russellpublishing.co.uk/news/14447/ebv-derived-micrornas/2016-12-09T15:18:13+00:00https://drug.russellpublishing.co.uk/news/14452/lifestyle-vs-bad-luck/2016-12-21T14:35:54+00:00https://drug.russellpublishing.co.uk/news/14455/brain-diseases-manifest-retina-eye/2016-12-21T14:42:17+00:00https://drug.russellpublishing.co.uk/news/14459/epigenetics-lymphoma-new/2016-12-21T14:41:47+00:00https://drug.russellpublishing.co.uk/news/14466/asceneuron-receives-parkinsons-research-grant-michael-j-fox-foundation/2016-12-21T14:40:58+00:00https://drug.russellpublishing.co.uk/news/14472/orchard-therapeutics-operations/2016-12-21T14:40:23+00:00https://drug.russellpublishing.co.uk/news/14488/breast-cancer-screening/2016-12-09T15:18:12+00:00https://drug.russellpublishing.co.uk/news/14496/pancreatic-cancer-metastases/2016-12-21T14:40:04+00:00https://drug.russellpublishing.co.uk/news/14499/myths-must-overcome-ensure-successful-commercialisation-biosimilars/2016-12-09T15:18:11+00:00https://drug.russellpublishing.co.uk/news/14520/fight-antimicrobial-resistance/2017-01-19T11:10:52+00:00https://drug.russellpublishing.co.uk/news/14532/new-study-genetic-genomics/2016-12-21T14:37:42+00:00https://drug.russellpublishing.co.uk/news/14539/humabody-collaborate-million/2016-12-21T14:37:08+00:00https://drug.russellpublishing.co.uk/news/14544/foetal-amplifier-brain/2016-12-21T14:36:46+00:00https://drug.russellpublishing.co.uk/news/14548/fructose-diabetes-floodgates/2016-12-21T14:34:04+00:00https://drug.russellpublishing.co.uk/news/14554/charles-river-laboratories-acquires-agilux-laboratories-inc/2017-01-19T11:05:06+00:00https://drug.russellpublishing.co.uk/news/14562/envigo-ocsial-intertek-nanotubes/2016-12-21T14:20:26+00:00https://drug.russellpublishing.co.uk/news/14567/neuropilin-2-deficiency-edema/2016-12-21T14:20:02+00:00https://drug.russellpublishing.co.uk/news/14572/smart-fatty-liver-blood/2016-12-21T14:19:36+00:00https://drug.russellpublishing.co.uk/news/14583/ablynx-merck-nanobodies-research/2018-06-29T13:54:20+01:00https://drug.russellpublishing.co.uk/news/14588/schistosomiasis-forces-fight/2016-12-21T14:18:57+00:00https://drug.russellpublishing.co.uk/news/14594/irritable-bowel-syndrome-burden/2016-12-21T14:18:22+00:00https://drug.russellpublishing.co.uk/news/14598/leukaemia-crispr-genome-editing/2016-12-21T14:16:06+00:00https://drug.russellpublishing.co.uk/news/14606/anti-inflammatory-depression/2016-12-21T14:16:44+00:00https://drug.russellpublishing.co.uk/news/14611/hookipa-cancer-grant-ffg/2016-12-21T14:17:39+00:00https://drug.russellpublishing.co.uk/news/14614/denosumab-uclh-grant/2016-12-21T14:15:27+00:00https://drug.russellpublishing.co.uk/news/14623/tweaking-immune-response/2016-12-21T14:15:08+00:00https://drug.russellpublishing.co.uk/news/14663/als-mutation-protein-target/2016-12-19T17:36:32+00:00https://drug.russellpublishing.co.uk/news/14667/elsevier-start-up-biotech-hive/2016-12-19T17:36:11+00:00https://drug.russellpublishing.co.uk/news/14671/show-money-get-funding-biomedical-research-within-academia-andor-industry/2016-12-19T17:34:01+00:00https://drug.russellpublishing.co.uk/news/14742/nhs-pharmacy-integration-fund/2016-12-19T17:35:55+00:00https://drug.russellpublishing.co.uk/news/14751/nhs-care-five-year/2016-12-19T17:35:29+00:00https://drug.russellpublishing.co.uk/news/14755/robots-interventional-needles/2016-12-19T17:35:12+00:00https://drug.russellpublishing.co.uk/news/14761/new-biologic-drug-benefits/2017-01-19T10:19:04+00:00https://drug.russellpublishing.co.uk/news/14765/dopamine-neurons-parkinsons/2016-12-19T17:34:19+00:00https://drug.russellpublishing.co.uk/news/14781/biocartis-ngs-prep-panels/2017-01-20T10:32:48+00:00https://drug.russellpublishing.co.uk/news/14832/e3-3-million-to-improve-medical-imaging-detail-tenfold/2016-12-19T17:33:01+00:00https://drug.russellpublishing.co.uk/news/14840/nitro-drugs-neglected-diseases/2016-12-19T17:15:27+00:00https://drug.russellpublishing.co.uk/news/14845/ebola-virus-target-human/2016-12-19T17:32:40+00:00https://drug.russellpublishing.co.uk/news/14863/jangobio-hormone-replacement-therapy/2016-12-19T17:12:03+00:00https://drug.russellpublishing.co.uk/news/14867/targovax-oystein-soug-ceo/2016-12-19T17:15:07+00:00https://drug.russellpublishing.co.uk/news/14881/artes-biosun-co-develop-hpv-vaccine/2016-12-19T17:14:44+00:00https://drug.russellpublishing.co.uk/news/14886/molecular-commando-hypoxic/2016-12-19T17:14:12+00:00https://drug.russellpublishing.co.uk/news/14892/fibre-optics-research/2016-12-19T17:13:53+00:00https://drug.russellpublishing.co.uk/news/14901/gut-microbes-immunotherapy-melanoma/2016-12-19T17:13:27+00:00https://drug.russellpublishing.co.uk/news/14905/anti-inflammatory-pre-term-birth/2016-12-19T17:13:06+00:00https://drug.russellpublishing.co.uk/news/14920/100-times-love-hormone/2016-12-19T17:12:29+00:00https://drug.russellpublishing.co.uk/news/14928/science-engineering-technology/2016-12-19T16:56:41+00:00https://drug.russellpublishing.co.uk/news/14941/antonijevic-chief-medical-officer/2016-12-19T16:56:19+00:00https://drug.russellpublishing.co.uk/news/14968/uk-artificial-clinical-stage/2017-01-19T10:29:14+00:00https://drug.russellpublishing.co.uk/news/14972/hiv-test-performed-usb-stick/2016-12-19T16:53:53+00:00https://drug.russellpublishing.co.uk/news/14986/protein-drug-resistant-bowel-cancer/2016-12-19T16:54:36+00:00https://drug.russellpublishing.co.uk/news/14993/marker-aggressive-prostate-cancer/2016-12-19T16:51:59+00:00https://drug.russellpublishing.co.uk/news/15026/heptares-jitsubo-peptide/2016-12-19T16:51:39+00:00https://drug.russellpublishing.co.uk/news/15048/3d-printed-customised-insoles-diabetes-patients/2016-12-19T16:50:40+00:00https://drug.russellpublishing.co.uk/news/15097/cell-medica-off-the-shelf/2016-12-19T16:46:29+00:00https://drug.russellpublishing.co.uk/news/15106/pharma-parallel-trade-beyond-brexit-eu-falsified-medicine-directive/2016-12-09T15:18:01+00:00https://drug.russellpublishing.co.uk/news/15108/personalised-breast-cancer/2016-12-19T16:46:01+00:00https://drug.russellpublishing.co.uk/news/15117/psoriatic-arthritis-research/2016-12-19T16:45:44+00:00https://drug.russellpublishing.co.uk/news/15127/promising-antibiotic-programme/2017-01-19T11:25:06+00:00https://drug.russellpublishing.co.uk/news/15137/genetic-differences-amino-acid/2016-12-10T18:07:32+00:00https://drug.russellpublishing.co.uk/news/15140/parasitic-worm-resistance/2016-12-19T16:44:46+00:00https://drug.russellpublishing.co.uk/news/15151/system-detect-spinal-deformity/2016-12-19T16:44:03+00:00https://drug.russellpublishing.co.uk/news/15183/oncology-epigenetic-target/2018-06-21T16:41:09+01:00https://drug.russellpublishing.co.uk/news/15190/genetic-irritable-bowel-syndrome/2016-12-10T18:35:10+00:00https://drug.russellpublishing.co.uk/news/15291/aicuris-gains-us-nih-support-preclinical/2016-12-10T18:24:19+00:00https://drug.russellpublishing.co.uk/news/15296/vaccine-fatal-prescription-opioid/2016-12-19T16:35:04+00:00https://drug.russellpublishing.co.uk/news/15301/kymab-secures-100-million/2016-12-10T17:59:13+00:00https://drug.russellpublishing.co.uk/news/15307/mouth-cancer-rates-soar-20-years/2016-12-10T17:57:37+00:00https://drug.russellpublishing.co.uk/news/15327/hot-topic-pharmaceutical-water-systems-discussed-pharmaceutical-microbiology-2017/2016-12-19T16:37:48+00:00https://drug.russellpublishing.co.uk/news/15335/german-research-training-group/2016-12-10T18:16:14+00:00https://drug.russellpublishing.co.uk/news/15366/orchard-alliance-oxford-biomedica/2016-12-10T17:54:50+00:00https://drug.russellpublishing.co.uk/news/15371/enhanced-crispr-cell-type/2016-12-10T17:47:11+00:00https://drug.russellpublishing.co.uk/news/15394/charles-river-laboratories-demonstrates-expertise-crisprcas9-genome-engineering-technology/2016-12-10T17:52:26+00:00https://drug.russellpublishing.co.uk/news/15420/pancreatic-islet-transplantation/2016-12-11T16:27:52+00:00https://drug.russellpublishing.co.uk/news/17941/organoids-qgel-million/2017-09-26T09:32:30+01:00https://drug.russellpublishing.co.uk/news/18681/jai-patel-enterome/2017-09-26T09:32:29+01:00https://drug.russellpublishing.co.uk/news/18685/mission-therapeutics-appoints-colin-goddard-chairman/2017-09-26T09:32:27+01:00https://drug.russellpublishing.co.uk/news/18690/can-genetic-testing/2017-09-26T09:32:28+01:00https://drug.russellpublishing.co.uk/news/18701/diabetic-purslane-mimics-insulin/2018-01-08T14:27:16+00:00https://drug.russellpublishing.co.uk/news/19025/nanohyperthermia-tumour/2017-09-26T09:32:26+01:00https://drug.russellpublishing.co.uk/news/19034/macular-degeneration/2017-09-26T09:32:25+01:00https://drug.russellpublishing.co.uk/news/19041/scientists-zika-deadly/2017-09-26T09:32:25+01:00https://drug.russellpublishing.co.uk/news/19140/tsris-rat-memories/2017-09-26T09:31:25+01:00https://drug.russellpublishing.co.uk/news/19243/molecule-activates-cannabinoid/2017-09-26T09:31:24+01:00https://drug.russellpublishing.co.uk/news/19298/antibiotic-spider-silk/2017-09-26T09:31:24+01:00https://drug.russellpublishing.co.uk/news/20269/immunotherapy-and-gene-therapy/2017-09-26T09:31:23+01:00https://drug.russellpublishing.co.uk/news/20523/global-partnership-ms/2017-09-26T09:31:23+01:00https://drug.russellpublishing.co.uk/news/20753/kymab-gates-foundation/2017-09-26T09:31:22+01:00https://drug.russellpublishing.co.uk/news/20800/women-in-science-award/2017-09-26T09:31:21+01:00https://drug.russellpublishing.co.uk/news/20836/macrophage-oncology-technology/2017-09-26T09:31:21+01:00https://drug.russellpublishing.co.uk/news/20988/chronos-and-aptuit-addictive/2017-09-26T09:31:20+01:00https://drug.russellpublishing.co.uk/news/21036/benevolentai-becomes-first-ai/2017-09-26T09:31:20+01:00https://drug.russellpublishing.co.uk/news/21063/latest-revision-fda-combination-product-guidance-presented-pre-filled-syringes-boston-summit/2017-01-11T16:18:57+00:00https://drug.russellpublishing.co.uk/news/21118/target-anti-alzheimer/2017-09-26T09:31:19+01:00https://drug.russellpublishing.co.uk/news/21142/takeda-acquire-ariad-pharmaceuticals/2019-10-23T10:52:25+01:00https://drug.russellpublishing.co.uk/news/21214/idbs-workbook-cloud/2017-09-26T09:31:18+01:00https://drug.russellpublishing.co.uk/news/21236/amgen-immatics-t-cell-engaging/2017-09-26T09:31:17+01:00https://drug.russellpublishing.co.uk/news/21331/screening-properties-pill/2017-09-26T09:31:17+01:00https://drug.russellpublishing.co.uk/news/21345/harvard-researchers-chip/2017-09-26T09:31:16+01:00https://drug.russellpublishing.co.uk/news/21370/benzodiazepines-alzheimers/2017-09-26T09:31:16+01:00https://drug.russellpublishing.co.uk/news/21381/astrazeneca-provide-insight-biomarkers-personalised-treatment-asthma-copd-2017/2017-01-16T11:27:15+00:00https://drug.russellpublishing.co.uk/news/21383/jpnd-launches-e23-million-call-neurodegenerative-disease-research/2017-09-26T09:31:15+01:00https://drug.russellpublishing.co.uk/news/21397/big-pharma-standards-group/2017-09-26T09:31:14+01:00https://drug.russellpublishing.co.uk/news/21537/stemtek-tebu-bio-tissue-culture/2017-09-26T09:31:14+01:00https://drug.russellpublishing.co.uk/news/21557/exco-intouch-eu-us/2017-09-26T09:31:13+01:00https://drug.russellpublishing.co.uk/news/21563/new-depressive-behaviour/2017-09-26T09:31:13+01:00https://drug.russellpublishing.co.uk/news/21589/tsri-scientists-use-ligands/2017-09-26T09:31:12+01:00https://drug.russellpublishing.co.uk/news/21595/scientists-ethical-organoids/2017-09-26T09:31:12+01:00https://drug.russellpublishing.co.uk/news/21617/amr-exclusive-new-innovations-microbome-targeted-products/2017-01-24T12:48:19+00:00https://drug.russellpublishing.co.uk/news/21647/smi-release-exclusive-interview-ahead-paediatric-clinical-trials-2017/2017-01-30T15:59:30+00:00https://drug.russellpublishing.co.uk/news/21655/charles-river-laboratories-announces-progress-update-collaboration-moderna-therapeutics/2017-01-30T16:13:47+00:00https://drug.russellpublishing.co.uk/news/21676/lorenz-mayr-joins-drug-discovery-2017-speaker-lineup/2017-08-24T12:00:24+01:00https://drug.russellpublishing.co.uk/news/21690/oncolytic-virotherapy-europe-congress-2017/2017-02-02T08:56:43+00:00https://drug.russellpublishing.co.uk/news/21699/colorectal-metastases-biomarker/2017-09-26T09:31:11+01:00https://drug.russellpublishing.co.uk/news/21703/love-hormone-labour/2017-09-26T09:31:10+01:00https://drug.russellpublishing.co.uk/news/21718/breath-oesophageal-cancer/2017-09-26T09:31:10+01:00https://drug.russellpublishing.co.uk/news/21721/stop-epigenetics-pain/2017-09-26T09:31:09+01:00https://drug.russellpublishing.co.uk/news/21726/quotient-clinical-expands-usa-acquisition-seaview-research-specialist-clinical-pharmacology-business/2017-02-07T10:01:19+00:00https://drug.russellpublishing.co.uk/news/21766/molecular-devices-introduces-spectramax-id3-multi-mode-microplate-reader/2017-02-08T15:16:23+00:00https://drug.russellpublishing.co.uk/news/21767/klimovsky-chief-development-officer/2018-06-29T13:53:28+01:00https://drug.russellpublishing.co.uk/news/21792/zika-vaccine-research-group/2017-09-26T09:31:08+01:00https://drug.russellpublishing.co.uk/news/21808/wellcome-antibiotic/2017-09-26T09:31:08+01:00https://drug.russellpublishing.co.uk/news/21814/cancer-research-grand-challenge/2017-09-26T09:31:06+01:00https://drug.russellpublishing.co.uk/news/21842/orexin-septic-shock/2017-09-26T09:31:07+01:00https://drug.russellpublishing.co.uk/news/21855/vk2809-viking-rare-diseases/2017-09-26T09:31:06+01:00https://drug.russellpublishing.co.uk/news/21875/congenital-muscular-dystrophy/2017-09-26T09:31:05+01:00https://drug.russellpublishing.co.uk/news/21884/orion-research-foundation/2017-09-26T09:31:05+01:00https://drug.russellpublishing.co.uk/news/21885/quotient-clinical-announces-second-us-acquisition-qs-pharma/2017-02-14T10:33:38+00:00https://drug.russellpublishing.co.uk/news/21891/mitochondrial-lipids-cardiolipin/2017-09-26T09:31:04+01:00https://drug.russellpublishing.co.uk/news/21896/alzheimers-oligomerisation/2017-09-26T09:31:04+01:00https://drug.russellpublishing.co.uk/news/21907/liverpool-head-neck/2017-09-26T09:31:03+01:00https://drug.russellpublishing.co.uk/news/21955/janssen-gsk-provide-keynote-addresses-controlled-release-delivery-2017/2017-02-20T15:21:47+00:00https://drug.russellpublishing.co.uk/news/21975/significant-epilepsy-gene-myoclonic/2017-09-26T09:31:02+01:00https://drug.russellpublishing.co.uk/news/21990/adverse-drug-reactions/2017-09-26T09:31:02+01:00https://drug.russellpublishing.co.uk/news/21995/pfizer-director-biostatistics-explores-adaptive-dose-finding-designs-oncology-early-phase-trials/2017-02-22T14:19:42+00:00https://drug.russellpublishing.co.uk/news/21998/brain-machine-interfaces/2017-09-26T09:31:01+01:00https://drug.russellpublishing.co.uk/news/22016/new-discovery-huntingtons-disease/2017-12-12T10:46:42+00:00https://drug.russellpublishing.co.uk/news/22042/system-failures-sample-management/2017-02-24T10:42:56+00:00https://drug.russellpublishing.co.uk/news/22046/stem-cell-marking-study/2017-09-26T09:31:00+01:00https://drug.russellpublishing.co.uk/news/22053/deep-learning-predicts-hematopoietic-stem-cell-development/2019-10-23T10:54:27+01:00https://drug.russellpublishing.co.uk/news/22059/obesity-reprogram-muscle-stem-cells/2017-09-26T09:30:59+01:00https://drug.russellpublishing.co.uk/news/22067/blood-stem-cells-can-rejuvenated/2017-09-26T09:30:58+01:00https://drug.russellpublishing.co.uk/news/22081/professor-alzheimers-pathology/2017-09-26T09:30:58+01:00https://drug.russellpublishing.co.uk/news/22091/changes-rna-schizophrenia/2017-09-26T09:30:57+01:00https://drug.russellpublishing.co.uk/news/22109/new-drug-lead-identified-tuberculosis/2017-09-26T09:30:57+01:00https://drug.russellpublishing.co.uk/news/22115/nanoinjection-increases/2017-10-27T15:18:24+01:00https://drug.russellpublishing.co.uk/news/22164/scandinavian-programme-human-proteins/2017-03-08T16:24:44+00:00https://drug.russellpublishing.co.uk/news/22191/vitamin-c-effective-targeting-cancer-stem-cells/2017-03-09T12:40:28+00:00https://drug.russellpublishing.co.uk/news/22195/stem-cell-reprogramming-factor-shown-control-key-metabolic-change/2017-03-09T12:50:26+00:00https://drug.russellpublishing.co.uk/news/22197/marijuana-component-may-help-treat-anxiety-substance-abuse-disorders/2017-03-09T13:01:22+00:00https://drug.russellpublishing.co.uk/news/22200/muscle-cryomicroscopy-images-provide-model-nanomachines/2017-10-27T15:16:15+01:00https://drug.russellpublishing.co.uk/news/22236/gaba-shown-trigger-stem-cell-production-retina/2017-03-10T15:39:31+00:00https://drug.russellpublishing.co.uk/news/22260/pfizer-expands-clinical-research/2017-09-26T09:30:56+01:00https://drug.russellpublishing.co.uk/news/22263/sanofi-lonza-partner-biologics/2017-03-15T11:55:24+00:00https://drug.russellpublishing.co.uk/news/22268/pain-management-interviews-centrexion-therapeutics-zoetis-released-ahead-pain-therapeutics-2017/2017-03-14T12:14:42+00:00https://drug.russellpublishing.co.uk/news/22333/3d-visualisation-pancreas/2019-11-06T09:34:06+00:00https://drug.russellpublishing.co.uk/news/22360/new-role-old-immune-cell-may-lead-novel-therapies-infection-cancer/2017-05-16T10:32:07+01:00https://drug.russellpublishing.co.uk/news/22365/charles-river-laboratories-chiesi-farmaceutici-spa-announce-extension-integrated-respiratory-drug-discovery-program/2017-05-23T15:49:00+01:00https://drug.russellpublishing.co.uk/news/22381/bowel-cancer-parkinsons-disease/2017-03-19T19:26:18+00:00https://drug.russellpublishing.co.uk/news/22385/new-uk-research-centre-antimicrobial-drug-development/2017-03-17T08:55:07+00:00https://drug.russellpublishing.co.uk/news/22388/non-animal-technologies/2017-03-17T11:32:12+00:00https://drug.russellpublishing.co.uk/news/22412/robotic-tools-surgery/2017-03-20T11:49:55+00:00https://drug.russellpublishing.co.uk/news/22423/novel-genes-identified-pten/2017-03-20T14:04:28+00:00https://drug.russellpublishing.co.uk/news/22460/pistoia-alliance-laboratory-safety/2017-03-21T16:50:04+00:00https://drug.russellpublishing.co.uk/news/22465/hearing-loss-tinnitus/2017-03-22T13:49:42+00:00https://drug.russellpublishing.co.uk/news/22471/artificial-intelligence-gp/2017-03-22T14:35:27+00:00https://drug.russellpublishing.co.uk/news/22478/pancreatic-cancer/2017-03-24T09:07:44+00:00https://drug.russellpublishing.co.uk/news/22483/biologic-treatments-inflammatory/2017-03-23T10:28:41+00:00https://drug.russellpublishing.co.uk/news/22489/3d-bioprinted-cartilage-cells/2021-03-11T15:32:48+00:00https://drug.russellpublishing.co.uk/news/22499/prostate-cancer-screening/2017-03-23T11:23:40+00:00https://drug.russellpublishing.co.uk/news/22517/aprea-therapeutics-tumour-suppressor/2017-03-24T11:34:17+00:00https://drug.russellpublishing.co.uk/news/22521/stem-cell-copd/2017-03-24T12:05:01+00:00https://drug.russellpublishing.co.uk/news/22537/colorectal-cancer-cells/2017-03-24T14:39:53+00:00https://drug.russellpublishing.co.uk/news/22566/research-genome-reorganisation/2017-03-30T12:28:10+01:00https://drug.russellpublishing.co.uk/news/22583/new-study-reports-cannabinoid/2017-09-26T10:07:25+01:00https://drug.russellpublishing.co.uk/news/22592/nexeon-acquires-license-iot/2017-03-30T16:17:56+01:00https://drug.russellpublishing.co.uk/news/22599/world-leading-imaging-centre-excellence-opened-glasgow/2017-03-30T16:57:06+01:00https://drug.russellpublishing.co.uk/news/22605/plasticell-signs-stem-cell/2017-03-31T16:00:16+01:00https://drug.russellpublishing.co.uk/news/22614/daiichi-sankyo-neglected-diseases/2017-04-03T09:33:15+01:00https://drug.russellpublishing.co.uk/news/22617/biomaterials-apple-waste/2017-04-03T10:49:20+01:00https://drug.russellpublishing.co.uk/news/22625/intellicyt-launches-novel-assay-system-accelerate-cell-line-development/2019-01-17T10:26:25+00:00https://drug.russellpublishing.co.uk/news/22634/essen-bioscience-launches-incucyte-s3-live-cell-analysis-platform/2018-09-10T11:47:17+01:00https://drug.russellpublishing.co.uk/news/22657/elimination-specific-neurons/2017-04-03T16:14:55+01:00https://drug.russellpublishing.co.uk/news/22679/charles-river-laboratories-announces-launch-triple-immunodeficient-mouse-model-oncology-research/2017-05-30T15:20:05+01:00https://drug.russellpublishing.co.uk/news/22682/genomic-data-portal/2017-04-04T10:41:40+01:00https://drug.russellpublishing.co.uk/news/22685/new-gene-discovered-drives-cancer-drug-resistance/2017-04-04T11:03:58+01:00https://drug.russellpublishing.co.uk/news/22731/mini-brains-nervous-system/2017-05-23T15:47:47+01:00https://drug.russellpublishing.co.uk/news/22736/nimbus-therapeutics-enters-strategic-partnership-charles-river-laboratories-advance-new-therapeutic-programs/2017-05-23T15:47:02+01:00https://drug.russellpublishing.co.uk/news/22740/finger-prosthesis-provides-clues-brain-health/2017-04-05T16:50:08+01:00https://drug.russellpublishing.co.uk/news/22744/stem-heart-failure/2017-04-06T09:39:18+01:00https://drug.russellpublishing.co.uk/news/22747/new-meningitis-bacteria-research/2017-04-06T10:58:26+01:00https://drug.russellpublishing.co.uk/news/22764/biomarkers-established/2017-04-07T12:06:19+01:00https://drug.russellpublishing.co.uk/news/22769/mini-brain-petri-dish/2017-04-07T12:29:23+01:00https://drug.russellpublishing.co.uk/news/22778/hebrew-university-launches-cannabinoid-research-centre/2017-04-07T15:47:18+01:00https://drug.russellpublishing.co.uk/news/22783/medicortex-brain-injury-diagnostics/2017-04-10T16:28:43+01:00https://drug.russellpublishing.co.uk/news/22788/uncover-bacteria-burst-cells/2017-04-10T16:36:03+01:00https://drug.russellpublishing.co.uk/news/22811/benevolentai-drug-discovery/2017-04-12T10:21:06+01:00https://drug.russellpublishing.co.uk/news/22814/premature-cell-genome-editing/2017-04-12T13:22:43+01:00https://drug.russellpublishing.co.uk/news/22819/brain-cancer-children/2017-04-12T13:53:59+01:00https://drug.russellpublishing.co.uk/news/22824/polyphor-pseudomonas-aeruginosa/2017-04-12T14:19:54+01:00https://drug.russellpublishing.co.uk/news/22827/antiparasitic-brain-tumours/2017-04-12T14:33:25+01:00https://drug.russellpublishing.co.uk/news/22832/eu-infectious-diseases/2017-04-12T15:10:05+01:00https://drug.russellpublishing.co.uk/news/22852/plasticell-produce-red-blood-cell/2017-04-18T09:53:26+01:00https://drug.russellpublishing.co.uk/news/22861/specialised-blood-vessels-tumour/2017-04-19T14:07:02+01:00https://drug.russellpublishing.co.uk/news/22864/2-5-million-cancer-research-uk/2017-04-19T15:44:15+01:00https://drug.russellpublishing.co.uk/news/22867/zika-antibody-discovery/2017-04-19T16:41:20+01:00https://drug.russellpublishing.co.uk/news/22875/plasticell-pluripotent-stem-cells/2017-04-20T09:51:56+01:00https://drug.russellpublishing.co.uk/news/22878/mechanism-allowing-bacteria/2017-04-20T11:07:53+01:00https://drug.russellpublishing.co.uk/news/22899/mobile-health-million-funding/2017-04-20T16:24:47+01:00https://drug.russellpublishing.co.uk/news/22912/novel-molecular-pathway/2017-04-24T11:59:31+01:00https://drug.russellpublishing.co.uk/news/22915/obesity-behind-surge-kidney-cancers/2017-04-24T10:42:17+01:00https://drug.russellpublishing.co.uk/news/22919/microdermics-microneedle/2017-04-24T11:54:30+01:00https://drug.russellpublishing.co.uk/news/22925/pfizer-antibiotic-resistance/2017-04-24T12:19:43+01:00https://drug.russellpublishing.co.uk/news/22944/novel-method-detect-toxic-p19-cells/2017-04-25T14:34:34+01:00https://drug.russellpublishing.co.uk/news/22950/uk-institutes-sign-global-educational-partnership-medecins-sans-frontieres/2017-04-26T11:15:44+01:00https://drug.russellpublishing.co.uk/news/22953/rare-paediatric-disorder-treatment/2017-04-26T11:52:31+01:00https://drug.russellpublishing.co.uk/news/22958/screening-colorectal-cancer/2017-04-26T12:22:16+01:00https://drug.russellpublishing.co.uk/news/22962/tracking-unstable-chromosomes/2017-04-26T14:37:14+01:00https://drug.russellpublishing.co.uk/news/22966/removing-old-cells-osteoarthritis/2017-04-26T15:14:04+01:00https://drug.russellpublishing.co.uk/news/22970/immune-system-brain/2017-04-26T15:47:07+01:00https://drug.russellpublishing.co.uk/news/22977/antibacterial-wound-crustaceans/2017-05-02T10:18:02+01:00https://drug.russellpublishing.co.uk/news/22986/nose2brain-multiple-sclerosis-therapy/2017-05-02T12:04:44+01:00https://drug.russellpublishing.co.uk/news/22987/functional-brain-epileptic-seizures/2017-05-02T11:12:47+01:00https://drug.russellpublishing.co.uk/news/22994/3d-bioprinter-form-cartilage/2017-11-07T12:24:17+00:00https://drug.russellpublishing.co.uk/news/23007/nus-scientists-develop-novel-chemical-dye-improve-liver-cancer-imaging/2017-09-26T10:07:25+01:00https://drug.russellpublishing.co.uk/news/23034/dna-epigenetic-inheritance/2017-05-03T10:02:57+01:00https://drug.russellpublishing.co.uk/news/23037/microrna-carotid/2017-05-03T10:26:22+01:00https://drug.russellpublishing.co.uk/news/23041/pathways-leading-beta-cell/2017-05-03T10:51:17+01:00https://drug.russellpublishing.co.uk/news/23046/petct-paediatric-tumours/2017-05-03T12:05:46+01:00https://drug.russellpublishing.co.uk/news/23049/cancer-causing-virus/2017-05-03T12:26:08+01:00https://drug.russellpublishing.co.uk/news/23051/new-angle-attack-sma/2017-05-03T12:45:07+01:00https://drug.russellpublishing.co.uk/news/23062/ai-based-smartphone/2017-05-03T15:04:16+01:00https://drug.russellpublishing.co.uk/news/23066/post-nuclear-exposure/2017-05-03T16:37:37+01:00https://drug.russellpublishing.co.uk/news/23070/researchers-create-roadmap-bipolar-disorder-affects-brain/2017-05-04T10:10:10+01:00https://drug.russellpublishing.co.uk/news/23087/focus-international-regulations-ivd/2017-05-05T09:44:08+01:00https://drug.russellpublishing.co.uk/news/23090/shedding-light-brakes-akt-activity/2017-05-05T10:35:38+01:00https://drug.russellpublishing.co.uk/news/23093/zika-virus-target/2017-05-05T12:30:00+01:00https://drug.russellpublishing.co.uk/news/23104/new-chlamydia-drug-targets/2017-05-08T10:10:57+01:00https://drug.russellpublishing.co.uk/news/23116/new-cell-separator/2017-05-08T14:22:03+01:00https://drug.russellpublishing.co.uk/news/23121/suppressor-liver-cancer/2017-05-08T15:42:52+01:00https://drug.russellpublishing.co.uk/news/23124/metabolic-typhoid-fever/2017-05-09T09:38:10+01:00https://drug.russellpublishing.co.uk/news/23127/new-bioinformatics-evolution/2017-05-09T10:00:31+01:00https://drug.russellpublishing.co.uk/news/23130/stress-biopolar/2017-05-09T10:19:37+01:00https://drug.russellpublishing.co.uk/news/23135/research-virtual-reality/2017-05-09T10:55:20+01:00https://drug.russellpublishing.co.uk/news/23138/lung-study-mice/2017-05-09T11:13:23+01:00https://drug.russellpublishing.co.uk/news/23142/immune-cells-found-derived-specialised-progenitors/2017-05-09T11:57:26+01:00https://drug.russellpublishing.co.uk/news/23153/bodies-defence-bacteria-discovered/2017-05-09T12:51:09+01:00https://drug.russellpublishing.co.uk/news/23165/oxford-genetics-licenses-crispr-technology-biotherapeutic-discovery/2017-05-10T15:30:16+01:00https://drug.russellpublishing.co.uk/news/23179/orion-project-open-science/2017-05-10T10:53:04+01:00https://drug.russellpublishing.co.uk/news/23196/exscientia-announces-eur250-million-collaboration-multiple-product-development-licence-option-agreement-sanofi/2018-01-08T11:15:39+00:00https://drug.russellpublishing.co.uk/news/23253/biopharmaspec-protein-structure/2017-05-11T16:11:26+01:00https://drug.russellpublishing.co.uk/news/23260/dr-quaratino-chief-medical/2017-05-12T12:32:06+01:00https://drug.russellpublishing.co.uk/news/23267/dartmouth-tuberculosis-vaccine/2017-05-12T11:34:58+01:00https://drug.russellpublishing.co.uk/news/23271/plasma-membrane-signaling/2017-05-12T11:50:55+01:00https://drug.russellpublishing.co.uk/news/23272/dna-mutations-feline-treatment/2017-05-12T12:15:27+01:00https://drug.russellpublishing.co.uk/news/23287/health-data-ecosystems/2017-05-15T11:20:26+01:00https://drug.russellpublishing.co.uk/news/23295/immune-system-attack-cancer/2017-05-15T12:58:37+01:00https://drug.russellpublishing.co.uk/news/23298/new-lung-organoids/2017-05-15T13:12:08+01:00https://drug.russellpublishing.co.uk/news/23304/researchers-find-anaemia/2017-05-15T13:24:22+01:00https://drug.russellpublishing.co.uk/news/23307/tumour-suppressor-cancer/2017-05-15T13:41:59+01:00https://drug.russellpublishing.co.uk/news/23311/colon-chicago/2017-05-15T15:08:44+01:00https://drug.russellpublishing.co.uk/news/23314/anticancer-leidenfrost-effect/2017-05-15T15:20:05+01:00https://drug.russellpublishing.co.uk/news/23320/stem-cell-development/2017-05-16T10:38:14+01:00https://drug.russellpublishing.co.uk/news/23326/ebola-survivors-unique-retinal-scar/2017-05-16T10:47:12+01:00https://drug.russellpublishing.co.uk/news/23329/collaborations-early-drug-discovery/2017-05-23T15:46:12+01:00https://drug.russellpublishing.co.uk/news/23333/new-approach-epilepsy-therapies/2017-05-16T12:05:53+01:00https://drug.russellpublishing.co.uk/news/23335/assay-clotting-ability-accurately-predicts-need-transfusion-trauma-patients/2017-05-16T11:30:57+01:00https://drug.russellpublishing.co.uk/news/23344/squamous-cell-carcinomas/2017-05-16T14:11:44+01:00https://drug.russellpublishing.co.uk/news/23350/plans-lyme-disease/2017-05-16T15:46:16+01:00https://drug.russellpublishing.co.uk/news/23351/charles-river-laboratories-announces-updates-oncology-business/2017-05-23T15:45:24+01:00https://drug.russellpublishing.co.uk/news/23363/new-gene-variant-als/2017-05-17T12:02:33+01:00https://drug.russellpublishing.co.uk/news/23368/zika-virus-brain-tumour/2017-05-18T10:33:47+01:00https://drug.russellpublishing.co.uk/news/23373/opitz-syndrome/2017-05-18T10:58:29+01:00https://drug.russellpublishing.co.uk/news/23374/preclinical-candidate-cgrp-antagonist-selected-advancement-potential-migraine-treatment/2017-05-18T11:08:38+01:00https://drug.russellpublishing.co.uk/news/23383/spread-tau-protein/2017-05-18T14:45:50+01:00https://drug.russellpublishing.co.uk/news/23390/dfg-research-training-group/2017-05-22T11:07:49+01:00https://drug.russellpublishing.co.uk/news/23398/researchers-growth-blood-vessels/2017-05-22T12:24:10+01:00https://drug.russellpublishing.co.uk/news/23404/antibodies-messengers-nervous-system/2017-05-22T15:16:04+01:00https://drug.russellpublishing.co.uk/news/23409/fungal-microbiome-mice/2017-05-23T10:10:08+01:00https://drug.russellpublishing.co.uk/news/23424/protective-responses-appear-weaker-neural-stem-cells-huntington-disease-patients/2017-05-23T12:16:23+01:00https://drug.russellpublishing.co.uk/news/23426/cancer-drug-common-allergies/2017-05-23T13:42:33+01:00https://drug.russellpublishing.co.uk/news/23450/blood-test-offers-improved-breast-cancer-detection-tool-reduce-use-breast-biopsy/2017-05-24T13:47:28+01:00https://drug.russellpublishing.co.uk/news/23452/largest-psoriasis-meta-analysis/2017-05-24T13:55:04+01:00https://drug.russellpublishing.co.uk/news/23455/alzheimers-parkinsons-huntingtons-share/2017-05-24T14:04:41+01:00https://drug.russellpublishing.co.uk/news/23459/blood-marker-diabetes-patients/2017-05-25T11:10:33+01:00https://drug.russellpublishing.co.uk/news/23462/flexible-cancer-diagnosis/2017-05-25T11:29:01+01:00https://drug.russellpublishing.co.uk/news/23465/making-biological-drugs-spider-silk-protein/2017-05-25T14:08:38+01:00https://drug.russellpublishing.co.uk/news/23468/acute-myeloid-leukaemia/2017-05-25T14:20:39+01:00https://drug.russellpublishing.co.uk/news/23471/antibody-effective-radiation/2017-05-25T16:36:54+01:00https://drug.russellpublishing.co.uk/news/23485/water-chiral-superstructure/2017-05-26T13:49:31+01:00https://drug.russellpublishing.co.uk/news/23491/faulty-immune-cells-baldness/2017-05-26T14:30:31+01:00https://drug.russellpublishing.co.uk/news/23495/scientists-jump-hurdle-hiv/2017-05-26T15:36:43+01:00https://drug.russellpublishing.co.uk/news/23506/chronic-heart-failure/2017-05-30T08:54:58+01:00https://drug.russellpublishing.co.uk/news/23510/crispr-gene-editing-mutations/2017-05-30T09:06:07+01:00https://drug.russellpublishing.co.uk/news/23514/new-antibiotic-vancomycin/2017-05-30T09:19:29+01:00https://drug.russellpublishing.co.uk/news/23518/healing-wounds-therapy/2017-11-03T10:36:30+00:00https://drug.russellpublishing.co.uk/news/23522/new-mouse-model/2017-05-30T09:55:23+01:00https://drug.russellpublishing.co.uk/news/23527/optibrium-drug-development/2017-05-30T10:24:17+01:00https://drug.russellpublishing.co.uk/news/23568/immune-cardiomyoctyes/2017-06-01T10:50:14+01:00https://drug.russellpublishing.co.uk/news/23573/queens-bowel-cancer/2017-06-01T11:37:22+01:00https://drug.russellpublishing.co.uk/news/23576/sophia-ai-unlocks-power-exome/2017-06-01T11:50:26+01:00https://drug.russellpublishing.co.uk/news/23580/human-cell-atlas/2017-06-01T12:28:38+01:00https://drug.russellpublishing.co.uk/news/23585/scientists-give-tumour-fighting-cells/2017-06-01T13:54:52+01:00https://drug.russellpublishing.co.uk/news/23589/gut-microbiota-medication/2017-06-01T14:33:06+01:00https://drug.russellpublishing.co.uk/news/23689/attacking-resistance/2017-06-06T12:57:44+01:00https://drug.russellpublishing.co.uk/news/23695/cells-change-type-help-hinder-immunity/2017-06-06T14:00:35+01:00https://drug.russellpublishing.co.uk/news/23701/diabetes-drug-cardiovascular-disease/2017-06-06T15:06:15+01:00https://drug.russellpublishing.co.uk/news/23706/dogs-help-breast-carcinoma-research/2017-06-06T16:41:39+01:00https://drug.russellpublishing.co.uk/news/23709/micro-developing-epilepsy/2017-06-06T16:49:23+01:00https://drug.russellpublishing.co.uk/news/23721/method-improve-vitro-tests/2017-06-06T17:00:41+01:00https://drug.russellpublishing.co.uk/news/23731/eisai-charles-river-laboratories-announce-extension-integrated-drug-discovery-partnership/2017-06-07T11:26:00+01:00https://drug.russellpublishing.co.uk/news/23749/researchers-sonic-hedgehog/2017-06-08T10:01:33+01:00https://drug.russellpublishing.co.uk/news/23754/immunoswitch-particles-may-key-effective-cancer-immunotherapy/2017-06-08T12:12:49+01:00https://drug.russellpublishing.co.uk/news/23755/sophia-liquid-biopsies-fight-cancer/2017-06-08T12:15:42+01:00https://drug.russellpublishing.co.uk/news/23763/mechanism-type-2-diabetes/2017-06-08T12:26:46+01:00https://drug.russellpublishing.co.uk/news/23767/snake-antiplatelet-drug/2017-06-08T14:08:08+01:00https://drug.russellpublishing.co.uk/news/23771/new-leukemia-treatment/2017-06-08T16:46:09+01:00https://drug.russellpublishing.co.uk/news/23779/arming-t-cells-fight-cancer/2017-06-09T09:59:36+01:00https://drug.russellpublishing.co.uk/news/23787/screening-genetic-diseases/2017-06-12T10:33:54+01:00https://drug.russellpublishing.co.uk/news/23793/artificial-intelligence-heart/2017-06-12T10:50:51+01:00https://drug.russellpublishing.co.uk/news/23796/study-discovers-proteins-suppress-growth-breast-cancer-tumours/2017-06-12T11:23:09+01:00https://drug.russellpublishing.co.uk/news/23803/balance-movement-improved/2017-06-12T15:02:13+01:00https://drug.russellpublishing.co.uk/news/23806/new-leukaemia-patients/2017-06-12T15:39:01+01:00https://drug.russellpublishing.co.uk/news/23809/nanotechnology-prostate-cancer/2017-06-12T15:52:36+01:00https://drug.russellpublishing.co.uk/news/23813/new-cellular-imaging/2017-06-12T16:54:27+01:00https://drug.russellpublishing.co.uk/news/23818/major-new-appetite-regulator/2017-06-13T10:34:00+01:00https://drug.russellpublishing.co.uk/news/23823/western-diet-mice/2017-06-13T11:04:48+01:00https://drug.russellpublishing.co.uk/news/23826/drug-heart-valve-calcification/2017-06-13T11:42:14+01:00https://drug.russellpublishing.co.uk/news/23829/new-collaborating-centre-physical-activity-health/2017-06-13T12:32:57+01:00https://drug.russellpublishing.co.uk/news/23832/nanoparticle-destruction-cancer-cells/2017-06-13T12:50:31+01:00https://drug.russellpublishing.co.uk/news/23835/blood-cell-discovery/2017-06-13T13:04:27+01:00https://drug.russellpublishing.co.uk/news/23839/database-abpi-tool/2017-06-13T14:08:06+01:00https://drug.russellpublishing.co.uk/news/23845/abcellera-antibody-discovery-teva/2017-06-13T17:00:45+01:00https://drug.russellpublishing.co.uk/news/23860/new-microbial-genomes-discovered/2017-06-19T09:10:47+01:00https://drug.russellpublishing.co.uk/news/23866/mental-health-organisations/2017-06-15T10:53:18+01:00https://drug.russellpublishing.co.uk/news/23869/new-imaging-centre/2017-06-15T11:19:44+01:00https://drug.russellpublishing.co.uk/news/23872/numab-antibody-collaboration/2017-06-15T11:53:09+01:00https://drug.russellpublishing.co.uk/news/23876/groups-research-health/2017-06-22T11:07:26+01:00https://drug.russellpublishing.co.uk/news/23879/artificial-medical-record-tech/2017-06-15T12:27:55+01:00https://drug.russellpublishing.co.uk/news/23888/molecular-devices-launches-imagexpress-nano-system-cellreporterxpress-software/2017-06-16T08:44:24+01:00https://drug.russellpublishing.co.uk/news/23918/solution-ddi-analysis/2017-06-21T12:02:37+01:00https://drug.russellpublishing.co.uk/news/23924/single-gene-mutations-eczema/2017-06-21T14:13:11+01:00https://drug.russellpublishing.co.uk/news/23933/new-study-proves-e-aspects-predict-benefit-mechanical-thrombectomy/2017-06-22T09:45:36+01:00https://drug.russellpublishing.co.uk/news/23940/dynamic-dna-helps-ward-off-gene-damage/2017-06-22T11:08:18+01:00https://drug.russellpublishing.co.uk/news/23943/diabetes-monitoring-platform/2017-06-22T14:20:52+01:00https://drug.russellpublishing.co.uk/news/23948/reduces-eczema-inflammation/2017-06-22T16:31:30+01:00https://drug.russellpublishing.co.uk/news/23960/digital-software-gets-300000-boost/2017-06-23T14:56:02+01:00https://drug.russellpublishing.co.uk/news/23965/3d-printing-with-living/2017-06-26T16:50:30+01:00https://drug.russellpublishing.co.uk/news/23968/polycystic-ovary-syndrome/2017-06-26T17:01:13+01:00https://drug.russellpublishing.co.uk/news/23973/new-gene-mutations-found-white-blood-cells-rheumatoid-arthritis-patients/2017-06-27T10:49:31+01:00https://drug.russellpublishing.co.uk/news/23976/cancer-research-uk-sets-latest-20m-grand-challenges-beat-cancer-sooner/2017-06-27T12:04:37+01:00https://drug.russellpublishing.co.uk/news/23979/hpv-testing-cervical-pre-cancer/2017-06-27T15:05:14+01:00https://drug.russellpublishing.co.uk/news/23983/collaboration-identify-antibacterial/2017-06-27T16:12:29+01:00https://drug.russellpublishing.co.uk/news/23990/novel-metabolic-fatty-acids/2017-06-28T16:50:05+01:00https://drug.russellpublishing.co.uk/news/23994/uc-biologist-looks-butterflies/2017-06-28T17:11:02+01:00https://drug.russellpublishing.co.uk/news/23999/study-sheds-light-ovarian-cancer-spreads/2017-06-28T17:27:35+01:00https://drug.russellpublishing.co.uk/news/24002/first-haploid-human-stem-cells-change-face-medical-research/2017-06-29T11:47:36+01:00https://drug.russellpublishing.co.uk/news/24007/biogeneration-ventures-secures-fund/2017-06-29T12:08:57+01:00https://drug.russellpublishing.co.uk/news/24011/new-web-bowel-cancer/2017-06-29T12:29:48+01:00https://drug.russellpublishing.co.uk/news/24024/augmented-reality-system/2017-06-30T11:30:37+01:00https://drug.russellpublishing.co.uk/news/24031/unlocking-power-research-data/2017-06-30T11:48:57+01:00https://drug.russellpublishing.co.uk/news/24038/antibiotic-resistance-study/2017-06-30T12:22:31+01:00https://drug.russellpublishing.co.uk/news/24051/milking-new-robot-extract-scorpion-venom/2017-07-03T09:07:16+01:00https://drug.russellpublishing.co.uk/news/24054/study-oestrogen-receptor/2017-07-03T10:08:35+01:00https://drug.russellpublishing.co.uk/news/24057/improved-accuracy-testing-cancer-drugs/2017-07-03T10:40:16+01:00https://drug.russellpublishing.co.uk/news/24060/cellular-ageing-cancer-development/2017-07-03T11:07:00+01:00https://drug.russellpublishing.co.uk/news/24066/cannabis-drug-treats-glaucoma/2017-07-17T15:57:41+01:00https://drug.russellpublishing.co.uk/news/24069/ryboquin-gene-therapy/2017-07-03T11:52:53+01:00https://drug.russellpublishing.co.uk/news/24072/extra-funding-immunotherapy-research/2017-07-03T13:37:36+01:00https://drug.russellpublishing.co.uk/news/24076/lymph-node-metastases-may-not-always-source-cancers-spread/2017-07-03T14:57:40+01:00https://drug.russellpublishing.co.uk/news/24084/new-study-links-antibiotic-triclosan/2017-07-03T16:01:42+01:00https://drug.russellpublishing.co.uk/news/24087/lung-cancer-screening-could/2017-07-03T16:56:02+01:00https://drug.russellpublishing.co.uk/news/24099/research-highlights-differences-mice/2017-07-04T16:52:50+01:00https://drug.russellpublishing.co.uk/news/24114/genetic-dj-growing-cells-remix-genes/2017-07-06T12:26:59+01:00https://drug.russellpublishing.co.uk/news/24117/scientists-uncover-structure-tau-filaments-alzheimers-disease/2017-07-06T14:25:50+01:00https://drug.russellpublishing.co.uk/news/24132/sepsis-single-drop-blood/2017-07-07T10:32:08+01:00https://drug.russellpublishing.co.uk/news/24136/gout-inflammatory-diseases/2017-07-07T10:55:10+01:00https://drug.russellpublishing.co.uk/news/24140/collaboration-antibiotic-resistance/2017-07-07T15:23:49+01:00https://drug.russellpublishing.co.uk/news/24158/pancreatic-cancer-headed/2017-07-10T15:06:25+01:00https://drug.russellpublishing.co.uk/news/24166/new-biomarker-shows-promise-pitch-side-brain-injury-test/2017-07-10T12:04:57+01:00https://drug.russellpublishing.co.uk/news/24169/scientists-discover-membrane/2017-07-10T12:26:17+01:00https://drug.russellpublishing.co.uk/news/24173/cancer-research-warwick/2017-07-10T14:12:14+01:00https://drug.russellpublishing.co.uk/news/24180/simple-test-predicts-cancer/2017-07-10T15:08:46+01:00https://drug.russellpublishing.co.uk/news/24187/gut-bacteria-foods/2017-07-10T16:10:16+01:00https://drug.russellpublishing.co.uk/news/24192/hidden-herpes-virus-may-play-key-role-ms-brain-disorders/2017-07-11T10:34:47+01:00https://drug.russellpublishing.co.uk/news/24195/researchers-use-smartphone-data-global-study-physical-activity/2017-07-11T11:11:36+01:00https://drug.russellpublishing.co.uk/news/24220/genetic-variants-lung-cancer/2017-07-13T08:50:01+01:00https://drug.russellpublishing.co.uk/news/24224/miniature-human-heart-created-rat-hearts/2017-07-13T10:45:06+01:00https://drug.russellpublishing.co.uk/news/24228/targeting-broken-metabolism-immune-cells/2017-07-13T11:14:21+01:00https://drug.russellpublishing.co.uk/news/24231/heart-failure-gut-bacteria/2017-07-13T11:51:18+01:00https://drug.russellpublishing.co.uk/news/24236/dfg-approves-new-research-unit/2017-07-13T12:29:54+01:00https://drug.russellpublishing.co.uk/news/24239/elsevier-hive-pharma-biotech-start-ups/2017-07-13T13:48:32+01:00https://drug.russellpublishing.co.uk/news/24248/study-reveals-liver-injury/2017-07-13T16:47:28+01:00https://drug.russellpublishing.co.uk/news/24251/huntingtons-disease-research/2017-07-13T16:58:06+01:00https://drug.russellpublishing.co.uk/news/24265/grant-awarded-tackle-psychosis-india/2017-07-17T14:58:34+01:00https://drug.russellpublishing.co.uk/news/24272/researchers-bone-marrow-lesions/2017-07-18T11:14:00+01:00https://drug.russellpublishing.co.uk/news/24275/two-new-genes-linked-alzheimers-risk/2017-07-18T11:39:12+01:00https://drug.russellpublishing.co.uk/news/24276/new-device-detects-tumour-cells-blood/2017-07-18T11:44:51+01:00https://drug.russellpublishing.co.uk/news/24287/improved-cancer-immunotherapy/2017-09-26T09:52:42+01:00https://drug.russellpublishing.co.uk/news/24290/feinstein-institute-identifies-potential-cause-lupus/2017-07-18T14:55:50+01:00https://drug.russellpublishing.co.uk/news/24302/86-million-funding-uk-technology/2017-07-18T15:52:56+01:00https://drug.russellpublishing.co.uk/news/24306/new-bacterial-mechanism-crispr-cas/2017-07-19T09:48:21+01:00https://drug.russellpublishing.co.uk/news/24311/antibiotic-insight-may-help-battle-bacterial-resistance/2017-09-26T09:52:41+01:00https://drug.russellpublishing.co.uk/news/24319/new-way-found-boost-immunity-fight-cancer-infections/2017-09-26T09:52:40+01:00https://drug.russellpublishing.co.uk/news/24331/benevolentai-cheminformatics/2017-07-20T16:37:12+01:00https://drug.russellpublishing.co.uk/news/24338/takeda-rd-excelead/2017-07-25T16:28:32+01:00https://drug.russellpublishing.co.uk/news/24353/polyphor-achieves-antibiotics/2017-07-21T15:07:20+01:00https://drug.russellpublishing.co.uk/news/24360/orphan-drug-market-double/2017-07-21T11:29:14+01:00https://drug.russellpublishing.co.uk/news/24370/new-pathway-alzheimers-disease/2017-07-24T10:19:47+01:00https://drug.russellpublishing.co.uk/news/24383/new-bladder-cancer-treatment/2017-07-24T11:29:23+01:00https://drug.russellpublishing.co.uk/news/24394/new-therapeutic-approach-ovarian-cancer/2017-07-28T14:27:44+01:00https://drug.russellpublishing.co.uk/news/24409/paediatric-tumours-trial/2017-07-25T10:16:14+01:00https://drug.russellpublishing.co.uk/news/24421/crispr-cas9-prevents-angiogenesis/2017-07-25T11:55:05+01:00